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1. DIET AND CANCER  
1.1 Cancer facts and statistics  
Cancer is the second cause of death worldwide [1], rendering it to be one of the most devastating 
diseases one can encounter in human life. The disease lays a very heavy burden on the afflicted 
individual as well as his or her loved ones. Furthermore, besides the unmistakable social impact, 
cancer also comprises a very high economic impact, not only for the patient, but also for society 
as a whole. In fact, compared to any other worldwide occurring cause of death, cancer accounts 
for the highest drain on economy due to direct medical costs and loss of productivity because of 
(temporary or permanent) disability and premature death [2]. 
In 2012, an estimated number of 1.4 million new cancer cases and 8.2 million cancer deaths 
occurred globally. Moreover, the International Agency for Research on Cancer (IARC) predicts 
an ever-increasing global cancer burden over the next few decades, soon reaching a total number 
of more than 20 million new cancer cases per year [1]. Improved cancer diagnosis and treatment 
has led to a vast decline in cancer mortality. In fact, overall cancer survival has doubled in the 
last 40 years [3]. In contrast, overall cancer incidence is on the rise, which is mainly caused by the 
increase in overall life expectancy; the longer people live, the bigger the chance of the occurrence 
and accumulation of mutations that lead to the possible onset for cancer initiation, promotion 
and progression (see figure 1 and section 1.2.3).  
 
With a worldwide incidence of respectively 13 %, 11.9 % and 9.7 %, lung cancer, breast cancer 
and colorectal cancer (CRC) represent the most prevalent types of cancer (figure 2). Combined 
with prostate, liver and stomach cancer; those 3 main cancer types contribute to 55 % of global 
cancer incidence. In more developed regions, lung, breast, colorectal and prostate cancer account 
for half of the total cancer incidence, whereas in less developed regions, lung, breast, colorectal 
and prostate cancer, combined with liver and cervical cancer contribute to just over half of total 
cancer incidence. In Belgium, breast cancer is the most prevalent cancer type, followed by 
prostate cancer and CRC (figure 3) [1].  
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Figure 1. Since cancer risk increases with age, long life expectancy causes an increased 
cancer incidence [3]. 
 
 
Figure 2. Worldwide cancer incidence in 2012 [1]. 
  
 
Chapter I  
 
  
5 
 
  
 
Figure 3. Belgian cancer incidence in 2012 [1]. 
 
1.2 The origin(s) of cancer 
1.2.1 Cancer history in brief 
The earliest written documentation of cancer dates back to an Egyptian scroll from 3000 BC, the 
Edwin Smith Papyrus, describing a case of breast cancer; ‘cool to the touch, bulging and 
spreading all over the breast’ [4]. Throughout history the ‘what?’ and ‘how?’ of cancer was a 
much-debated subject. Ancient Egyptians merely blamed the gods, whilst Hippocrates (400 BC) 
believed an excess of ‘black bile’ (one of ‘the 4 body fluids’) was the underlying cause of cancer 
[5]. As time went by and medicine evolved, scientists developed many different hypotheses 
(some more plausible than others), but it wasn’t until the 18th and 19th century that the 
foundation for cancer epidemiology and modern oncology was laid. Invention of the modern 
microscope, implementation of autopsies (which required ‘rebellion’ against religious beliefs), 
and the possibility to perform surgery with anesthesia significantly contributed to the ever-
evolving field of oncology [6-8]. 
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1.2.2 The cause(s) of cancer 
Percival Pott, an English physician from the 18th century, was the first to hypothesize and 
confirm that cancer can be caused by exposure to environmentally occurring carcinogens by 
linking the exposure to chimney soot (formed due to the incomplete combustion of e.g. coals) to 
the prevalence of scrotal cancer in chimney sweepers [9]. Nowadays, it has become clear that 
environmental carcinogens constitute the main cause of cancer because approximately 90 % of 
cancer deaths cannot be attributed to genetics [10]. Unfortunately, for the vast majority of non-
hereditary cancers, the causative exposures and exact mechanism of cancer initiation, promotion 
and progression are highly complex, contributing to the fact that, even up to date, the underlying 
mechanisms remain mostly unexplained. Environmental exposures are difficult to track and 
characterize. Hence, with regard to the initiation and/or promotion of cancer, it is difficult to 
fully grasp the key exposures [11]. According to the World Health Organization (WHO), most 
cancers are associated with environmental, lifestyle, or behavioral exposures. This includes 
smoking of tobacco, consumption of alcohol, infections, reproductive and hormonal factors, diet, 
obesity, physical activity, occupation, (ionizing, ultraviolet and electromagnetic) radiation, (air, 
water and soil) pollution, pharmaceutical drugs, and naturally occurring chemical carcinogens 
through different routes of exposure [12]. 
 
1.2.3 The different stages in cancer development 
The development of cancer constitutes a complex multi-step process that is characterized by the 
unregulated division of ‘abnormal’ cells. This multi-step process can be divided into four 
sequential steps: tumor initiation, tumor promotion, malignant conversion, and tumor 
progression.  
During the initial phase of initiation, a permanent genetic change in proto-oncogenes and/or 
tumor suppressor genes (i.e. genes that ‘manage’ normal cell division) occurs. For chemically 
induced carcinogenesis, the formation of carcinogen-DNA adducts appears to be a necessary 
prerequisite for tumor initiation. DNA adduct formation that leads to the activation of a proto-
oncogene or the inactivation of a tumor-suppressor gene can thus initiate carcinogenesis. The 
initiating carcinogen can be intrinsically genotoxic or requires prior activation during 
metabolisation in the body itself [13, 14]. 
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After initiation, a selective clonal expansion of initiated cells under the influence of a ‘promotor’ 
can induce the second phase in cancer development; tumor promotion. During the phase of 
promotion, the clonal expansion of initiated cells will eventually lead to the production of a 
larger population of cells that are at risk of further genetic changes and malignant conversion. 
During this phase, frequent exposure to one or more promotors appears to be more important 
than exposure to a single high dose. Promotion will eventually give rise to the growth of benign 
or premalignant lesions [13]. 
Malignant conversion, the third phase in cancer development (not always considered as a 
separate phase), requires transformation of a pre-neoplastic cell to a neoplastic cell that expresses 
a malignant phenotype. This requires further genetic changes, of which the probability is in fact 
considerably low. Those genetic changes can be caused by DNA-damaging agents or errors 
during DNA replication (the latter is less common than the first) [13]. 
In the ‘final’ phase of tumor development, the tumor progresses in a more aggressive manner. 
Tumor cells express a malignant phenotype and begin to grow uncontrollably, possibly also 
invading surrounding tissues. Furthermore, this can be followed by dissemination of tumor cells 
from the primary tumor location, with the occurrence of regional and distant metastasis [13, 15]. 
 
 
 
Figure 4. Colorectal cancer progression [16]. 
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1.3 The human diet: the good, the bad and the ugly 
Food is vital, but many of the regularly consumed foodstuffs are rather ‘unhealthy’, and possibly 
even pro-carcinogenic. Since food is an important part of our day-to-day lives, investigation of 
the relation between the human diet and initiation and/or progression of disease is extremely 
relevant. Therefore, causal links between diet and the possible onset of disease has always been 
of particular interest. After all, only if the underlying mechanisms can be unraveled, preventive 
strategies and guidelines can be developed to reduce the burden of an ‘unhealthy’ diet [12].  
Over the years, a confident link between the consumption of a certain diet (or specific foodstuff) 
and the development of certain types of cancers has been established. For example, the ‘Western 
diet’ (high intake of fat, sugar and meat) has been implemented in the development of CRC, 
breast cancer and prostate cancer, whilst alcoholic beverage consumption has been linked to for 
example, cancer of the oral cavity, larynx, pharynx, oesophagus and liver [17].  
The ‘what?’ and ‘how?’ behind the diet-related development of cancer can occur via different 
routes of exposure and molecular mechanisms. First of all, dietary genotoxins can occur naturally 
because of their direct or indirect natural occurrence (e.g. safrole is inherent to e.g. nutmeg, black 
pepper, and cinnamon [18] (direct exposure), ptaquiloside residues can occur in milk from 
bracken-fed cattle [19] (indirect exposure)). Secondly, the foodstuff at hand can contain 
carcinogenic chemicals due to contamination during one of the many stages of food production 
(e.g. mycotoxins produced by molds on grains [20], heterocyclic amines (HCAs) formed during 
high-temperature cooking of meat [21]). Thirdly, and lastly, the digestion and metabolisation of 
food can also (erroneously) lead to the (increased) endogenous formation of carcinogenic 
metabolites. For example, the gut microbiota play a significant role in the transformation of 
xenobiotics, which can lead to de novo production of toxins [22]. Exposure to environmental 
carcinogens can thus occur via different pathways, and continuously throughout one’s life. Of 
course, whether or not dietary exposure to carcinogens indeed induces the initiation, promotion, 
malignant transformation, and progression of cancer depends on several other factors including 
the level and extent of exposure, individual rates of metabolisation/detoxification, the rate of 
mutagenicity of the genotoxin at hand, the exact location of a mayhap induced mutation (in 
proto-oncogenes or not), and efficiency of DNA repair [23].  
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2. THE DNA ADDUCTOME  
2.1 The DNA adductome as a part of the exposome 
Assessment of the exposure to the large spectrum of environmental factors and their direct or 
indirect role in the onset and further development of disease has proven to be a challenge. In 
2005, Wild introduced the ‘exposome’ as a complementary concept to the ‘genome’; a term that 
was introduced at least 10 years before [24]. The genome contains the whole of all genetic 
material of a certain organism (encompassing all of its inheritable traits), whilst the exposome 
encompasses all of the encountered exposures of a certain individual over the course of its, his 
or her lifetime, from the very early stages of conception and embryonic development through to 
adulthood, old age and death. In contrast to the individual genome, which is set at conception, 
the individual exposome evolves continuously throughout one’s life [11, 24-26].  
In light of genotoxicity and carcinogenicity studies, the DNA adductome, which consists of all 
DNA adduct types and levels present in a certain DNA sample, and can be considered as a part 
of the exposome, is of particular interest. DNA adducts originate from the interaction and 
subsequent covalent bonding between an electrophilic molecule and nucleophilic sites in DNA 
(i.e. the guanine (G), adenine (A), cytosine (C) and thymine (T) nucleobases) [27, 28]. The 
majority of DNA reactive molecules have the potential to lead to mutations and chromosomal 
alterations during DNA replication via formation of DNA adducts or DNA strand breaks, thus 
possibly resulting in carcinogenesis later on [29]. Therefore, DNA adduct formation is deemed 
to be the first step in chemically induced carcinogenesis [27].  
 
2.2 DNA adduct analysis as a means to study genotoxin exposure, 
metabolism and effect 
DNA adducts originate from the exposure of cellular DNA to endo- as well as exogenous 
genotoxins. Tissues and cells are exposed to endogenously generated chemicals through several 
(patho)physiological processes on a daily basis, including attack of DNA by e.g. reactive oxygen 
and carbonyl species, lipid peroxidation products (LPOs), estrogens and S-adenosylmethionine 
(gene expression regulator and methyl donor). [30]. However, in toxicology and cancer risk 
assessment the exogenous exposure to xenobiotics is deemed more important [31]. Examples of 
exogenous DNA adduct formation consists of DNA damage by dietary toxins such as 
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mycotoxins, acrylamide and HCAs [32-34]. In addition, several other environmental lifestyle 
factors can also significantly contribute to genotoxin exposure and exogenous DNA adduct 
formation; e.g. smoking, alcohol, certain industrial occupations, and living conditions [35-37].  
The direct measurement of genotoxic chemicals in body tissues and fluids does not take into 
account important factors such as interindividual differences in exposure, absorption and 
distribution. Moreover, these chemicals may have a rapid turnover in the body, making direct 
measurement impossible. Hence, assessment of the DNA adductome offers a more thorough 
view of the different biological pathways involved in genotoxin exposure. This is especially 
pertinent since individual heterogeneity in genotoxin metabolism and DNA repair specifically 
complicates a straightforward assessment of the effect of certain genotoxins. Accordingly, 
holistic assessment of all DNA adduct types and levels (‘DNA adductome mapping’) provides a 
more appropriate tool to study the biological effect of a genotoxic chemical. The arguments 
raised above demonstrate the fact that DNA adducts show great potential as ‘biomarkers of 
exposure’ or ‘biomarkers of internal dose’. Furthermore, since DNA adducts represent the 
amount of genotoxin that ‘successfully’ reached the DNA molecule in a certain individual, they 
can even act as a ‘biomarker of the biological effective dose’ of a certain genotoxic substance for 
that particular individual [38, 39]. 
Although interpretation of DNA adduct formation is complicated by several interfering factors, 
the field of DNA adductomics shows great potential in different areas of research. DNA 
adductome mapping does not only enable research into genotoxin exposure, but can also 
provide information on interindividual differences in genotoxin detoxification or activation. For 
example, Haugen and colleagues demonstrated a gender related difference in susceptibility to 
DNA adduct formation in tobacco smokers due to a significantly higher expression level of lung 
cytochrome P450 1A1 in women [40]. Genetic polymorphisms in DNA repair can also be a 
source of interindividual variation in DNA adduct levels [39]; e.g. Xia and co-workers recently 
published research on interindividual differences in aflatoxin B1 (AFB1) DNA adduct formation 
due to certain genetic polymorphisms in a DNA repair gene [41]. 
In addition to information on exposure to genotoxins, interindividual differences in genotoxin 
metabolisation and individual susceptibility to DNA damage and repair, DNA adduct analysis 
also provides important evidence on the possible long-term adverse health effects of genotoxic 
chemicals. When DNA adducts are introduced to the DNA sequence, the resulting DNA 
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damage may lead to mutagenesis and carcinogenesis [29]. At the time, there are at least three 
cases in which a causal link between the occurrence of DNA adducts and cancer incidence have 
been confirmed; firstly, aflatoxin B1 DNA adducts and their link to hepatocellular carcinoma 
[42]; secondly, the case of polycyclic aromatic hydrocarbon DNA adducts and cervical cancer 
[43], and thirdly, the link between aristolochic acid consumption (via consumption of 
Aristolochia plants), aristolactam DNA adduct formation and transitional cell (urothelial) 
carcinoma of the upper urinary tract [44]. For many other exo- or endogenous DNA adducts, 
potential clues for the probable relationship between DNA adduct levels in tissue and cancer 
incidence are accumulating, emphasizing the significance of DNA adduct studies in the field of 
toxicology and cancer epidemiology [38, 39]. DNA adduct research may not provide the full 
answer but can certainly aid with the elucidation of cancer susceptibility and mechanisms, and 
potentially lead to improved cancer prevention and/or development of treatments for at-risk 
individuals. In figure 5, the position of DNA adduct formation in the pathway of genotoxin 
exposure, metabolism and effect is presented to illustrate the potential use of DNA adduct 
analysis for in-depth assessment of genotoxin exposure, metabolism and effect. 
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3. DIET-RELATED DNA ADDUCT FORMATION IN 
RELATION TO CARCINOGENESIS 
Although the regular consumption of food is an absolute necessity, several foods and foodstuffs 
can also exert adverse health effects; the human diet, which is quite variable and complex, 
contains numerous beverages and food sources that consist of various ingredients and 
contaminants that may harbor mutagenic and carcinogenic toxicants. The uptake of those 
genotoxins via food can result in diet-related DNA adduct formation (figure 6), possibly even on 
a daily basis. 
 
 
Figure 6. DNA adduct formation in the pathways that link diet and carcinogenesis. 
 
An extensive literature review was executed to assess the current knowledge on diet-related 
DNA adduct formation. What follows, is a comprehensive overview and several examples of 
(groups of) diet-related DNA adducts that are or have been under investigation. In addition, the 
mutagenic and carcinogenic role of the described diet-related DNA adducts is explored to 
question or affirm the proposed causality between diet, DNA adduct formation and 
carcinogenesis.  
Consumption
Metabolisation
Detoxification Activation
Excretion DNA	adduct	formation
Carcinogenesis
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3.1 Naturally Occurring Toxins 
Several potent toxins are naturally present in food and/or feed, some of which are genotoxic and 
known to induce DNA adduct formation upon ingestion, as discussed below.  
 
3.1.1 Mycotoxins in food and feed 
The first group of diet-related DNA adducts are those generated by mycotoxins. Mycotoxins are 
secondary, toxic metabolites produced by food and feed-contaminating fungi. Several 
mycotoxins are well known for their diverse adverse health effects [20]. Aflatoxins, 
sterigmatocystin, ochratoxin, fumonisin, zearalenone, and some other toxins produced by 
Penicillium spp. are mycotoxins that demonstrate carcinogenic potential upon ingestion [32]. 
Nonetheless, only one mycotoxin, Aflatoxin B1 (AFB1), has been classified as a human 
carcinogen by the International Agency for Research on Cancer [45]. The AFB1 mycotoxin 
appears to be a potent carcinogen in different species and different organs, such as the liver 
(major target organ), lungs, kidneys, and colon. Exposure to AFB1 can lead to the formation of 
different AFB1-specific DNA adducts but can also increase levels of nonspecific endogenous 
DNA adducts like 8-hydroxyguanine (8-OH-G) [32]. AFB1-N7-G is the major AFB1 DNA 
adduct and is an established biomarker of AFB1 exposure and effect, since research has 
definitively linked the prevalence of AFB1-N7-G in liver DNA to the incidence of hepatocellular 
carcinoma [31, 42, 46]. 
Aflatoxin M1, an AFB1 metabolite, is also able to bind to DNA, but to a lesser extent compared 
with AFB1. DNA adduct formation by dietary exposure to sterigmatocystin, ochratoxin A, and 
zearalenone has been reported as well [47-49], although structural elucidation of the DNA 
adducts formed is still lacking. Nonetheless, some of these mycotoxins can generate aspecifc 
DNA adduct formation through the promotion of lipid peroxidation (see 3.4 Oxidative DNA 
damage below), which is the case not only for the previously discussed AFB1 but also for other 
compounds, e.g. ochratoxin A and the T-2 trichothecene mycotoxin [32, 50, 51]. 
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3.1.2 Pyrrolizidine alkaloids  
Pyrrolizidine alkaloids are secondary plant metabolites known for induction of hepatotoxicity, 
carcinogenicity, genotoxicity, teratogenicity, and pneumotoxicity. Pyrrolizidine alkaloid–
containing plants are widely spread across the globe (13 different plant families and 3 % of all 
flowering plants) and are often associated with poisoning of livestock, wildlife, and humans [52]. 
The presence of pyrrolizidine alkaloids has been reported in milk, honey, eggs, meat, salads, 
medicinal herbs, bread, grains, cereal, tea, and other beverages [29, 52, 53]. Adduction to 
proteins and DNA by pyrrolizidine alkaloid metabolites (e.g. dehydropyrrolizidine) is deemed 
responsible for the acute, subacute, and chronic effects of this extensive group of plant 
compounds [29]. The carcinogenic effects of pyrrolizidine metabolites have been demonstrated 
in different tissues and several animal models, and is associated at least in part with TP53 gene 
mutations [53]. Upon attack of DNA, the dehydropyrrolizidine molecules can induce at least 4 
different DNA adducts with G as well as with A [54, 55]. 
 
3.1.3 Ptaquiloside in bracken fern 
Ptaquiloside is the long-known major toxin in bracken fern (Pteridium aquilinum) [19, 56]. Both 
epidemiological and in vivo studies have illustrated the development of bladder and 
gastrointestinal tumors after chronic ptaquiloside exposure in animals and humans [56-58]. 
Although bracken ferns are not commonly included in the human diet, ferns were (or are still) 
consumed as the occasional wild food source in some regions or cultures [19, 59]. However, the 
most common way of human exposure appears to be aerial exposure to spores and the 
consumption of ptaquiloside-contaminated milk from bracken-fed cattle [19, 60]. 
Exposure to ptaquiloside has been linked to ptaquiloside-specific DNA adduct formation. 
Unstable and “active” breakdown products of ptaquiloside (ptaquilosin and ptaquilosin dienone) 
have DNA-alkylating properties and are most prone to attack A (at N3) and G (at N7) 
nucleobases, resulting in DNA adduct formation and DNA strand breaks [61]. Prakash et al. [62] 
demonstrated that grazing on bracken led to ptaquiloside exposure, ptaquiloside-DNA adduct 
formation, and H-ras mutations in the ileum of sheep. The carcinogenic effects of bracken and 
ptaquiloside through DNA adduct formation and H-ras proto-oncogene activation were further 
reinforced by follow-up research [63]. 
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3.1.4 Azoxyglycosides in cycads 
Cycads (Cycadales) are a species of (sub)tropical plants with historical economical, ornamental, 
and medicinal value [64]. Cycas seeds or nuts are a source of starch and are known to be 
consumed more frequently in times of famine (e.g. World War II). Some indigenous populations 
still use cycads during the preparation of certain traditional foods, although Westernization has 
significantly reduced this phenomenon [50, 65, 66]. Nevertheless, it is well known that Cycadales 
plant materials contain toxic azoxyglycosides such as cycasin and macrozamin, which can induce 
acute gastrointestinal complaints and chronic neurotoxic as well as genotoxic effects [67]. After 
ingestion, the azoxyglycosides are transformed to methylazoxymethanol aglycone (and its active 
methyldiazonium ion), eventually resulting in mutagenic, teratogenic, and carcinogenic effects via 
DNA alkylation in several species and organs [66, 68]. DNA adducts generated by 
methylazoxymethanol include O6-methyl-G (O6-MeG) and N7-methyl-G (N7-MeG) [66], 
although research on this topic appears to be quite sparse. 
 
3.1.5 Herbs, spices, flavors and fragrances 
Many foodstuffs contain herbs and spices to add flavor and fragrance. In some foods, the use of 
herbs and spices is omitted and replaced by the use of synthetic flavors and fragrances. Whether 
natural or synthetic, some of the chemical compounds that provide flavor and/or fragrance can 
induce genotoxic and carcinogenic effects. 
Safrole is a naturally occurring plant compound present in sassafras oil, certain essential oils, and 
spices such as nutmeg, black pepper, and cinnamon [18]. Over the years, different 
epidemiological studies have linked safrole ingestion to DNA adduct formation and 
carcinogenesis (e.g. oral, esophageal, and liver cancer) [69-71]. The toxic effects of safrole appear 
to be associated with lipid peroxidation and oxidative DNA damage (please see 3.4 Oxidative 
DNA damage for more details on oxidative DNA damage), resulting in the formation of 8-OH-
G, a nonspecific DNA adduct related to oxidative stress [72]. Safrole also induces, though less 
frequently, safrole-specific DNA adducts at the N2 position of guanine and the N6 position of 
adenine [69, 73]. Since safrole and related compounds such as dihydrosafrole and isosafrole have 
long been known to be hepatotoxic and carcinogenic [74], their use as additives is prohibited [75]. 
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The flavoring substances estragole and methyleugenol are closely related to safrole 
(alkenylbenzenes). Estragole occurs naturally in tarragon, sweet basil, fennel, and anise. It can 
also be added to other foodstuffs like (non-)alcoholic beverages, canned fish, fats, and oils [76]. 
N2-(trans-isoestragol-3′-yl)-G, N2-(estragole-1′-yl)-G, 7-(trans-isoestragol-3′-yl)-G, and 8-(trans-
isoestragol-3′-yl)-G are 4 different estragole-specific types of DNA adducts. Mainly N2-(trans-
isoestragol-3′-yl)-G has been linked to estragole’s indirect genotoxicity and possible 
carcinogenicity [77]. Like estragole, methyleugenol occurs naturally in spices such as tarragon, 
fennel, basil, and anise, but it is also frequently added to baked foods, beverages, and candy. 
Methyleugenol consumption has been associated with the formation of DNA adducts [N6-(trans-
methylisoeugenol-3’-yl)-A and N2-(trans-methylisoeugenol-3’-yl)-G], chronic hepatotoxicity, and 
hepatocarcinogenicity [78]. Additional examples of alkenylbenzene compounds that induce 
DNA adduction are myristicin and apiols, such as those from dill and parsley [79]. 
Reports on the contemporary medicinal use of plant extracts from Aristolochia spp. date back to 
the 1940s. Its ascribed anti-inflammatory activity can be attributed to the presence of aristolochic 
acids, which are a group of nitrophenanthrene carboxylic acids [80]. In 1982, however, Mengs et 
al. [81] revealed that aristolochic acid was strongly genotoxic and carcinogenic in rats. Follow-up 
research also revealed acute nephrotoxicity in rodents and carcinogenicity in mice [82, 83]. 
Although pharmaceutical preparations with aristolochic acid were withdrawn from the market in 
different countries about 3 decades ago and the use of plant extracts containing aristolochic acid 
was explicitly prohibited or strongly discouraged, the use of aristolochic acid extracts has not 
disappeared entirely [80]. An important clinical case example is that of several Belgian women 
who were admitted to the hospital with aristolochic acid nephropathy in 1993 and 1994 after 
ingesting aristolochic acid–containing Chinese herbs during a slimming therapy [84]. According 
to Schmeiser et al. and Arlt et al., aristolochic acid nephropathy and carcinogenicity is caused by 
DNA adduct formation [85, 86]. This is supported by the retrieval of specific aristolochic acid 
DNA adducts and AAG to TAG nonsense mutations (in codon 139 [Lys → Stop] of exon 5) in 
a urothelial tumor from a patient with aristolochic acid–associated nephropathy [87, 88]. A more 
recent and extensive study in Taiwan confirmed the significant contribution of aristolochic acid 
to aristolochic acid–related DNA adduct formation, p53 mutations, and the incidence of 
carcinomas of the upper urinary tract [89]. 
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Other commonly naturally occuring or added flavors and fragrances are still under investigation. 
For example, Hossain et al. [90] recently investigated the DNA-damaging activities of several 
foodborne chemicals such as pyrogallol and gallic acid. The first is often found in smoked food 
because of the use of liquid smoke, and both compounds are commonly present in tea and 
coffee, the regular consumption of which is commonly associated with beneficial health effects. 
As such, pyrogallol is a perfect example to demonstrate the complex nature of dietary toxicity, 
since some individual foodborne chemicals seem to exhibit both DNA-damaging activity and 
health benefits [91, 92]. 
 
3.1.6 Marine toxins 
Research on marine toxin DNA adducts is very limited and still ongoing. Exposure to marine 
toxins often occurs through consumption of fish and shellfish that either produce these toxins 
themselves or have accumulated them after initial production by algae. Okadaic acid is a marine 
toxin mainly associated with acute gastrointestinal complaints due to diarrhetic shellfish 
poisoning. Although a controversial topic, chronic exposure to lower concentrations of okadaic 
acid through consumption of shellfish appears to be associated with tumor induction caused by 
genotoxicity and DNA adduct formation [93]. The formation of DNA adducts 5-methyl-G and 
8-OH-G is not specific for exposure of DNA to okadaic acid but does indicate okadaic acid 
genotoxicity as a result of alkylation and oxidation processes [94]. A different marine toxin, 
brevetoxin B (BTX-2), induces double DNA strand breaks, chromosomal alterations, and DNA 
adduct formation. However, exposure to this neurotoxin results mainly from inhalation of 
aerosols and not by ingestion [95]. Genotoxicity of additional marine toxins like domoic acid [96] 
has been reported, although no information on DNA adduct formation was available when this 
review was conducted. 
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Table 1. Confirmed DNA adducts originating from naturally occurring toxicants in food 
and feed. 
Genotoxin group  Causal genotoxin DNA adduct type 
Mycotoxins [32] Aflatoxin B1 Aflatoxin B1-G 
  Aflatoxin B1-A 
  Aflatoxin B1-C 
  Aflatoxin-FAPY-G 
  Hydroxy-Ga 
 Aflatoxin M1 Aflatoxin M1-G 
 Aflatoxin P1 Aflatoxin P1-G 
 Ochratoxin Ochratoxin-G 
 Sterigmatocystin Sterigmatocystin-G 
Pyrrolizidine alkaloids [54] Pyrrolizidine alkaloid metabolites Dehydropyrrolizidine-G 
Dehydropyrrolizidine-A 
Azoxyglycosides in cycads [66] Methylazoxymethanol aglycone Methyl-Ga 
Herbs, spices, flavors & 
fragrances 
Safrole [69, 72, 73] Safrole-G 
Safrole-A 
Hydroxy-Ga 
 Isosafrole [97] Isosafrole-G 
 Estragole [76] Estragole-G 
Estragole-A 
 Methyleugenol [98] Methyleugenol-G 
Methyleugenol-A 
 Aristolochic acid metabolites 
[80] 
Aristolactam I-G 
Aristolactam II-G 
Aristolactam I-A 
Aristolactam II-A 
Marine toxins [94] Okadaic acid Methyl-Ga 
Hydroxy-Ga 
aNonspecific DNA adduct 
  
 
Chapter I  
 
  
20 
 
  
 
Figure 7. DNA adduct formation by some of the natural occurring toxins or their 
metabolites upon attack of the guanine (G) nucleobase. 
 
 
3.2 Heating of foods 
Different genotoxic compounds can be formed during extensive heating of food products. 
Several important and well-known examples are described below.  
 
3.2.1 Acrylamide 
Acrylamide is a genotoxic, tumor-promoting chemical frequently used in polyacrylamide polymer 
synthesis in laboratories and industrial settings [99]. It can be introduced into the human diet 
through contamination and, more importantly, through formation during high-temperature 
cooking (baking or frying) of starchy foods like potatoes and cereals. Acrylamide is a known 
neurotoxin and was classified as a probable human carcinogen by the International Agency for 
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Research on Cancer in 1994 [99, 100]. Although acrylamide seems to have a relatively low 
carcinogenic potential, its high concentrations (measured in parts per million) after baking or 
frying of starchy foods may pose a threat [100]. The carcinogenic potential of acrylamide and, in 
particular, its active metabolite glycidamide could be at least partially explained by the 
genotoxicity related to DNA adduct formation [101]. Possible acrylamide/glycidamide DNA 
adducts include carboxyethyl-G and carbamoylhydroxyethyl-G [33]. Nonetheless, the 
carcinogenic potential of acrylamide in humans remains controversial [102]. 
 
3.2.2 Furans 
Furan and derivatives occur in a wide variety of heated food products like coffee, soy, caramel, 
bread, and meat [103]. These compounds give flavor to foods and are formed mainly by thermal 
degradation of pentoses. On the basis of hepatotoxicity and carcinogenicity in laboratory animals, 
the International Agency for Research on Cancer classified these compounds as possible human 
carcinogens [104]. Specific DNA adduct formation (e.g. N2-((furan-2-yl)methyl)-G and N6-
((furan-2-yl)methyl)-A) by furans or furan metabolites has been described and may contribute to 
the furan carcinogenicity reported earlier [105, 106]. However, the presence of furans is not 
limited to heated foodstuffs. Furans are often used in industrial settings, which results in furan-
polluted air and food. Because furans are dispersed in the environment, assessment of their 
effects from dietary intake exclusively is complicated. 
 
3.2.3 Polycyclic aromatic hydrocarbons & heterocyclic amines  
Polycyclic aromatic hydrocarbons (PAHs) are ubiquitous environmental pollutants formed as a 
result of incomplete combustion of organic material. Exposure to PAHs is commonly linked to 
tobacco smoking and occupation-related air pollution (e.g. occupations at risk include workers in 
iron, steel, aluminum and coal production, traffic police, bus maintenance workers, chimney 
sweepers, etc.), although diet, i.e. consumption of charcoal-broiled meat, appears to be an 
important confounding factor in biomonitoring studies of occupational exposure to PAHs [107-
109]. 
HCAs can be found in tobacco smoke condensates, diesel exhaust, and several food sources [21]. 
HCAs and PAHs are both well-known mutagens and carcinogens that occur in food in general 
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but are present at particularly high levels in meat cooked at high temperatures for a long period 
of time or held in or over an open flame [110]. 
Once HCAs are administered, their metabolization to N-hydroxy–heterocyclic amine derivatives 
is needed prior to formation of DNA adducts. Over 20 HCAs have been identified in foodstuffs, 
and several of them demonstrate DNA adduct formation at the C8 or N2 position of the G 
nucleobase. 2-Amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP) is the most common 
HCA, while 2-amino-3,4­dimethylimidazo[4,5-f]quinolone (MelQ), 2-amino-3-
methylimidazo[4,5-f]quinolone (IQ), and 2-amino-3,8-dimethylimidazo[4,5­f]quinoxaline (8-
MeIQx) are among the most potent bacterial mutagens ever tested (i.e., using the Ames test) [21]. 
Other HCAs with DNA adduction potential are 2-amino-3-methyl-imidazo[4,5-f]quinoxaline 
(IQx), 2-amino-3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxaline (DiMeIQx), 2-amino-9H-pyrido[2-
3-b]indole (AαC), 2-amino-3-methyl-9H-pyrido[2,3-b]indole (MeAαC), (2-amino-6-
methyldipyrido[1,2-a:3,2-d]imidazole (GluP1), and 3-amino-1-methyl-5H-pyrido[4,3-b]indole 
(TrpP2). In vitro and in vivo mutagenicity, however, is dependent on species, tissue, cell, and type 
of HCA. Nevertheless, carcinogenicity of HCAs has been reported at low doses in several 
species [110], and although a causal link has not yet been established, the presence of HCAs in 
well-done meat products has been linked to, for example colon, stomach, and breast cancer [31]. 
The International Agency for Research on Cancer has classified 8 HCAs, among which MeIQ, 
MeIQx, and PhIP, as possible human carcinogens and IQ as a probable human carcinogen [45]. 
Interaction of PAHs with DNA is indirect; prior to DNA attack, PAHs must be activated 
(commonly by cytochrome P450 enzymes) to electrophilic epoxides. The most extensively 
studied carcinogen of the past century is the PAH benzo[a]pyrene [108]. An important finding is 
that benzo[a]pyrene DNA adducts in cervical tissues appear to be the missing link between 
exposure to PAHs through tobacco smoking and cervical cancer. Most studies focus on 
exposure to PAHs through occupation and tobacco smoking, but some studies demonstrate a 
link between charcoal-broiled meat consumption and PAH DNA adduct levels 
(trihydroxytetrahydro-benzo[a]pyrenelyl-G due to benzo[a]pyrene exposure (and conversion to 
the genotoxic benzo[a]pyrene-diolepoxide intermediate) in blood cells [109, 111]. The findings 
indicating that diet significantly contributes to PAH exposure, however, awaits scientific 
confirmation. 
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Table 2. Confirmed DNA adducts induced by known genotoxins in heated foods. 
Genotoxin group Causal genotoxin DNA adduct type 
Acrylamide [33] Acrylamide Carbamoylethyl-G 
  Carbamoylhydroxyethyl-G 
  Carboxyhydroxyethyl-A 
  Carbamoylhydroxyethyl-A 
  Carboxyethyl-Ga 
  Carboxyethyl-Aa 
  Carboxyethyl-Ca 
Furans cis-2-butene-1,4-dial [105] 
 
cis-butene-dial-G 
cis-butene-dial-A 
cis-butene-dial-C 
 Furfuryl alcohol [106] Methylfuran-G 
Methylfuran-A 
 Hydroxymethylfurfural [112]  Furanformylmethyl-G 
Furanformylmethyl-A 
Heterocyclic amines [34] PhIP 
PhIP 
PhIP-G 
Hydroxy-PhIP-G 
 IQ IQ-G 
 IQx IQx-G 
 MeIQ MeIQ-G 
 MeIQx MeIQx-G 
 DiMeIQx DiMeIQx-G 
 MeAαC MeAαC-G 
 AαC AαC-G 
 GluP1 GluP1-G 
 TrpP2 TrpP2-G 
Polycyclic aromatic [113] B[a]P B[a]P-G 
B[a]P-A 
 B[a]PDE B[a]PDE-G 
B[a]PDE-A 
aNonspecific DNA adduct 
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Figure 8. DNA adduct formation by 4 major heat-induced toxins in food upon attack of 
the guanine (G) nucleobase. 
 
Acrylamide+ Carbamoylhydroxyethyl2G+
Furfuryl+alcohol+ Methylfuran2G+
PhIP+ PhIP2G+
B[a]P+ B[a]PDE2G+
++G+
++G+
++G+
++G+
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3.3 Alcohol 
Ethanol consumption is a proven cause of cancer and has long been linked to the occurrence of 
hepatocellular carcinomas and squamous-cell carcinomas of the oral cavity, pharynx, larynx, and 
esophagus [114]. More recently, breast and CRC were added to that list [115]. As is the case for 
many cancers, the exact underlying etiology of alcohol-induced carcinogenesis is still unknown. 
Animal studies demonstrated that acetaldehyde, the main metabolite of ethanol, can induce 
tumor formation in rats and hamsters, which led the IARC to classify acetaldehyde in group 2B, 
i.e. “possibly carcinogenic to humans,” in 1999 [116]. A study conducted by Fang and Vaca [117] 
documented that acetaldehyde DNA adducts may be the missing link between alcohol 
consumption and different cancer types, since levels of acetaldehyde-generated DNA adducts in 
alcohol abusers were significantly higher than those in controls. Follow-up in vitro research 
showed that acetaldehyde induced DNA adduct formation in human buccal cells [118], and 
several other studies confirmed the formation of different DNA adducts by acetaldehyde in vitro 
[119, 120]. DNA adducts generated by acetaldehyde include N2-ethyl-G, N2-4-hydroxybutyl-G or 
N2-3-hydroxybutyl-G and 1,N2-propano-G [37]. Although acetaldehyde may contribute to 
ethanol toxicity and carcinogenesis, ethanol consumption also increases the production of 
reactive oxygen species and LPOs [121]. Both reactive oxygen species and LPOs are likely to 
attack DNA, providing the basis for an additional hypothesis on alcohol-related carcinogenesis. 
More details on DNA adduct formation by reactive oxygen species and LPOs are presented 
below. DNA adducts originating from direct and/or indirect alcohol genotoxicity are shown in 
table 3. 
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3.4 Oxidative DNA damage 
Reactive oxygen species and reactive nitrogen species are formed continuously during the 
biochemical reactions of normal cellular metabolism. Reactive oxygen species (ROS) and reactive 
nitrogen species such as superoxide (O2
−), hydrogen peroxide (H2O2), hydroxyl radicals (HO·), 
singlet oxygen (1O2), nitrous anhydride (N2O3), peroxynitrite (ONOO
−), nitryl chloride (NO2Cl), 
and nitric oxides (NO) can directly or indirectly induce endogenous/background levels of altered 
nucleobases [122-124]. Examples of DNA adducts formed by the interaction of reactive oxygen 
species or reactive nitrogen species with DNA include 8-nitro-G, 8-OH-G, 2-hydroxy-A, 
thymine glycol, and cytosine glycol [30, 124]. 
ROS attack not only DNA but also other macromolecules such as lipids and proteins. When 
ROS and iron interact with lipids like polyunsaturated fatty acids in membrane phospholipids, 
LPOs are formed [121, 125]. In turn, those LPOs can exert both cytotoxic and genotoxic effects. 
During lipid peroxidation, different electrophilic epoxides and aldehydes are formed. A major 
LPO with mutagenic and carcinogenic properties is malondialdehyde (MDA). Attack of DNA by 
MDA primarily yields the DNA adduct M1G, although M1A, M1C, and other DNA adduct types 
are formed as well [126, 127]. Additional examples of lipid peroxidation end products with 
DNA-damaging properties are acetaldehyde, malondialdehyde-acetaldehyde conjugates, 
hydroxynonenal, crotonaldehyde, and acrolein [37, 125]. 
Both LPOs and their resulting DNA adducts can occur endogenously following production of 
reactive oxygen species or reactive nitrogen species during physiological oxidative stress [122, 
128]. On the other hand, several exogenous or pathophysiological sources of oxidative stress, 
such as immune responses, chronic inflammation, radiation, chemicals, drugs, and dietary 
imbalance, can also contribute to oxidation of DNA [125, 128, 129]. Dietary imbalance can 
result from the overconsumption of energy, dietary fat (polyunsaturated fatty acids, in particular), 
and red and processed meat, which has been associated with an elevated incidence of chronic 
diseases like chronic pancreatitis, coronary heart disease, inflammatory bowel disease, diabetes, 
and cancer (e.g. oral, pharyngeal, stomach, prostate, pancreatic, and colon) [129-136]. Several 
studies have either (a) linked the occurrence of higher levels of oxidative stress, production of 
LPOs, and DNA adduct formation to the consumption or digestion of fat and meat, or (b) have 
established an association between the detection of increased levels of DNA adducts in different 
tissues and a documented disease status [125, 128, 129, 132, 137-141]. Follow-up studies could 
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provide more detailed information on diet–cancer causality and the exact underlying etiological 
mechanisms. An overview of oxidative stress–related DNA adduct formation is provided in 
table 3. 
 
3.5 Alkylating N-nitroso compounds 
Alkylating agents are genotoxic, mutagenic, and cytotoxic via interaction with DNA, RNA, and 
proteins. Some are ubiquitous or are formed endogenously during metabolism, while others are 
administered in high doses as chemotherapeutic agents [142]. DNA adducts generated by 
alkylation are unspecific, so at times, one can only speculate on the causal chemical [143]. 
Alkylation of DNA bases can occur at the O or N atom in DNA nucleobases and, in general, 
alkylation at O atoms of nucleobases is mutagenic and genotoxic, while N-alkylation leads 
predominantly to cytotoxic effects [142]. This is why considerable research has focused on the 
possible carcinogenic effects of adducts like O6-MeG and O6-carboxymethyl-G (O6-CMG), 
although N7-MeG and N7-carboxymethyl-G are formed in higher concentrations upon attack of 
DNA by methylating and carboxymethylating agents, respectively [30, 144, 145]. 
Different types of chemicals have alkylating properties and some of them are diet or lifestyle 
related. Acrylamide, alcohol, and okadaic acid are examples that have already been described 
above, but an additional group of chemicals with DNA-alkylating properties are the endogenous 
or exogenous N-nitroso compounds (NOCs). The methylazoxymethanol compound, discussed 
previously, is an example of a naturally occurring exogenous NOC. 
The presence of NOCs in foodstuffs and the accidental toxic effects were first noticed around 
1964, when feeding of sodium nitrite–preserved herring caused hepatotoxicity in sheep [146]. 
Researchers later discovered that nitrosation of amines could lead to the formation of 
nitrosodimethylamine [147]. Confirmation of the carcinogenicity of nitrosodimethylamine 
followed shortly [148], and since then, the toxicity of many different NOCs in different species 
has been investigated thoroughly. Human exposure to NOCs can occur through occupation and 
lifestyle habits like smoking, but according to Lijinksy [147, 149], who has reviewed the 
occurrence, chemistry, and biology of NOCs extensively, diet represents the most important 
route of NOC exposure. Common foodstuffs containing NOCs are beer, certain spices, smoked 
fish and smoked fish products, and meat products such as smoked or cured pork, sausages and 
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fried bacon [150, 151]. In addition, besides NOCs present in foodstuffs, nitrosamines and 
nitrosamides can also be easily formed in the stomach by the interaction of nitric oxide or nitrite 
from metabolism, food, or saliva and secondary or tertiary amines from food or pharmaceutical 
drugs [123, 147]. A similar process can occur in the large bowel, where microbial fermentation of 
proteins leads to the production of amines. Nitrosation of those amines can then generate the 
formation of NOCs [152]. 
Tumor induction by nitrosamines or nitrosamides has been demonstrated in different tissues like 
liver, lung, kidney, bladder, tongue, bone, nervous system, and gastrointestinal tract [147]. Lung 
cancer is associated mainly with tobacco smoke and tobacco-specific NOCs, although dietary 
NOCs may contribute as well [153]. The exact mechanism of tumor induction and/or 
promotion by NOCs is not entirely clear; therefore, further research is warranted. Table 3 
provides an overview of alkylation-induced DNA adducts. 
 
3.6 Ingestion and cellular incorporation of DNA adducts from dietary 
origin 
Food contains abundant genomic DNA of vegetable, fungal, and animal origin, including 
damaged DNA and, thus, DNA adducts. There is a broad range of damaged 
nucleotides/nucleosides/nucleobases in food, although the type of DNA lesions present 
depends on food species, growth conditions, and environmental parameters during food 
production processes. Following ingestion, these foodborne DNA lesions can be erroneously 
incorporated into human cellular DNA as a result of imperfections in DNA synthesis [171]. 
Research on possible adverse health effects of DNA damage in food is scarce, but the 
mutagenicity of certain externally administered DNA adducts has been reported [172-174]. 
Furthermore, it is worth noting that the administration of certain chemotherapeutic agents such 
as purine and pyrimidine analogs – which interfere with DNA synthesis in rapidly dividing 
malignant cells – is anything but new [175, 176]. Spilsberg et al. [171] recommended that novel 
and traditional foods should be screened for DNA adducts to gain more knowledge on this 
subject. 
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3.7 Discussion and conclusion 
The modern human food chain includes countless foodstuffs and ingredients. Classification and 
determination of the biochemical activities and possible toxic effects of all bioactive molecules in 
the food chain seems unfeasible and highly complex. In addition, food can be easily 
contaminated with other environmental chemicals of non-food origin during the various stages 
of production, packaging, storage, and transport, thus rendering research of food-related toxicity 
and disease even less straightforward. Nevertheless, years of research on dietary toxicity have 
revealed the possible acute and chronic toxic effects of certain foodstuffs and their inherent 
bioactive molecules. As a result, some edibles have been excluded from the food web as much as 
possible (e.g. Aristolochia plant spp. extracts, because of aristolochic acid toxicity; discussed 
above), while others have been thoroughly evaluated and are considered safe (e.g. mushrooms 
containing hydrazine [116]). 
In vitro and in vivo experiments have documented the formation of different types of DNA 
adducts as a result of exposure to certain dietary chemicals. The levels of those DNA adducts 
have been linked to certain pathophysiological processes like oxidative stress and chronic 
diseases including cancer [30, 125, 177]. Consequently, causal links between chemicals in food, 
DNA adduct formation, and carcinogenesis seem very likely, emphasizing the importance of 
further investigation of the exact origin and consequences of specific and nonspecific 
endogenous and exogenous DNA adduct formation. 
Although DNA adduct studies can be complex, research on DNA adducts can provide useful 
insight into different physiological and pathophysiological pathways [38, 178]. Qualitative or 
quantitative assessment of xenobiotic chemicals in bodily matrices can reflect environmental 
exposure and the degree of intake and/or excretion, depending on the chemical and matrix at 
hand. DNA adduct levels, on the other hand, provide information on not only the exposure to 
and uptake of certain genotoxic chemicals but also the metabolization, detoxification, activation, 
distribution, and any resulting genotoxic effects of these chemicals [39]. As such, DNA adducts 
provide important clues on interindividual differences in genetic polymorphisms in DNA repair 
and susceptibility to cancer initiation and development [41, 177]. Hence, DNA adducts are not 
merely biomarkers of exposure but are also, more importantly, biomarkers of an internal dose or 
a biologically effective dose [38]. 
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A DNA adduct of interest should be established as a biomarker of both exposure and effect to 
confidently link dietary genotoxin exposure to carcinogenesis through DNA adduct formation. 
To ratify a certain DNA adduct as a biomarker of effect, specific criteria must be met. For 
example, the prevalence of DNA adducts should be strongly, consistently, and specifically linked 
to disease outcome [107]. To date, the most prominent and confirmed example of pathogenic 
diet-related DNA adduct formation is the formation of AFB1-N7-G DNA adducts in the liver 
due to AFB1 exposure and the subsequent onset of hepatocellular carcinoma [31]. Diet- and 
exposure-related DNA adduct formation is still under investigation for potential links between 
e.g. red meat consumption and the development of CRC [141, 177, 179], alcohol consumption 
and the development of cancers like hepatocarcinoma and colon carcinoma [180, 181], 
methyleugenol ingestion and hepatocarcinoma [182], and aristolochic acid exposure and 
urothelial cancer [183]. 
In conclusion, it can be stated that, although the puzzle is far from complete, evidence of the 
carcinogenic effects of diet-related DNA adduct formation is accumulating due to the fact that 
different sources of dietary genotoxins have been linked to both in vivo and in vitro DNA adduct 
formation. The in-depth investigation of diet-related genotoxin exposure, the therewith 
associated DNA adduct formation and disease outcome will provide further insight into diet- 
and lifestyle-related carcinogenesis. 
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4. INVESTIGATION OF THE COLORECTAL CANCER 
INITIATING AND/OR PROMOTING ROLE OF RED 
MEAT CONSUMPTION BY MEANS OF DNA ADDUCT 
ANALYSIS 
4.1 Colorectal cancer 
As was already mentioned before (1.1 Cancer facts and statistics), CRC is the third most 
common cancer type worldwide. More specifically, CRC is the third most common cancer in 
men, and the second most common in women. Almost 55 % of CRC cases occur in more 
developed regions (figure 9), reflecting the fact that CRC mainly is a ‘Western’ disease [1, 184]. 
Only 10 % of CRC cases are hereditary, which means the vast majority of CRC cases have a 
predominant environmental cause [12]. Composition of the diet, obesity and physical inactivity 
significantly contribute to CRC risk [12]. More importantly, about 70 % of CRC cases could be 
prevented by dietary and lifestyle changes [185, 186]. According to the World Cancer Research 
Fund (WCRF) and WHO, the consumption of red meat and processed meat, consumption of 
alcoholic beverages, body fatness, abdominal fatness, and factors leading to greater adult attained 
height (or its consequences) can cause CRC. In contrast, physical activity protects against colon 
cancer. Evidence also suggests that the consumption of garlic, milk, and calcium might also 
protect against CRC. Unfortunately, despite the convincing epidemiological evidence, the 
underlying, causative pathways have not yet been clarified and defined in detail [12, 187]. 
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Table 4 lists the relative risk of the major contributing dietary and lifestyle factors for CRC. 
Accordingly, several cancer research organizations and institutes (e.g. World Cancer Research 
Fund International) recommend to avoid smoking, avoid, and at least limit alcohol consumption, 
eat less than 500 g of red meat per week and avoid/limit processed meat consumption, but be 
‘physically active’, maintain a healthy weight, and eat more reduced-fat dairy products, grains, 
vegetables, fruits and beans on their websites (www.wcrf.org and www.cancer.org). 
 
Table 4. Relative colorectal cancer risk of the major contributing dietary and lifestyle 
factors [188]. 
Factor  Relative risk 
Factors that increase risk   
 Alcohol consumption (heavy vs. nondrinkers) 1.6 
 Obesity 1.2 
 Red meat consumption 1.2 
 Processed meat consumption 1.2 
 Smoking (current vs. never) 1.2 
Factors that decrease risk   
 Physical activity 0.7 
 Dairy consumption 0.8 
 Fruit consumption 0.9 
 Vegetable consumption 0.9 
 Total dietary fiber (10 g/day) 0.9 
 
 
4.2 Evidence on the link between red and processed meat consumption 
and colorectal cancer 
Epidemiological research has demonstrated a strong correlation between the consumption of red 
meat, and the consumption of processed meat, with CRC incidence and mortality. However, 
correlation does not necessarily reflect causation. Therefore, the hypothesized carcinogenic 
effect of meat consumption has always been, and still remains, a controversial topic. 
Nevertheless, on the 26th of October 2015, the IARC issued a press release stating that red meat 
is ‘probably carcinogenic to humans’ (group 2B) “based on limited evidence that the 
consumption of red meat causes cancer in humans and strong mechanistic evidence supporting a 
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carcinogenic effect”, and that processed meat is ‘carcinogenic to humans’ (Group 1) “based on 
sufficient evidence in humans that the consumption of processed meat causes CRC”. Red meat 
was defined as all types of mammalian muscle meat, such as beef, veal, pork, lamb, mutton, 
horse, and goat. Processed meat was defined as meat that has been transformed through salting, 
curing, fermentation, smoking, or other processes to enhance flavour or improve preservation. 
Most processed meats contain pork or beef, but processed meats may also contain other red 
meats, poultry, offal, or meat by-products such as blood [189]. 
 
4.3 Hypotheses on the link between red and processed meat consumption 
and colorectal cancer  
Over the years, different hypotheses on red and processed meat carcinogenicity have been put 
forward. These hypotheses have been reviewed and discussed extensively over the years. To 
create an overview, the major hypotheses are discussed briefly below.  
 
4.3.1 Refuted hypotheses  
4.3.1.1 Total/saturated fat 
A first hypothesis suggests that the high saturated fat content of red and processed meat, and/or 
the ‘Western’ diet in general, increases CRC risk through (1) an increased excretion of secondary 
bile acids, (2) an increase in free fatty acids, and/or (3) induction of a higher risk for obesity. Yet, 
several independent studies have not been able to confirm the link between the intake of total 
(saturated) fat and CRC promotion [190-193]. Anyway, other foodstuffs besides red and 
processed meat also contain high amounts of saturated animal fat (e.g. dairy products), which 
directly interferes with the hypothesis focusing on red and processed meat intake [191]. 
 
4.3.1.2 Protein 
High total meat intake equals high protein intake. Excess protein is fermented in the large bowel, 
which results in the formation of toxic breakdown products (e.g. amines, phenols and H2S). 
Hence, high total meat intake and excess protein intake was hypothesized to initiate and/or 
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promote CRC. However, in line with the hypothesis on total (saturated) fat, researchers have not 
been able to link total meat intake and/or excess protein fermentation in the gut to CRC risk. 
Rendering this hypothesis to fall short [130, 191, 193, 194]. 
 
4.3.2 Current hypotheses 
4.3.2.1 The heme hypothesis 
At the time, with regard to red meat, researchers are mainly focusing on one specific hypothesis; 
the heme hypothesis. The heme hypothesis is based on the fact that red meat (e.g. beef) contains 
a considerably higher amount of heme iron in comparison to white meat (e.g. poultry); red meat 
contains an at least 10-fold higher heme iron content under the form of the myoglobin protein, 
to which it owes its dark red color [190, 195, 196].  
Pierre et al. were the first to document that the digestion of meat can promote carcinogenesis in 
the rat colon, dependent on heme concentration [197]. The exact underlying mechanism has not 
been elucidated yet, but it was hypothesized that heme iron catalyzes the formation of genotoxic 
NOCs, and cyto- and genotoxic LPOs [190]. In addition, heme may also exert direct toxic effects, 
although this is mostly uncharted at the time [191].  
 
4.3.2.1.1 Catalyzation of oxidation 
On multiple occasions, dietary heme has been linked to the urinary excretion of 1,4-
dihydroxynonane mercapturic acid (DHN-MA), a lipid peroxidation marker [197, 198]. Hence, it 
was hypothesized that ingested heme iron catalyzes (lipid per)oxidation processes. Ferrous iron 
(cfr. heme iron) can stimulate the formation of ROS and LPOs through the self-maintaining 
Fenton reaction [199]. More specifically, Fe2+ and Fe3+ can respectively be oxidized and reduced 
to their respective counterparts Fe3+ and Fe2+ through interaction with H2O2, resulting in the 
production of hydroxyl and hydroperoxyl radicals. These ROS maintain a cascade of oxidative 
reactions, leading to the direct or indirect oxidation of macromolecules including lipids, proteins 
and DNA. As such, meat oxidation processes can interfere with CRC initiation and promotion 
via the induction of oxidative stress and/or DNA adduct formation [190, 191, 196, 200].  
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4.3.2.1.2 Catalyzation of N-nitrosation 
As was explained previously (3.5 Alkylating N-nitroso compounds), there are several possible 
routes of NOC-exposure, including dietary intake and endogenous formation in the gut. Several 
studies have demonstrated that dietary heme iron, but not inorganic iron and/or meat protein, 
significantly increases fecal NOC-levels of human volunteers consuming a red meat diet [201-
204]. Hence, it appears that heme iron catalyzes NOC-formation upon red meat digestion. More 
specifically, it has been hypothesized that heme can capture NO (e.g. after release by S-
nitrosothiols under alkaline conditions in the small bowel), resulting in the formation of nitrosyl 
heme. Since nitrosyl heme can act as a nitrosating agent, heme iron could indeed promote 
endogenous NOC-formation [195]. 
The link between processed meat consumption and CRC appears to be more pronounced than 
for fresh red meat consumption. The vast majority of processed meats are produced by curing of 
red meat like beef, and mainly pork. After curing, the heme iron present is readily nitrosylated. 
Furthermore, Santarelli et al. documented that heme nitrosylation appears to be essential for the 
promotion of CRC through processed meat digestion [205]. Nitrosylated heme iron appears to 
be more reactive and thus also more toxic than non-nitrosylated heme iron [190, 205, 206], 
possibly explaining the more pronounced association of processed meat consumption with CRC.  
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Figure 10. Hypotheses on CRC promotion and inhibition through the diet, including the 
heme hypothesis, according to Bastide et al. [190]. 
 
4.3.2.2 The white meat controversy 
The so-called ‘white meat controversy’ is based on the observation that (1) processed meat 
consumption has a more pronounced correlation with CRC risk compared to fresh red meat, (2) 
processed meat is mainly constituted from pork, but (3) the difference in heme iron content 
between pork and white meat is not very pronounced, questioning the the dose-response effect 
of heme with regard to CRC. So, although the heme hypothesis has received a lot of scientific 
support, it appears that the heme hypothesis can only partly explain the link between (processed) 
meat consumption and an increased risk of CRC.  
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In light of this, Demeyer, Mertens, De Smet and Ulens [191] recently discussed the potential 
interfering role of mammalian cell surface sialic acid N-glycolylneuraminic acid (Neu5Gc). 
Humans cannot produce Neu5Gc, but accumulate Neu5Gc from red meat (lamb, pork and beef) 
and bovine milk consumption [207]. Since Neu5Gc is a ‘foreign’ molecule, production of 
antibodies and chronic inflammation might occur in response [208], hence contributing to the 
progression of CRC as inflammation is suggested to play a role in CRC development. The intake 
of milk products is inversely associated with CRC risk, but the synergistic effects of heme and 
Neu5Gc in (processed) red meat might offer a plausible explanation for the carcinogenic actions 
of (processed) red meat. Furthermore, the significantly higher levels of calcium in milk compared 
to processed meat, may further explain the adverse health effects of processed meat 
consumption, but CRC protective attributes of the consumption of calcium-rich dairy products 
[12].  
 
4.3.2.3 Heterocyclic amines and polycyclic aromatic hydrocarbons 
It was hypothesized that the formation of HCAs and PAHs during high temperature cooking of 
meat could be the underlying cause of red and processed meat carcinogenicity in the colon and 
rectum. However, since it has repeatedly been documented that cooked fish and poultry (= 
white meat) often contain equal or even higher levels of HCAs compared to red meat (e.g. beef 
and pork) [209], and the consumption of red, but not white meat, increases CRC risk, the 
formation of HCAs could not solely explain the observed link between red meat consumption 
and CRC [190, 192]. For PAHs, the cooking method, but not the type of meat seems to be 
associated with the level of exposure to PAHs. Processing of meat other than cooking, e.g. 
curing and smoking, could potentially also lead to elevated PAH concentrations. Red and 
processed meat intake as well as CRC risk could not be confidently linked with exposure to 
higher levels of PAHs [191, 210], rendering the HCA and PAH hypothesis to fall short at first 
glance. Nevertheless, the white meat controversy ushers to dig deeper; pointing out that 
additional mechanisms (besides the direct toxic effects of N-nitrosation and (lipid per)oxidation) 
might also contribute to red and processed meat associated CRC risk. With regard to PAHs and 
HCAs, it could be of importance that e.g. red meat induced oxidation processes can induce 
metabolic activation of PAHs and/or HCAs, an essential step in HCA as well as PAH induced 
mutagenesis and carcinogenesis (as explained previously; 3.2.3 Polycyclic aromatic hydrocarbons 
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& heterocyclic amines). For example, it has previously been demonstrated that (a) certain LPOs 
can induce COX-2 upregulation [211], (b) COX-2 can activate PAHs as well as HCAs [212], and 
(c) COX-2 expression is linked to CRC development [213]. Hence, new as well as old hypotheses 
should be given sufficient attention and studied more in-depth. 
 
4.4 DNA adduct analysis to assess the genotoxicity of red (and processed 
red) meat consumption  
The field of DNA adduct research is a highly promising area due to the proposed causal link 
between the prevalence of certain environmental genotoxins, the formation of DNA adducts 
and the onset of certain nonhereditary cancer types [42-44]. Furthermore, DNA adduct research 
does not only enable investigation of genotoxin exposure, uptake, and metabolism but can also 
provide us with information on the individual rate of DNA repair and individual susceptibility to 
permanent DNA damage, mutagenesis, and carcinogenesis [39, 41]. Luckily, a multidisciplinary 
approach and the continuously evolving field of analytical apparatus (will be discussed in “Liquid 
chromatography coupled to mass spectrometry as the analytical tool of choice”) available 
provide us with the appropriate tools for in-depth DNA adduct research in several specialized 
areas of research. As such, induction of DNA adduct formation due to e.g. N-nitrosation and 
oxidation processes via red meat consumption represents a highly interesting research topic to 
further unravel the link between red meat consumption and the development of CRC. 
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5. LIQUID CHROMATOGRAPHY COUPLED TO MASS 
SPECTROMETRY AS THE ANALYTICAL TOOL OF 
CHOICE  
5.1 The prominent advantages of mass spectrometry-based DNA adduct 
analysis  
DNA adduct analysis requires very sensitive and highly specific analytical techniques and 
methodologies. For years, 32P-postlabeling was the most utilized technique, and for some DNA 
adducts types, a sensitivity of 1 adduct per 1010 nucleotides could be achieved [214]. 
Unfortunately, false positives and artifacts are common when using this approach [215]. Mass 
spectrometry (MS) based detection techniques on the other hand, enable accurate identification 
of DNA adducts and can also provide structural information, in which other analytical methods 
often fall short. Multiple analytical techniques have contributed to the current knowledge on 
DNA adducts and DNA adduct detection techniques, which have been reviewed extensively 
[107, 216, 217]. The most important (dis)advantages of different analytical 
technologies/methodologies for DNA adduct analysis are summarized in table 5. This shows 
that some of the most commonly applied techniques may offer sufficient sensitivity, but without 
structural information and vice versa, or that specificity and sample preparation issues exist. In 
contrast, MS detection excels in specificity and structural identification [216-218].  
More than a decade ago, Koc et al. stated that the only disadvantage of MS in the field of DNA 
adduct analysis was its sensitivity [215]. Over the years, sensitivity has continued to improve [28, 
218] as different research groups have focused on optimization of DNA adduct detection 
methods with MS [99, 219-225], including research into non-manual data mining and sequencing 
to locate DNA adduction sites [226, 227]. Because of ongoing technical advancements and the 
use of stable isotope labeled internal standards, MS currently offers a reliable tool to measure low 
DNA adduct levels with the highest specificity [214-216, 218]. Coupling of MS with LC by 
means of the electrospray interface (ESI) has enabled analysis of DNA adducts in very complex 
biological matrixes [228] while avoiding complex and labor-intensive sample preparation with 
derivatization for the initially envisioned use of GC-couplings [229].   
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Table 5. The most prominent advantages and disadvantages of different analytical DNA 
adduct detection methods [216, 217]. 
Analytical technique Advantage(s) Disadvantage(s) 
Accelerator MS Most sensitive method for DNA 
adduct detection (up to 1 adduct 
per 1012 nucleotides) 
Need for administration and 
incorporation of 14C/3H-labeled 
compounds, specialized 
equipment, limited specificity, 
lack of structural information 
Electron capture detection Sensitive (< 1 adduct per 108 
nucleotides) 
Only applicable for electro-
chemically active DNA adducts; 
lack of versatility, poor 
identification 
Fluorescence detection Easy, robust, low cost Only applicable for fluorescent 
DNA adducts; lack of versatility 
Immunoassay Easy, robust, low cost Need for DNA adduct-specific 
antibodies, cross-reactivity; lack 
of specificity 
Immunohistochemistry Easy, robust Need for DNA adduct-specific 
antibodies, only semi 
quantitative, poor identification, 
limited structural information 
Ligase Mediated - Polymerase 
Chain Reaction 
Determination of DNA 
adduction at sequence level  
Low sensitivity (≈ 2.5 adducts 
per 104 nucleotides), variable 
specificity 
Nuclear Magnetic Resonance Provides structural information 
and identification 
No quantitation 
32P-postlabelling Sensitive (up to 1 adduct per 1010 
nucleotides), requires low 
amounts of DNA (1 - 10 µg), 
versatile, widely applicable 
Limited specificity, no structural 
information, need for 
radiolabelling 
Radiolabeled binding assay Easy No structural information, need 
for radiolabelling, interference 
with contaminants, need for high 
amounts of DNA (0.5 – 3 mg) 
GC-MS Provides structural information 
and identification, good 
sensitivity; up to1 adduct per 109 
nucleotides 
Need for specialized equipment 
(and internal standards), need for 
derivatization, induction of 
artifacts (oxidative DNA damage 
due to derivatization) 
LC-MS Provides structural information 
and identification, good 
sensitivity; up to 1 adduct per 109 
nucleotides 
Need for specialized equipment 
(and internal standards) 
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5.2 Targeted vs. untargeted DNA adduct analysis 
An important advantage of MS, in contrast to many other DNA adduct detection methods, is 
the possibility to detect both “targeted” and “untargeted” DNA adducts by means of full scan 
MS. Targeted DNA adduct detection (also known as “profiling”) refers to the detection of 
known types of DNA adducts, which implies that the MS system specifically scans for the 
presence of certain compounds of interest to assess their presence and abundance, while all 
other molecules in the sample are disregarded completely. On the other hand, untargeted 
analysis (also known as “fingerprinting”), refers to the detection of all compounds present, even 
if unknown or deemed irrelevant at the time [230]. The full scan data of biological samples can 
be searched for the presence of other DNA adduct types (known or unknown) in parallel or 
retrospectively, providing potentially highly relevant additional information. The targeted 
detection of DNA adducts accords with the bottom-up approach, whereas the untargeted 
mapping or fingerprinting of DNA adducts facilitates a top-down approach (figure 11). 
 
 
Figure 11. Targeted singular DNA adduct analysis vs. DNA adduct profiling vs. 
untargeted DNA adduct mapping. 
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5.3 Practical considerations for (mass-spectrometry-based) DNA adduct 
research 
5.3.1 Internal standards  
In recent years, the sensitivity of MS for DNA adduct quantitation purposes has increased 
significantly. The use of stable isotope labeled internal standards has provided a means to 
quantitate with high accuracy [215, 217, 218]. An internal standard can be manufactured by 
replacing one or several atoms in the DNA adduct structure with their 2H, 13C, 15N, or 18O 
isotopes. Because of the nearly identical chemical characteristics, these types of internal 
standards are well-suited for correction of variation due to losses during sample handling and 
preparation, local matrix effects, and possible fluctuations in sensitivity during analysis [215, 218]. 
In addition, the use of labeled (and unlabeled) (internal) standards facilitates compound 
identification by enabling comparison of the retention times that were obtained for different 
compounds.  
Unfortunately, appropriate internal standards for DNA adducts are not always easily obtained 
commercially [216]. Furthermore, there may be some concerns regarding the stability of the 
labeled internal standards [218]. Some deuterated DNA adduct analogues (e.g., d2-O6-CMG) lack 
chemical stability and are prone to decomposition due to exchange of deuterium for hydrogen 
[218, 231]. The stability of 13C, 15N, and 18O labeled DNA adducts seems to be less cause for 
concern, as their degradation likely parallels the breakdown of their unlabeled counterparts [215]. 
Furthermore, the internal standard should ideally differ in mass by 3 units from that of the 
compound under investigation. Hence, the use of 13C, 15N and 18O labeled internal standards is 
the obvious choice.  
If there is no appropriate and stable internal standard available at the time, analysis and 
quantitation by means of an external calibration line offers a possible alternative, although a less 
accurate approach for DNA adduct quantitation [218]. However, this offers no scope for 
correction due to sample preparation issues.  
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5.3.2 DNA adduct stability  
Sufficient knowledge on chemical stability of DNA adducts is extremely important for correct 
interpretation of results [38, 217].  However, it appears that only a limited number of studies 
have studied the stability of a limited number of adduct types, which was discussed in detail by 
Himmelstein et al [216].  DNA adduct stability depends on several factors including pH (e.g. 
M1dG is not stable under alkaline conditions [232]) and composition of storage buffers (e.g. Tris 
buffer induces M1dG instability [233]). Sample matrix (e.g. embedded in liver vs. kidney or other 
sample types [234]), sample processing (e.g. contamination by RNA can add to N7-MeG levels 
[235]), storage temperature (M1dG and benzo[a]pyrene DNA adducts, among others [233, 236]) 
and, last but not least, DNA adduct type or chemical composition (e.g. O6-MeG appears to be 
more stable than N7-MeG and N3-methylguanine [237]) also influence DNA adduct stability. In 
contrast, it appears that the number of freeze-thaw cycles and long-term storage might not 
significantly reduce DNA adduct stability [238-240]. 
In order to avoid incorrect interpretation and loss of results, sample handling and storage should 
be considered in a case-by-case manner and executed carefully and consistently. To improve 
knowledge on DNA adduct stability, researchers should opt to conduct more DNA adduct 
stability studies focusing on different DNA adduct types, sample handling and storage 
conditions; e.g. taking the use of certain DNA buffers and the optimum storage temperature into 
account. In the meantime, DNA should preferably be stored at -80°C, while evaporation to 
dryness may prevent early decomposition of DNA adducts [216]. 
 
5.3.3 Sample preparation 
Sample preparation is considered to be one of the most critical steps in analytical chemistry in 
general, but in particular for DNA adduct quantitation since DNA adducts are embedded in a 
complex matrix of abundantly present unmodified DNA building blocks [215]. To enable the 
simultaneous detection of a multitude of DNA adducts, sample preparation should be kept to a 
minimum, as extensive sample preparation procedures may induce artifacts (e.g. formation of 
oxo-dG during sample preparation), loss of sample and relevant information (due to, e.g., 
instability issues). In addition, sample preparation (cleanup and enrichment) can be quite time 
consuming and labor intensive. However, sufficient release of DNA adducts from the DNA 
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sequence (DNA hydrolysis efficiency), enrichment and removal of unwanted matrix constituents 
are indispensable [215, 216, 218]. 
DNA adducts can be detected individually as adducted nucleotides, nucleosides or nucleobases 
upon DNA hydrolysis, DNA adduct extraction and enrichment. The choice of measuring either 
adducted oligonucleotides, nucleotides, nucleosides or nucleobases greatly influences sample 
separation needs. Analysis of (oligo-)nucleotides is least common and requires enzymatic 
digestion of DNA. Likewise, analysis of nucleosides requires enzymatic digestion and is the most 
common method of sample preparation for mass spectrometry-based DNA adduct analyses. 
Thermally labile modified nucleobases can be released by means of thermal hydrolysis. More 
stable adducted nucleobases can be retrieved with thermal hydrolysis at high temperature or 
strong acid hydrolysis. By combining acid and thermal hydrolysis, both altered and unaltered 
nucleobases are cleaved from the DNA sequence [218]. Nonetheless, Kato et al. found that a 
single approach may not release all adducts, and had to employ two different enzymatic 
hydrolysis methods to prepare their samples, resulting in a doubled workload [241]. These 
procedures are lengthy and have multiple steps that may cause changes to the DNA and the 
adduct profile, which must be thoroughly investigated during method development.  
To improve the sensitivity, sample cleanup, and enrichment upon DNA hydrolysis or digestion 
are highly recommended [214, 216]. The envisioned removal of unmodified DNA building 
blocks and interfering contaminants (e.g. highly polar compounds that interfere with ionization) 
is required to minimize signal and ionization suppression [215, 218]. Frequently utilized on- or 
offline techniques for DNA adduct enrichment include immunoaffinity column purification, 
HPLC column switching, and solid phase extraction [214, 215, 218]. However, care must be 
taken with selection of the appropriate stationary phases and elution buffers to avoid 
degradation/loss of the adducts. In addition, immunoaffinity column purification can only be 
implemented prior to targeted analysis due to the specificity of the antibodies in use [242]. 
Therefore, this particular technique is only suited for targeted DNA adduct analyses but not 
DNA adductomics.  
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5.3.4 Study design  
The choice of an appropriate study design is considered to be one of the most important factors 
in DNA adduct studies. The exposome is very complex, dynamic, and continuously changing 
[26]. Therefore, measurement of the exposome or DNA adductome at one isolated moment in 
time will not answer all related research questions. Thus, assessment of individual exposure 
requires longitudinal studies [25, 38]. According to Wild, full characterization of the individual 
exposome requires an extensive number of sequential measures throughout a lifetime, or at the 
least, a smaller number of measures to assess exposures over a series of extended periods [26]. In 
addition, exposomics studies should also consider the interfering influence of other very 
important factors like sample handling, fixation, storage and tracking, lack of tissue homogeneity, 
differences in individual susceptibility, and genetic polymorphisms [38, 243]. Consequently, only 
well throughout long-term and large-scale (e.g. many individuals, appropriate controls and 
different tissue types) studies will enable correct and thorough assessment of DNA adduct 
profile.  
 
5.3.5 Surrogate vs. target tissue  
Ideally, DNA adduct formation should be monitored in the considered target tissue. A technical 
and ethical difficulty is that target tissue is not always easily obtained and/or available. A possible 
solution to that problem is the use of appropriate surrogate tissues like blood, urine, and 
exfoliated (e.g. buccal or gastrointestinal epithelial) cells, provided that DNA adduct levels in 
target and surrogate tissue are distinctly related and a sufficient amount of DNA can be collected. 
Typically, procedures use an initial amount of 100 µg of DNA although some require less; e.g. 
the most recent method by Kanaly et al. used 15 µg of DNA per injection [244]. If no data on 
correlation of particular DNA adducts in surrogate vs. target tissue are available, correlation 
studies should be performed during or prior to biomonitoring studies. Researchers must also 
consider the possibility that a certain type of surrogate tissue may be more appropriate than 
others or that a well-suited surrogate tissue simply does not exist [38, 245]. For example, 
although Wiencke et al. [246] were able to demonstrate the use of mononuclear blood cells as an 
appropriate surrogate tissue for lung tissue to study tobacco-associated DNA adduct formation, 
Kriek and coworkers were unable to correlate PAH-DNA adduct levels in white blood cells and 
lung tissue in lung cancer patients [247]. 
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5.3.6 Method validation 
Over the past 30 years, several papers have reported the development of new methods for the 
detection of single or plural DNA adducts in different matrixes. The use of analytical methods 
for DNA adduct detection and quantification in biomonitoring studies necessitates thorough 
evaluation of reliability and fit-for-purpose. This requires assured specificity, accuracy, precision 
and sensitivity, acceptable recovery and reproducibility, information about the assay and 
compound stability, and the assessment of detection and quantification limits [248]. Moreover, 
intra- and inter-laboratory variability need to be assessed and properly addressed [216]. However, 
at present, detailed and specific guidelines concerning the validation and interpretation of 
validation parameters of an analytical method for the detection of DNA adducts or possible 
biomarkers do not exist. 
Since biomarkers could provide interesting opportunities for the pharmaceutical industry, both 
the U.S. Food and Drug Administration (FDA) and European Medicines Agency (EMA) are 
aware of the urgency to establish proper validation guidelines for biomarker assays. In 
consequence, suitable guidelines are to be published as soon as possible [248, 249]. In 2013, the 
FDA published draft guidance for industry on bioanalytical method validation. In this draft 
guidance, the agency stated the following: “The accuracy, precision, selectivity, range, 
reproducibility, and stability of a biomarker assay are important characteristics that define the 
method. The approach used for pharmacokinetic assays should be the starting point for 
validation of biomarker assays, although FDA realizes that some characteristics may not apply or 
that different considerations may need to be addressed” [248]. In agreement, the EMA published 
a concept paper on good genomics biomarker practices in 2014 [249], which acknowledged and 
documented the need for guidance concerning choice and proper use of technology and 
methodology for genomic biomarker analysis in a clinical setting. Since DNA adducts are 
regarded as biomarkers of exposure and (possible) biomarkers of effect, the future FDA and 
EMA guidelines could provide a basis for validation of DNA adduct detection methods as well. 
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6. SPECIFIC FOCUS AND AIM OF THIS STUDY 
This PhD project envisioned to further unravel the possible causative role of red meat 
consumption in colorectal carcinogenesis via chemically induced DNA adduct formation.  
At the very start of this PhD, the possible cyto- and genotoxic effects of red vs. white meat were 
studied by means of the in vitro digestion of beef, pork and chicken. More specifically, the effect 
of meat type and heme content on cytotoxicity, lipid peroxidation, and the formation of 2 
specific NOC-related DNA adducts (i.e. O6-CMG and O6-MeG) were assessed using a targeted 
approach, all of which is described in Chapter II. 
To allow more in-depth assessment of the genotoxic effects of red meat consumption and 
digestion, the need for an untargeted ‘omics’ approach presented itself. Therefore, to be able to 
extensively investigate alkylation and (lipid per)oxidation related DNA adduct formation in 
relation to the NOC hypothesis as well as the lipid peroxidation hypothesis, a DNA adductomics 
methodology was developed and validated successfully. The optimization as well as a 
demonstration of the in vitro and in vivo application of the new methodology is described in 
Chapter III.  
Chapter IV reports the use of the newly developed DNA adductomics methodology to map the 
DNA adductome of red vs. white meat digests that were obtained by means of the in vitro 
digestion of chicken and beef. The effect of the addition of calcium (to meat preparations) on 
DNA adduct formation was investigated as well. 
In Chapter V, red vs. white meat genotoxicity, in the form of DNA adduct formation, was 
investigated on a much larger scale. In addition, the interfering role of myoglobin, carnitine or 
lysine was investigated to further unravel and mechanistically support the underlying 
mechanisms of red meat toxicity. 
The hypothesized genotoxicity of red meat consumption was also assessed in vivo, i.e. Chapter 
VI describes a rat feeding trial, during which 24 Sprague-Dawley rats received a diet with beef or 
chicken. Furthermore, to assess the interfering role of dietary fat, some rats were fed a chicken 
or beef diet supplemented with lard. After the 14-day feeding trial, shifts in the DNA adductome 
of liver, duodenum and colon were assessed to investigate the in vivo formation of DNA adducts 
due to red meat and/or lard digestion. 
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Finally, in Chapter VII, the main findings and conclusions from this PhD project are 
recapitulated, integrated and discussed comprehensively. The future needs, challenges and 
perspectives are addressed as well. 
 
Throughout this dissertation, the following research questions will be addressed: 
v Does red meat digestion promote lipid peroxidation? 
v Does red meat digestion stimulate the formation of N-nitroso compounds? 
v Can red meat digestion interfere with cell proliferation and viability? 
v Does red meat digestion give rise to the (increased) formation of certain types of DNA 
adducts? 
v How does red meat digestion alter the DNA adductome? 
v Does the supplementation of calcium alter the DNA adductome? 
v Does the addition of lard (to a meat preparation) alter the DNA adductome? 
v Does myoglobin addition alter the DNA adductome? 
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ABSTRACT 
Epidemiological and clinical studies have demonstrated that the consumption of heme-rich meat 
may contribute to the risk of colorectal cancer. Two hypotheses have been put forward to 
explain this causal relationship, i.e. NOC formation and lipid peroxidation. In this study, the 
NOC-related DNA adduct O6-CMG and the LPO product MDA were measured in individual in 
vitro gastrointestinal digestions of meat types varying in heme content (beef, pork, chicken). 
While MDA formation peaked during the in vitro small intestinal digestion, alkylation and 
concomitant DNA adduct formation was observed in seven (out of 15) individual colonic 
digestions using separate fecal inocula. From those, two heme-rich meat digestions demonstrated 
a significantly higher O6-CMG formation (p < 0.05). MDA concentrations proved to be 
positively correlated (p < 0.0004) with heme content of digested meat. The addition of 
myoglobin, a heme-containing protein, to the digestive simulation showed a dose–response 
association with O6-CMG (p = 0.004) and MDA (p = 0.008) formation. The results suggest the 
heme-iron involvement for both the LPO and NOC pathway during meat digestion. Moreover, 
results unambiguously demonstrate that DNA adduct formation is very prone to inter-individual 
variation, suggesting a person-dependent susceptibility to colorectal cancer development 
following heme-rich meat consumption. 
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In vitro gastrointestinal digestion, Malondialdehyde, Meat consumption,  
N-nitroso compounds, O6-carboxymethylguanine 
  
 
Chapter II 
 
  
70 
 
  
1. INTRODUCTION 
Epidemiological and clinical studies have demonstrated that the consumption of meat, and in 
particular red and processed meat is associated with certain health risks [1, 2]. Regular or high 
consumption of red and processed meat has been linked to the risk of CRC [1], coronary heart 
disease and also type 2 diabetes [2-4]. The link between red meat consumption and CRC on the 
one hand and red meat and type 2 diabetes on the other might even be intertwined [5, 6]. As a 
plausible origin for the increased CRC risk, the formation of endogenous NOCs has been 
hypothesized, since a dose–response relationship with the fecal excretion of NOCs for red and 
processed meat but not for white meat intake has been established [7-9]. The role of heme, 
abundantly present in red beef meat (1.8 mg/100 g) [10], in the fecal excretion of NOCs has 
been confirmed [11]. Heme can become readily nitrosylated and act as a nitrosating agent and 
thus promote the formation of NOCs [12]. A high-heme diet has also been suggested as a 
mechanistic basis in the observed correlation between lipid peroxidation (LPO) and increased 
CRC risk [13].  
NOCs, such as nitrosamines, nitrosamides or nitrosoguanidines, are known to be potent 
carcinogens. The alkylation of DNA is likely to be a major effect of metabolized N-alkyl-NOCs, 
which are able to interact with the nucleophilic centres of DNA bases [14, 15]. In addition, 
several nitrosated glycine derivatives have been shown to react with DNA in vitro to give NOC-
derived, i.e. carboxymethyl (e.g. O6-carboxymethyl-2’-deoxyguanosine, O6-CMdG), and to a 
lesser extent methyl adducts (e.g. O6-methyl-2’-deoxyguanosine, O6-MedG) [15-17]. Since glycine 
is one of the most common dietary amino acids, it would appear likely that nitrosation products 
of glycine would constitute a major source of alkylating agents in the human gastrointestinal tract 
(GIT) [18, 19]. This was reinforced by the detection of O6-CMdG and O6-methyl-2’-
deoxyguanosine in colonic biopsies and human blood DNA [17, 20, 21]. Additionally, O6-CMdG 
is not repaired by either bacterial or mammalian O6-methylguanine-DNA methyltransferase 
(MGMT) under in vitro conditions suggesting that this adduct is likely to accumulate in cellular 
DNA of GIT tissue and possibly represents a promutagenic lesion [15, 21]. The identification 
and quantification of very low DNA adduct levels, in vivo or in vitro requires ultrasensitive 
methodologies. This is in particular true for the analysis of human samples or in vitro applications 
on cell lines, where only small amounts of sample, and therefore DNA, are available. The 
different methods currently used for DNA adduct analysis include, i.e. immunoassays [22, 23], 
32P-postlabelling [24], GC-ECD [25] and HPLC with fluorescence detection [16, 26]. For several 
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years now, mass spectrometric detection has been playing an increasingly important role in the 
field of DNA adduct detection [27-30], since it achieves a perfect balance between a high 
specificity and sensitivity. Because of this, we developed an UHPLC-MS/MS method for the 
simultaneous detection of O6-methyl-G (O6-MeG) and O6-CMG adducts, with LODs of 30 and 
50 fmol/mg DNA, respectively [31].  
Lipids are biological targets of various reactive oxygen and nitrogen species. This oxidative stress 
leads to free radical chain reactions and subsequent formation of a vast array of by-products 
including aldehydes [32, 33]. The main aldehyde formed from the peroxidation of 
polyunsaturated fatty acids is MDA, a DNA-reactive product capable of forming exocyclic DNA 
adducts, of which most of these are anticipated to be highly mutagenic [34]. The mutagenicity 
and carcinogenicity of MDA has been confirmed in mammalian cells as well as in animals [34], 
and has been put forward as a plausible hypothesis for the link between high red meat 
consumption and CRC [13]. A variety of methods described in literature allow the detection and 
quantification of MDA in biological matrices. Nowadays, the most commonly employed method 
utilizes the reaction of MDA with thiobarbituric acid, resulting in the well-known thiobarbituric 
acid reactive substances (TBARS) assay [35]. Its product can be detected by colorimetry (532–
535 nm) or fluorimetry (excitation at 532 nm and emission at 553 nm) [38]. It is an easy and 
inexpensive method, however MDA may be bound to matrix molecules and therefore 
undetectable without an adequate step to liberate it, such as alkaline hydrolysis [36].  
Mechanistic studies investigating the correlation between red meat consumption and LPO as 
well as NOC-related DNA adduct formation are scarce. Therefore, during this study, in vitro 
gastrointestinal digestive simulations of different meat types were undertaken to determine 
which specific digestive processes are involved in the formation of the harmful NOC-related 
DNA adducts O6-MeG and O6-CMG and the LPO product MDA. DNA adduct formation was 
assessed by quantitatively measuring O6-MeG and O6-CMG using LC-QqQ-MS/MS. The LPO 
product MDA was directly measured by means of a TBARS assay. 
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2. MATERIALS AND METHODS 
2.1 Reagents and chemicals 
(Caution: Potassium diazoacetate (KDA) is carcinogenic. It should be handled in a well-
ventilated fume hood with extreme care and personal protective equipment.)  
The chemical standard O6-MeG was purchased from Sigma-Aldrich (St. Louis, MO, USA) and 
the internal standard O6-methyl-d3-guanine was obtained from Toronto Research Chemicals Inc. 
(Toronto, Canada). O6-CMG standard was derived via acidic hydrolysis with 0.1 M formic acid at 
70°C for 1 h, of O6-carboxymethyl-2-deoxyguanosine (O6-CMdG, purity > 96 %) [24]. The 
stock solutions of the chemical standards O6-MeG and O6-CMG were prepared in ethanol at a 
concentration of 6.06 and 4.8 mol/mL, respectively, and diluted with deionized water for 
obtaining working solutions of 818/81.8/8.18 fM and 646/64.6/6.46 fM, respectively. A 
working solution of O6-methyl-d3-guanine (118.9 fM) in deionized water was prepared as internal 
standard (IS). All solutions were stored in dark glass bottles at -20°C.  
KDA, a known nitrosated glycine derivative [15, 17], was synthesized via alkaline hydrolysis of 
ethyldiazoacetate (EtDA) Sigma-Aldrich) [16]. The stock solution of 800 mM KDA was made 
up of 1.14 g of EtDA and 11.4 mL of 1.8 M KOH, and mixed for 4 h at room temperature in 
the dark. Working solutions were obtained through dilution with PBS buffer [16].  
Reagents were of analytical grade (VWR International, Merck, Darmstadt, Germany) when used 
for extraction and purification, and of Optima R MS grade for MS application (Fisher Scientific 
UK, Loughborough, UK), respectively. 
 
2.2 Incubation conditions 
2.2.1 Collection and preparation of human fecal samples 
Fecal samples were obtained from 15 healthy volunteers (ten males and five females) between 
the ages of 20 and 60. Donors were on a Western-type diet and none had a history of digestive 
pathology nor had received antibiotics during 6 months prior to the sampling. All donors of 
fecal material were recruited among the laboratory personnel and their family members through 
informal announcement, after which all participating volunteers gave their written informed 
consent. The obtained data and volunteer information were analyzed anonymously and de-
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identified. The research was approved by the Federal Public Service of Health, Food Chain 
Safety and Environment, Belgium, but there was no need to submit an application to the ethical 
committee due to the non-invasive nature of the voluntary donation of fecal samples. 
Fecal slurries of 20 % w/v fresh inocula were prepared by homogenizing (stomacher 400 Classic 
Laboratory Blender, Seward, West Sussex, UK) the feces with PBS (0.1 M, pH 7), containing 1 
g/L sodium thioglycolate as reducing agent. The particulate matter and biomass were removed 
by centrifugation for 2 min at 500 x g. For storage purposes at -80°C, 20 % (v:v) of glycerol 
(99.5 %; Analar Normapur, Fontenaysous-Bois, France) was added to the supernatant as a 
cryoprotectant. 
 
2.2.2 Simulated gastrointestinal digestion 
Static in vitro incubation experiments of meat varying in heme content (chicken, beef and to a 
small extent pork) were performed in autoclaved penicillin flasks. The meat was therefore 
subjected to a sequential simulation of stomach, small and large intestinal digestion according to 
Van de Wiele et al. [37]. The different meat samples were obtained at a local butcher shop and 
their heme content was measured according to Hornsey [38]. A typical in vitro stomach digestion 
consisted of an incubation of 4 g of prepared meat (cooked for 10 min at 80°C to mimic a 
Western meal preparation) with pepsin (10 mg/L) for 2 h at pH 1.5 at a 1:10 ratio (v:v). Next, 
bile salts (6.0 g/L) and pancreatic enzymes supplemented as pancreatic powder of bovine origin 
(0.9 g/L) were added to the stomach suspension at a 1:2 ratio (v:v) to simulate small intestinal 
conditions. Small intestinal digestive simulation consisted of an incubation for 4 h at pH 7. 
Finally, for the colonic digestion, fecal microbiota (1:3 ratio (v:v)) and Simulator of the Human 
Intestinal Microbial Ecosystem (SHIME) broth (1:4 ratio (v:v)) were added to the small intestinal 
incubation mixture and incubation was continued for another 72 h after 1 h of N2 flushing. The 
colon suspension contained in vitro cultured microbiota that was isolated from human feces and 
is considered representative of the in vivo colon microbial ecology after a growth stabilization 
period in Brain Heart Infusion (BHI) broth at a 1:9 ratio (v:v) in N2 atmosphere. As a control, 
meat samples were incubated with inactive fecal microbiota. To this extent, fecal microbiota was 
autoclaved for 30 min (121°C, 1 bar overpressure). For investigating the heme-iron hypothesis, 
an additional in vitro digestion was performed with the fecal inoculum of an O6-CMG-producing 
volunteer (ID n° 7, as listed in table 1). Besides the beef, different amounts of myoglobin were 
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supplemented at the start of the digestion, i.e. 0, 2.8, 14.1 and 28.3 nmol of myoglobin per mL of 
digestive fluid, respectively.  
To avoid photocatalytic effects, all digestions were performed in amber flasks. Each batch 
culture was sealed with butylrubber stops and anaerobiosis was obtained by flushing the flasks 
with N2 alternating every 2 min with vacuum suction during 1 h. Resazurin (2 mg/L) was added 
as redox indicator to the fecal slurry and to the colonic stage of the digestion. A pink colour 
indicated a redox potential higher than -80 mV, a colourless solution showed a redox potential 
below this limit, i.e. anaerobic. The redox potential in the large intestine typically ranges between 
-150 and -280 mV [39]. During the in vitro digestion, sampling of stomach, small intestine and 
large intestinal digestion (at 0, 24, 48 and 72 h of the colonic incubation) was done using syringes, 
causing as little disturbance as possible to the bacterial environment. The samples were then 
stored at -20°C before analysis. All experiments were performed in triplicate. A schematic 
overview of the in vitro gastrointestinal digestion of meat and consecutive analyses are presented 
in figure 1. 
 
Figure 1. Schematic overview of the experimental setup of the in vitro gastrointestinal 
digestions of meat and consecutive analyses. 
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2.3 Cell culture 
The human colon carcinoma cell line Caco-2 (American Type Culture Collection, Manassas, VA, 
USA) was cultured as a monolayer in DMEM (Gibco Invitrogen cooperation) containing 10 % 
fetal calf serum, 1 % non-essential amino acids and penicillin (100 U/mL) and streptomycin (0.1 
mg/mL; all from Sigma-Aldrich), at 37°C in a humidified 5 % CO2 atmosphere. Cells were 
passaged weekly, using 0.25 % trypsin-EDTA. For the experiments, Caco-2 cells were harvested 
at 80 % confluency. 
 
2.4 DNA extraction 
Caco-2 cells, grown in a monolayer culture (80 % confluency), were collected after a 5 min 
incubation at 37°C with 0.25 % trypsin-EDTA. Prior to cell lysis, a cell viability rate of 99 % was 
confirmed by trypan blue exclusion. For DNA extraction, cells were centrifuged for 5 min at 10 
000 x g at 4°C to obtain a pellet. Subsequently, 1 mL of DNAzolÒ reagent (Molecular Research 
Centre Inc., Cincinnati, OH, USA) was added per 1 x 107 of cells. Lysis of the cells was obtained 
by gently pipetting the mixture or inverting the assay tube. DNA was precipitated from the lysate 
by adding 0.5 mL of 100 % ethanol per mL of DNAzolÒ reagent used for the isolation. Next, 
the sample was mixed by inversion and stored at room temperature for 1–3 min. DNA, visible as 
a cloudy precipitate, was collected by spooling with a pipette tip, while carefully decanting the 
supernatant. In case the resulting sheared DNA would not spool, 5 min centrifugation at 5000 x 
g was applied to obtain a DNA pellet. Finally, the pellet was resuspended in 250–500 µL of TE 
(Tris-EDTA) buffer. The concentration of the collected DNA was determined by a Nanodrop 
ND-1000 Spectrophotometer (Isogen Lifescience, IJsselstein, The Netherlands). 
 
2.5 Assessment of cell injury 
A colorimetric cell proliferation assay, WST-1 (Roche Diagnostics, Switzerland) was used to 
assess the cell proliferation and viability of the Caco-2 cells. The tetrazolium salt WST-1 is a 
ready-to-use substrate that is cleaved by mitochondrial dehydrogenase, which is present in viable 
cells [40], to formazan dye [41]. The total activity of this mitochondrial dehydrogenase correlates 
with the number of viable cells, which is in turn quantified by absorbance at 450 nm with a 
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scanning multi-well spectrophotometer. This is a quick and easy manner to investigate the 
cytotoxic effect of digestion samples [42].  
Caco-2 cells (200 µL; 1.25 e5 cells/mL) were seeded on flat-bottom 96-well plates and incubated 
at 37°C, 5 % CO2 for 24 h. The next day, the DMEM medium was removed and replaced by 100 
µL of the digest filtrates diluted in DMEM at 1:10, 1:50 and 1:100. The adhered cells were 
incubated for 24 h with the digestive fluid. Afterwards, 10 µL of the ready-to-use WST-1 reagent 
was added to each well and incubated for 2 h at 37°C, UV-VIS absorption was measured at 450 
nm. Cell cytotoxicity was determined in quadruplicate and calculated accordingly: [((ANegative control - 
ABlank control) - (AExperimental value - ABlank control))/(ANegative control - ABlank control)] x 100; where AExperimental value is 
the absorbance of the sample, ABlank control is the absorbance of DMEM medium and ANegative control is 
the absorbance of cells incubated with DMEM medium. Additionally, some wells were treated 
with 10 % Triton X-100 solution as a positive control (no cell viability).  
For the WST-1 test, a sample selection was made based on the results of the chemical analysis of 
the NOC-related DNA adducts. To this end, the cytotoxicity of the colonic digestive samples 
was investigated. In total, six fecal inocula were selected, of which three that displayed DNA 
adduct formation during colonic digestion and three with no to low DNA adduct concentrations 
upon colonic digestion.  
 
2.6 Chemical analysis 
2.6.1 Extraction protocol for DNA adducts 
As a preparative step, all digestive samples were filtersterilized (0.22 m) to ensure the absence of 
bacterial cells. Afterwards, 182 µL of the filtersterilized sample was supplemented with 100 µg 
Caco-2 DNA and 5.95 pmol of O6-Me-d3-G (internal standard at 118.9 fM). Prior to the 
incubation step (18 h at 37°C, stirred at a constant speed of 150 RPM), the volume of the 
samples was standardized to 500 µL by means of TE buffer. The next day, an acidic hydrolysis (2 
mL of 0.1 M formic acid for 30 min) at 80°C was performed on all samples to release DNA 
bases, allowing detection of the individual targeted DNA adducts. Before applying the 
hydrolysate to a SPE cartridge which was conditioned with 2 mL of 100 % methanol and 
equilibrated with 2 mL deionized water, it was cooled down in crushed ice. The Oasis HLB SPE 
(30 mg, 1 mL) was, after loading the hydrolysate, eluted with 2 mL of 100 % methanol. The 
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collected fraction was then evaporated to dryness (90 min, 20°C) using a SpeedVacÒ Plus 
(Savant, Holbrook, NY, USA). Finally, the dried residue was redissolved in a total volume of 100 
µL of mobile phase consisting of 90/10 0.05 % acetic acid in deionized water/methanol [31]. As 
positive and negative control, 100 µg Caco-2 DNA in TE buffer was dissolved and incubated 
with and without the addition of 2 mM KDA, respectively.  
 
2.6.2 HPLC-MS/MS measurement of DNA adducts 
An extensive validation of the LC-MS/MS analysis method for the detection of the NOC-related 
DNA adducts O6-MeG and O6-CMG, characterised with an LOD of 30 and 50 fmol/mg DNA, 
respectively, as well as the selection of a proper internal standard was previously described by 
Vanden Bussche et al. [31].  
Before every analysis, injection of a standard mixture of the target compounds checked the 
operational conditions of the chromatographic device. Concentration of the analytes was 
calculated by fitting area ratios in a 12-point calibration curve, established in Caco-2 DNA 
fortified with O6-MeG and O6-CMG in the range of 0–817 and 0–645 pmol/mg DNA, 
respectively, with the IS at 118.9 fM. Instrument control and data processing were carried out 
with Xcalibur Software (Thermo Electron, San José, USA). 
 
2.6.3 Apparent total N-nitroso compound analysis 
The digestive samples were analysed by thermal energy analysis for the determination of the 
apparent total N-nitroso compounds (ATNCs). A selective chemical de-nitrosation with 
iodine/iodide reagent was performed to detect the ATNCs according to Kuhnle et al. [43]. A 
digestive homogenate of 100 µL was taken and incubated with 500 µL of aqueous 
sulphanilamide (50 mg/mL in 1 M HCl) for 5 min to remove unbound nitrite. Afterwards, the 
sample was injected into a custom-made purge-vessel containing the iodine/iodide reagent kept 
at 60°C. The released NO was transferred by nitrogen to the NOA chemiluminescence analyser 
(Model 88 et, Eco Physics, Duernten, Switzerland), via a condenser consisting of a NaOH (1 M) 
trap. For differentiation between the N-nitroso, nitrosothiol and nitroso-heme compounds, 
mercury (II) stable (nitrosothiols) and potassium ferricyanide stable (nitrosyl iron) compounds 
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were determined under exactly the same way as described above after an additional incubation 
with HgCl2 (53 mM) and K3Fe(CN)6 (4 mM), respectively. Results were expressed as mmol of 
NO released per L of digestive sample.  
 
2.6.4 TBARS assay 
The MDA concentration in the digestive samples was measured by a modified method in 
accordance with Grotto et al. [35]. TBARS were formed from the reaction of MDA with 2-
thiobarbituric acid in an acid environment. The absorbance of the coloured complex was 
measured spectrophotometrically (Genesis 8 UV-VIS Spectrometer, Spectronic-instruments, 
UK) at 532 nm with an LOD of 0.05 nmol/mL of digestive sample. The TBARS concentration 
was expressed in nmole MDA per mL of digestive fluid and determined by means of a 7-point 
calibration curve with 1,1,3,3-tetramethoxypropane (0–50 nmol/mL). 
 
2.6.5 Metabolic activity 
Liquid digestion samples (2 mL) were collected and frozen at -20°C to inhibit further bacterial 
activity. For analyzing short chain fatty acids (SCFA), the samples were extracted with diethyl 
ether prior to the analysis on a Di200 gas chromatograph (Shimadzu, Hertogenbosch, The 
Netherlands). The GC was equipped with a capillary free fatty acid packed column (EC-1000 
Econo-Cap column, Alltech, Laarne, Belgium; 25 m x 0.53 mm, film thickness 1.2 m), a flame 
ionisation detector and a Delsi Nermag 31 integrator (Thermo Separation Products, Wilrijk, 
Belgium). Nitrogen was used as carrier gas at a flow rate of 20 mL/min. The column 
temperature and the temperature of the injector and detector were set at 130°C and 195°C, 
respectively.  
For the analysis of phenolic compounds (indol, phenol and p-cresol), a liquid/liquid extraction 
with n-hexane was performed prior to the GC-MS detection (PolarisQ, Thermo Fischer 
Scientific, San Jose, CA, USA). The Trace GC 2000 Gas Chromatograph was fitted with a 
PolarisQ quadrupole ion trap mass spectrometer. Helium (99.99 % purity, Air Liquide, France) 
was used as carrier gas at a flow rate of 3 mL/min. A volume of 1 µL was injected (split flow 10 
mL/min, splitless time 1 min). The GC was equipped with a Bpx-5 column (SGE, Victoria, 
Australia; 25 m x 0.22 mm, film thickness 0.25 m), injector, ion source and transfer line 
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temperature were, respectively, 290°C, 260°C and 250°C. The column temperature consisted of 
a three-step temperature gradient starting at 40°C and went up to 350°C. Ammonia analysis was 
performed on a 1026 Kjeltec Auto Distillation apparatus (FOSS Benelux, Amersfoort, The 
Netherlands). Ammonium in the sample was liberated as ammonia by the addition of MgO. The 
released ammonia was distilled from the sample into a boric acid solution, which was 
subsequently back-titrated using a 665 Dosimat (Metrohm, Berchem, Belgium) and 686 
Titroprocessor (Metrohm). 
 
2.7 Statistics 
Linear mixed model analysis (TIBCO Spotfire S+R 8.2, Göteborg, Sweden) provided a powerful 
and flexible approach to handle the correlated data (i.e. repeated measurements on each fecal 
inoculum over time, etc.). In this model, both fixed as well as random effects were incorporated, 
respectively, the meat type and the variability between the different volunteers. Mixed models 
can also be extended to non-normal outcomes. Additionally, a paired t-test and an ANOVA 
fixed effect model (TIBCO Spotfire S+R 8.2) were applied to investigate the individual response 
variable per volunteer. 
 
 
3. RESULTS 
To investigate the influence of different meat types on specific metabolic and biological end 
points relevant to the gastrointestinal health status, in vitro digestive simulations were performed. 
Three different meat types (chicken, pork and beef) varying in heme content were selected, with 
the main focus on beef and chicken. To obtain representative microbial communities during the 
colonic in vitro digestion, 15 fecal inocula, obtained from healthy volunteers, were used in 
separate fermentation experiments. 
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3.1 Heme content of meat 
The heme contents of the different meat types were determined at 2.57 ± 0.08, 4.97 ± 0.11 and 
34.92 ± 0.35 nmol/g for chicken, pork and beef, respectively. Based on the heme analysis of the 
different meat types, the following heme concentrations were initially present in the incubation 
flasks: 1.40, 0.20, 0.10 nmol/mL for beef, pork and chicken, respectively. 
 
3.2 NOC-related DNA adducts 
The digestive fluids obtained during the different stages of the in vitro digestion were incubated 
with the extracted DNA of the colonic epithelial Caco-2 cell line to investigate the potential 
formation of O6-CMG and O6-MeG. After incubation and extraction, the samples were 
quantitatively analyzed for the presence of the O6-CMG and O6-MeG DNA adducts by LC-
MS/MS. As a positive control, Caco-2 DNA was incubated with 2 mM KDA, a reactive 
intermediate derived from nitrosated glycine, capable of inducing alkylation induced DNA 
adducts like O6-CMG and O6-MeG [15-17]. This resulted in the detection of O6-CMG at 10.4 ± 
1.1 pmol/mL and of O6-MeG at 1.4 ± 0.3 pmol/mL. Omitting KDA resulted in the absence of 
both DNA adducts.  
O6-CMG and O6-MeG could not be detected in the simulated digestive fluids of the stomach 
and small intestine after overnight incubation with Caco-2 DNA. In samples taken at the end of 
the colonic digestion (after 72 h of incubation), seven out of 15 colonic digests contained the 
possibly NOC-derived DNA adduct O6-CMG. The two positive female inocula and five positive 
male inocula all belonged to different age categories. At the start of the colonic digestion (0 h), 
five out of seven digests that were positive at 72 h, already contained low amounts (<55 
pmol/mL) of O6-CMG (table 1). The O6-CMG concentration in the positive digestive fluid 
samples increased significantly (p < 0.05) from 0 to 72 h for six fecal inocula, whereas one 
inoculum showed a borderline significant decrease (p = 0.094).  
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Table 1. Mean (± s.e.) concentrations of O6-CMG (pmol/mL) formed during in vitro 
colonic digestive simulation of chicken and beef by means of the fecal inocula of 15 
different individuals (N.D.: not detected; significantly higher with a *p-value < 0.10 or 
with a **p-value < 0.05). 
ID Sampling time (h) O6-CMG (pmol/mL) 
in chicken 
O6-CMG (pmol/mL) 
in beef 
1 0 33.7 ± 1.2 41.1 ± 4.5 
72 226.4 ± 6.5 539.3 ± 77.5* 
2 0 N.D. N.D. 
72 548.0 ± 33.2 1594.8 ± 119.2** 
3 0 9.7 ± 0.5 14.0 ± 0.3** 
72 174.0 ± 10.9 231 ± 14.1** 
4-6 0 N.D. N.D. 
72 N.D. N.D. 
7 0 29.9 ± 1.2 32.3 ± 2.1 
72 619.8 ± 21.7* 492.3 ± 25.6 
8 0 50.6 ± 2.0 54.4 ± 4.9 
72 1324.4 ± 103.4 1254.8 ± 75.1 
9 0 N.D. N.D. 
72 37.7 ± 0.8 39.8 ± 1.7 
10 0 N.D. N.D. 
 72 46.7 ± 1.3 39.6 ± 3.9 
11-15 0 N.D. N.D. 
72 N.D. N.D. 
 
Upon linear mixed effect modelling of means, a borderline significant difference (p = 0.055) was 
observed in O6-CMG DNA adduct formation between the different digested meats at the end of 
the colonic digestion. When looking at each of the seven O6-CMG positive fecal inocula 
individually (by means of paired t-test), the beef indicated a significantly higher genotoxic effect 
compared to the digested chicken (p < 0.05) for two out of seven inocula. The inoculum of one 
volunteer displayed a borderline significantly higher genotoxic effect for beef (p < 0.1; table 1). 
For one other inoculum, chicken proved to generate more DNA adducts compared to beef (p < 
0.1; table 1). Noteworthy was that O6-MeG was never detected in any of the digestive fluids of 
the 15 volunteers.  
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During a second experiment, additional digestions of pork (cfr. cytotoxicity of meat) with six 
different fecal inocula were performed. To this purpose, three O6-CMG-producing and three 
non-O6-CMG-producing fecal inocula were randomly selected. In figure 2, the O6-CMG 
concentrations of the three (out of six selected) fecal inocula, which produced the alkylation 
induced DNA adduct upon colonic digestion, are displayed. Two of these showed a significant 
difference (p < 0.05) between the generated O6-CMG adducts derived from the digested pork 
and chicken, whereas the third volunteer only displayed a borderline significant difference (p < 
0.1). The differences between the digested pork and beef were less pronounced (p < 0.1, only for 
two out of three inocula; figure 2).  
 
 
Figure 2. Mean (± s.e.) O6-CMG levels (pmol/mL) in the different colonic digestive 
samples (0, 24, 48, 72 h) for three different fecal inocula, performed in triplicate with 
three different meat types (Significantly higher than chicken with *p-value < 0.1 or **p-
value < 0.05 or ***p-value < 0.01; significantly higher than pork with °p-value < 0.1.). 
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Additionally, an investigation into the involvement of the colonic microbiota in the DNA adduct 
formation process was envisaged. To this extent, the six selected fecal inocula underwent 
autoclavation (121°C, 1 atm, 15 min) and in vitro digestive simulation of the different meat types. 
During this experimental set-up, it was not possible to detect O6-CMG or O6-MeG in any of the 
different digestive samples (data not shown).  
The addition of a fecal inoculum to the colonic stage of the in vitro digestion results in the 
presence of a large quantity of bacterial DNA, 7–8 log 10 colony forming units/mL digestive 
fluids. This bacterial DNA might undergo alkylation due to ongoing N-nitrosation taking place 
during the digestive process. In order to investigate the contribution of bacterial DNA to the 
formation of the O6-CMG DNA adduct, the addition of Caco-2 DNA to the incubation step of 
the digestive samples upon LC-MS/MS analysis was omitted. No significant differences (p > 
0.05) in DNA adduct levels were observed in the presence or absence of Caco-2 DNA.  
 
3.3 Cytotoxicity of digested meat 
The WST-1 proliferation assay was used to investigate the cytotoxic effect of the different meat 
types during in vitro colonic digestion. The digested meat samples were diluted 1:10, 1:50 and 
1:100. The latter two displayed only a small decrease in total cell activity (14.1 ± 0.6 %) compared 
to the control. The 1:10 dilution affected the enzymatic cell activity the most (25.3 ± 1.4 %). At 
the beginning of the colonic digestion (0 h), a limited but significantly higher cytotoxic effect 
could be observed for the digested chicken as compared to the beef (p = 0.053). For the digested 
beef samples, a non-significant increase in cytotoxicity (p > 0.1) was observed after colonic 
digestion (0 versus 72 h), in all six of the selected fecal inocula (figure 3). 
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Figure 3. Results of the WST-1 cell proliferation assay of Caco-2 cells incubated (24 h) 
with the colonic digestive fluids of different meat types (dilution 1:10; 0 and 72 h), 
calculated as the average of six fecal inocula incubations, each performed in triplicate (a, 
b: a bar with a different letter differs with a 90 % confidence interval).  
 
3.4 Total apparent N-nitroso compound analysis 
The main focus of the ATNC analysis was to single out the NOC fraction from the other NO-
contributing compounds, e.g. nitrosothiol, nitrosyl iron, by means of selective chemical 
denitrosation and chemiluminescence detection [43]. The presence of the NOC-related DNA 
adduct O6-CMG was detected during the colonic digestion and peaked towards the end, 
however no NOCs were found during this stage of the colonic in vitro digestion simulation. The 
only digestive fluids positive for NOCs were the stomach samples, this however at very low 
concentrations (<35 nmol of NO derived from NOCs detected per L of digestive sample), and 
with the highest concentration found for the digested beef samples (data not shown). 
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3.5 TBARS assay 
To determine the levels of the main LPO end product MDA in the digestive samples, a TBARS 
analysis was performed on all digestive fluids. The highest MDA concentrations (15 fecal inocula 
performed in triplicate, mean ± SE) were observed at the beginning of the colonic simulation (0 
h: 22.3 ± 4.9 nmol/mL and 17.5 ± 3.3 nmol MDA/mL in digestive fluids of beef and chicken, 
respectively) and decreased towards the end (72 h: 10.5 ± 6.1 nmol/mL and 6.9 ± 3.9 nmol 
MDA/mL for digested beef and chicken, respectively). By mixed linear effect modelling of the 
means, a significant difference was observed between the MDA results (p < 0.0001) between 0 
and 72 h of colonic digestion, but also between the different meat types (p < 0.0004). As 
displayed in figure 4, the direction of response for MDA formation appeared to be consistent 
towards the high-heme meat. 
 
Figure 4. MDA concentrations (mean ± s.e., performed in triplicate) for all 15 volunteers 
measured at the beginning of the in vitro colonic digestive simulation (0 h) for a low and 
high heme containing meat, chicken and beef, respectively. 
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3.6 Heme involvement 
It is speculated by Corpet [13] that heme iron could play a major role in cancer promotion [44]. 
This hypothesis is supported by a meta-analysis of epidemiological studies that shows a 
suggestive association between dietary heme and risk of colon cancer [45]. For this reason, an 
additional in vitro gastrointestinal digestive simulation comprising a sequential stomach, small 
intestinal and large intestinal digestion was performed. For the large intestinal digestion, a fecal 
inoculum of an O6-CMG- and high-MDA-producing volunteer was selected and added. 
Different amounts of myoglobin, the major heme-containing protein in mammalian muscle 
tissue, were added at the start (i.e. stomach) of the in vitro gastrointestinal beef simulation, 0, 2.8, 
14.1 and 28.3 nmol of myoglobin per mL of digestive fluid were supplemented, respectively. As 
depicted in table 2, a clear positive dose response could be noticed for the O6-CMG DNA 
adduct formation when heme-containing myoglobin was added to the digestion. An increase in 
the myoglobin dose (28.3 nmol/mL) resulted in significant higher concentration levels of O6-
CMG (p = 0.004, by ANOVA).  
All of the digestive samples of this experiment were also analyzed for their MDA levels, which 
peaked at 0 h of the colonic digestion. A positive dose response of MDA towards higher 
myoglobin concentration levels was also observed, with the most pronounced effect at the 
beginning (0 h) of the colonic digestion (p = 0.008) compared to the end (72 h) (p = 0.015). 
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Table 2. Mean (± s.e.) O6-CMG and MDA concentrations after the addition of different 
amounts of myoglobin to in vitro digestive simulations of beef (N.D.: not detected; a,b : 
means within a row with a different subscript differ significantly (p-value < 0.05)). 
 Sampling 
time (h) 
Amount of myoglobin added 
(nmol/mL digestive fluids) 
  0.0 2.8 14.1 28.3 
O6-CMG 
(pmol/mL) 
0 N.D. N.D. N.D. N.D. 
 72 2.3 ± 0.7a 7.8 ± 1.2a 12.4 ± 0.6a 36.4 ± 7.5b 
MDA 
(nmol/mL) 
0 15.8 ± 0.6a 17.4 ± 0.9a 19.7 ± 1.0ab 19.8 ± 0.5b 
 72 6.0 ± 0.1a 7.6 ± 0.7ab 7.8 ± 0.3ab 8.4 ± 0.2b 
 
 
3.7 Metabolic activity 
To evaluate the microbial fermentation during the three different meat incubations (bovine, 
porcine and poultry), SCFAs, indol, p-cresol, phenol and ammonia were monitored during the in 
vitro colonic digestive simulation (table 3 and 4). An increasing amount of SCFAs was produced 
during the colonic digestion approximating the acetic acid:propionic acid:butyric acid molar ratio 
of 60:20:20 as put forward by Cummings [46]. The digestion of the different meat types did not 
influence the SCFA profile significantly, the fecal inocula of the different volunteers however did 
as shown by the beef data (table 3 and 4). Similar results were obtained for the other meat types. 
Noteworthy is that elevated butyric acid profiles were observed for three out of six fecal inocula 
(four to six) at the end of the colonic digestion. The measured concentrations of indol, phenol, 
p-cresol and ammonia did not display significant differences between the different meat types 
and the different fecal inocula (data not shown).  
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Table 3. Mean (± s.e.) SCFA concentrations (mM) of the colonic suspensions of the beef 
digests for the fecal inocula of six selected volunteers (numbered 1 to 6) at 0 h of the 
colonic digestion (N.D. = not detected; a, b, c, d, e: means within a row with a different 
subscript differ (p < 0.05)). 
ID 1 2 3 4 5 6 
Acetic 
acid 
10.5 ± 0.2a 11.5 ± 1.6 ab 3.7 ± 0.4c 14.0 ± 0.1bd 14.3 ± 0.4bd 11.4 ± 
0.8abd 
Propionic 
acid 
1.0 ± 0.0a 2.5 ± 0.2a 1.7 ± 0.2a 7.9 ± 0.1b 6.9 ± 0.4c 2.0 ± 0.1a 
Butyric 
acid 
0.3 ± 0.0a 1.3 ± 0.8ab 8.2 ± 0.7c 23.3 ± 0.7d 10.5 ± 0.8c 2.6 ± 0.2b 
Branched 
acids 
N.D. N.D. N.D. 0.3 ± 0.0 N.D. N.D. 
 
 
Table 4. Mean (± s.e.) SCFA concentrations (mM) of the colonic suspensions of the beef 
digests for the fecal inocula of six selected volunteers (numbered 1 to 6) at 72 h of the 
colonic digestion (a, b, c, d, e: means within a row with a different subscript differ (p < 0.05)). 
ID 1 2 3 4 5 6 
Acetic 
acid 
52.7 ± 
2.3abde 
46.4 ± 2.1ab 34.9 ± 2.2c 21.9 ± 0.4ad 61.2 ± 
1.7abde 
51.0 ± 3.0ae 
Propionic 
acid 
9.2 ± 2.2a 22.2 ± 1.5b 20.6 ± 2.7ab 20.1 ± 0.6b 23.8 ± 1.2b 23.6 ± 1.5ab 
Butyric 
acid 
21.7 ± 2.6a 12.1 ± 
6.0abd 
16.6 ± 3.7cd 45.0 ± 
1.8bcd 
41.6 ± 
2.7abcde 
32.2 ± 1.0ab 
Branched 
acids 
13.1 ± 0.5a 3.2 ± 2.7bc 1.7 ± 0.6bc 0.6 ± 0.1abd 13.7 ± 0.9b 2.3 ± 0.3bc 
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4. DISCUSSION 
It has been suggested that heme iron may play a major role in CRC promotion. Two 
independent pathways have been hypothesised in explaining the link between heme and CRC 
promotion. Lipid peroxidation, on the one hand, resulting in the formation of potent aldehydes 
(i.e. MDA), capable of producing mutagenic DNA adducts, and the N-nitroso pathway, on the 
other hand, leading to DNA alkylation and DNA adduct formation [13]. The aim of this study 
was to explore both pathways in order to assess the potential genotoxicity and molecular 
mechanisms involved in different meat types varying in heme content (beef, chicken and pork) 
under simulated GIT conditions. To investigate the genotoxicity of the digested meat types, in 
terms of possible NOC-derived DNA adduct formation, two alkylation type DNA adducts were 
selected, namely O6-CMG and O6-MeG. Previous research has demonstrated their presence in 
colonic cell tissue, indicating their relevance in CRC promotion [20, 21]. To investigate the 
NOC-related DNA adduct formation potential of the different digestive fluids, the latter were 
incubated with extracted DNA of the human colorectal adenocarcinoma cell line Caco-2 prior to 
LC-MS/MS analysis. This approach was preferred over the incubation with whole cells, which 
displayed unacceptable inter-batch variation between the different passages of the cell cultures 
and a low sample throughput [31]. Furthermore, in previous research, we were able to 
demonstrate that DNA adduct concentrations did not significantly differ if a known NOC 
(KDA) was added to Caco-2 cells or to pre-extracted Caco-2 DNA [31]. 
The incubation results demonstrated that the O6-CMG DNA adduct was formed for seven out 
of 15 fecal inocula during the large intestinal (colonic) simulation and significantly increased 
towards the end of the colonic digestion (p < 0.05). 
When assessing the role of the different GIT compartments in the DNA alkylation pathway, the 
data of the ATNC measurements with nitrosyl iron as mean contributor and O6-CMG, both 
peaking at the end of the colonic digestion, reflect the significance of the large intestine. The key 
factor in the endogenous alkylation appears to be the presence of an active microbial community, 
which was acknowledged by the absence of O6-CMG when autoclaved fecal inocula were added 
to the batch cultures. Massay et al. [47] reported the same observation in germ-free rats, where 
N-nitrosation did not occur due to the absence of a normal microbial population. Moreover, the 
essential role of the individual microbiota is reflected by the observed inter-individual differences 
[48] in the formation of the O6-CMG DNA adduct (table 1). It is clear from literature that the 
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composition and metabolic activity of the colonic microbiota can differ considerably between 
and even in individuals during the course of their lifetime [48]. With respect to NOC formation, 
the N-nitrosating properties of certain bacteria colonizing the individual human gut (and a 
possible connection to carcinogenesis) have been demonstrated before [49-51]. Furthermore, the 
possible role (of the exact composition) of the individual gut microbiota in health and disease 
was already pointed out decades ago [52], and has been brought to the surface even more in 
recent years [53, 54]. Other examples of significant inter-individual differences in the 
transformation of dietary compounds or contaminants such as, phytoestrogens [55], heterocyclic 
aromatic amines [56], polycyclic aromatic hydrocarbons [37], etc. have been reported.  
For five out of seven O6-CMG-generating fecal inocula, the O6-CMG DNA adduct could 
already be detected at the mere beginning of the colonic digestion. The only difference between 
the small intestinal fluids, where O6-CMG was never detected, and the initial colonic digestive 
fluids (before 72 h of incubation), is the addition of the individual fecal inoculum. We concluded 
that for those five volunteers, O6-CMG was already present in the fecal inoculum, most probably 
due to in vivo formation of this DNA adduct prior to sampling. O6-CMG quantities in the fecal 
inocula of the two other volunteers may have been absent or below the detection limit of the 
utilized LC-MS/MS method. Indeed, the presence of O6-CMG in certain human fecal samples 
further demonstrates the in vivo relevance of O6-CMG since O6-CMG has previously been 
detected in various biological samples (i.e. blood, colonic biopsies and exfoliated colonocytes) 
[17, 20, 21, 31]. 
To investigate the genotoxicity of the different meat types (i.e. chicken and beef) with respect to 
the NOC pathway, a mixed model analysis of the entire dataset was performed. This statistical 
analysis demonstrated a borderline significantly higher (p = 0.055) O6-CMG concentration for 
beef versus chicken at the end of the colonic digestion (72 h). The suggested higher genotoxicity 
of red meat is in line with previous in vivo studies, indicating that a higher N-nitrosation occurs 
when heme-rich meat has been digested [7, 8, 21, 43]. Most of these studies used the fecal 
ATNC concentration to compare the dose response of heme-rich versus low-heme meat. 
Accordingly, ATNC analyses were performed on the digestive samples obtained from our in vitro 
stomach, small and large intestinal digestions to correlate the N-nitrosation process during the 
incubations with the obtained O6-CMG values. No NOCs were detected in the digestive fluids 
of the small and large intestinal digestion. This finding might also suggest as reported by Mirvish 
[18] that besides NOCs, other nitrite-derived alkylating agents may be responsible for the 
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formation of O6-CMG. Moreover, these agents might be unable to form O6-MeG, providing a 
potential additional explanation for the absence of O6-MeG. The largest fraction of the ATNC 
measured (data not shown) however consisted of nitrosyl iron, reinforcing the involvement of 
heme in the link between a high red meat diet and CRC [11, 13, 21, 43]. 
To mimic the human in vivo gastrointestinal digestion of meat, this study relied on sequential in 
vitro incubations. These in vitro models take into account the human physiology by simulating the 
transit through the human digestive tract, which can be executed either by using separate GI 
compartments or by sequential exposure of the food source to simulated mouth, gastric, small 
and large intestinal conditions [57-59]. Though the use of these types of batch cultures has its 
limitations, i.e. absence of gastrointestinal absorption, lack of interaction with the host colonic 
mucosa, etc., in vivo studies were not considered here due to lack of versatility in terms of 
mechanistic explorative work as well as time consuming and costly nature [60]. Furthermore, 
whenever possible, in vivo studies should be avoided due to ethical considerations. For this study, 
the advantage of sequential batch cultures lies with the fact that they allow to investigate which 
element or mechanism within the gastrointestinal digestion is involved in the studied process. To 
enable the use of different fecal inocula in a shorter time frame in combination with a 
consecutive multi-phase simulation of the GIT, static over dynamic batch cultures were 
preferred [57].  
The addition of pre-cultured microbiota (fecal inoculum) to the batch cultures resulted in the 
presence of a large quantity of bacterial DNA (350 pmol DNA/mL digestive fluids for 7–8 log 
10 colony forming units/mL). Analyzing the colonic digestive samples for O6-CMG without the 
incubation of Caco-2 DNA did not result in a significant difference in O6-CMG levels. This 
finding suggests that alkylation of the DNA occurred during the in vitro digestion, indicating the 
highly reactive nature of either NOCs, possibly explaining the absence of NOCs in the ATNC 
measurements of the colonic digestive fluids [61] or of other nitrite-derived alkylating agents. 
Under in vivo circumstances, alkylating agents that are produced in the colon will most likely not 
only bind to bacterial DNA, but through the intimate contact that exists between the microbiota 
and the colonic epithelium [62], also to human DNA, and result in the formation of DNA 
adducts. As a result, the measurement of the O6-CMG DNA adducts, although originating from 
bacterial or fecal exfoliate DNA in this study, is considered as a biomarker for potential DNA 
adduct formation in vivo.  
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Previously reported observations [15, 16] indicate that carboxymethylation at the O6 atom of 2’-
deoxyguanosine appeared to be a common feature when nitrosated glycine derivatives are 
formed. The reported concomitant methylation however appeared absent in our digestive 
simulations, and no O6-MeG adducts could be detected in the digestive fluids. O6-MeG can be 
repaired under in vitro circumstances by MGMT [15, 63], a repair mechanism expressed by the 
Caco-2 cell line [64]. Nevertheless, in our experiments, pre-extracted Caco-2 DNA was used, 
which is most likely depleted of any MGMT molecules as a result of the DNA extraction 
procedure [31]. Therefore, it is believed that MGMT could not have been responsible for the 
absence of O6-MeG. Indeed, in literature it has been consistently reported that the formation 
rate of O6-MeG compared to O6-CMG is significantly lower when incubating DNA with KDA 
[15, 16, 31], which could explain its absence. As for O6-CMG, only very recently a report was 
published of its ability to act as a MGMT substrate in synthetic oligodeoxyribonucleotides [65]. 
This finding could possibly undermine O6-CMG biomarker capacities for CRC. However, in a 
previously reported study by Vanden Bussche et al. [31], Caco-2 cells as well as the pre-extracted 
DNA thereof were incubated with KDA and similar levels of O6-CMG DNA adducts were 
formed, which might suggest that the MGMT repair system is not potent enough to repair a 
considerable amount of O6-CMG adducts. Based on this finding and the presence of O6-CMG 
in biological samples [20, 21, 31], it would still seem acceptable to consider O6-CMG as an 
adequate biomarker and potential causative agent for CRC.  
Next to the alkylation pathway, the peroxidation of polyunsaturated fatty acids with MDA as 
predominant product has been suggested by Corpet [13], as an additional mechanistic hypothesis 
for the existing link between dietary heme intake and CRC risk. The MDA measurements 
demonstrated significant differences (p = 0.0004) between the digestion of beef and chicken, 
suggesting the higher genotoxic potential of red meat consumption, with the highest levels 
generated before colonic digestion (table 2). These MDA levels may be correlated to the data of 
the WST-1 cell proliferation assay where only at the beginning of the colonic digestion a 
borderline significant difference was observed between the digested beef and chicken (p = 0.053). 
The latter effect disappeared towards the end of the colonic digestion, which could be linked to 
the decline in MDA level. However, it needs to be stated that the results of the cytotoxicity test 
proved inconclusive and tests based on different mechanisms, e.g. detection of caspase positive 
cells (marker for apoptosis) [66], checking membrane permeability by propidium iodides staining 
[67], might be advisable for future experiments. As for the significant MDA decrease during 
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colonic digestion, this could be attributed to different factors: i.e. degradation into volatile 
compounds, formation of Schiff bases through reaction with protein chains, reaction with 
bacterial DNA resulting in several DNA adducts (e.g. 3-(2-deoxy--D-erythro-
pentofuranosyl)pyrimido[1,2-]purin-10(3H)-one (M1dG) [23]), oxidation by bacterial aldehyde 
dehydrogenase activity [68] and presence of dietary fibre in the fecal inocula, which are known to 
bind MDA [69].  
An additional incubation experiment was performed to substantiate the heme iron hypothesis as 
potential causative CRC agent [13] by adding myoglobin to the in vitro digestion. Both O6-CMG 
and MDA increased significantly upon addition of 28.3 nmol myoglobin per mL of digestive 
fluid. These results indicate the involvement of the myoglobin protein and heme molecule, 
which are more present in red than white meat, in the active formation of O6-CMG and MDA. 
Next to the involvement of heme in the gastrointestinal formation of cyto- and genotoxic 
compounds upon red meat digestion, it is very likely that other factors may play a role in the 
formation pathway(s) of both MDA and the O6-CMG DNA adduct. As a first factor, the colonic 
microbiota consist of a complex mixture with several attributes that differ inter- and intra-
individually and even by anatomical site along the colon and their location within the lumen [48, 
54]. The colonic bacteria are constantly influenced by their surroundings; heme-Fe can, e.g. 
increase the prevalence of Enterobacteria and Bacteroidetes spp. and decrease Lactobacilli and 
Firmicutes spp. [70]. Additionally, it has been reported that certain Lactobaccilli and Bifidobacteria 
spp. are capable of producing nitric oxide (• NO) from nitrite [71]. Depending on the •NO to 
reactive oxygen species ratio, •NO can enhance or inhibit oxidation processes [72] and thus 
MDA formation. Of course, nitrite and •NO may play their part in the nitrosation pathway as 
well. Furthermore, high-fat diets give rise to a decrease in Bifidobacteria. Bifidobacteria are involved 
in the production of SCFAs such as butyrate, which is known for its beneficial anti-carcinogenic 
attributes. Another important and possibly interfering factor that is linked to diet is the 
remaining amount of polyunsaturated fatty acids (PUFAs) in feces [73] and thus also in the 
digestive flasks. Since PUFAs initiate the LPO process, variation in PUFA content (both in feces 
and meat) may reflect directly upon MDA formation. These and other modulating factors in 
both the O6-CMG and MDA formation pathway will influence the heme-Fe dose response. 
To evaluate whether proper microbial fermentation occurred during the in vitro digestion 
simulation, SCFA levels were monitored, since these are the main end products resulting from 
colonic bacterial fermentation of dietary carbohydrates. The most important SCFAs are acetic 
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acid, propionic acid and butyric acid, which occur in molar ratios of about 60:20:20 in the colon 
[46]. The SCFA profiles of the conducted in vitro digestions (table 3 and 4) indicated proper 
microbial fermentation, approximating the in vivo molar ratios. The SCFA profiles obtained from 
three out of six selected fecal inocula showed a significantly higher production of butyric acid. It 
is not uncommon that butyric acid increases or even exceeds the levels of propionic acid as a 
result of peptide supplementation [74], which may be considered as a probable cause since meat 
is an important protein source. Additionally, some human fecal bacteria are known as net 
consumers of acetic acid, resulting in the production of butyric acid [75], which could have been 
the case in our experimental set-up due to the extensive batch culture duration of 72 h. Butyric 
acid is known to exert important effects on cell differentiation and gut health [76] and is thought 
to play a protective role against CRC [77]. Indeed, the batch cultures with high butyric acid 
profiles were those with almost no O6-CMG formation (<15 pmol/mL). In this case, one could 
propose a potential butyrogenic effect, although further research would be required to confirm 
this. The other digestive products, i.e. phenol, indo, p-cresol and ammonia did not significantly 
differ between the different meat types or the fecal inocula. 
In this study, two independent pathways have been set forward to mechanistically explain the 
reported correlation between red meat consumption and CRC, namely the alkylation and LPO 
pathway. The in vitro experiments clearly demonstrated that both pathways depend on different 
mechanisms, but may both require the presence of myoglobin (representing the meat-specific 
heme iron fraction) as a catalytic agent. While endogenous alkylation was observed during 
colonic fermentation, MDA formation peaked during the small intestinal digestion. Moreover, 
the formation of the alkylated DNA adduct O6-CMG appeared to depend on the microbial 
composition, since the inter-individual variability of the fecal inocula influenced the DNA adduct 
formation considerably and autoclavation completely inhibited the process. A contributing factor 
in the MDA production was most likely the inherent fat content of the meat [8], since MDA is 
the main by-product of the peroxidation of polyunsaturated fatty acids, which is known to be 
prone to iron-mediation [78]. Both factors play a role in the MDA formation, which significantly 
differed between the digested beef and chicken (p < 0.0004).  
To conclude, our in vitro digestions confirmed that the consumption of high-heme meat (beef) 
may exert genotoxic effects in the GIT. As for the role of the gastrointestinal digestion, it was 
demonstrated that the duodenum displayed the highest LPO rate with subsequent MDA 
formation, while for the alkylated DNA adduct O6-CMG, the colon and its innate microbial 
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biota were proven to be vital and the basis for the significant observed variability between the 
individual fecal inocula. 
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ABSTRACT 
Exposure of DNA to endo- and exogenous DNA binding chemicals can result in the formation 
of DNA adducts and is believed to be the first step in chemically induced carcinogenesis. DNA 
adductomics is a relatively new field of research which studies the formation of known and 
unknown DNA adducts in DNA due to exposure to genotoxic chemicals. In this study, a new 
UHPLC-HRMS(/MS)-based DNA adduct detection method was developed and validated. Four 
targeted DNA adducts, which all have been linked to dietary genotoxicity, were included in the 
described method; O6-MeG, O6-CMG, pyrimido[1,2-a]purin-10(1H)-one (M1G) and α-methyl-γ-
hydroxy-1,N2-propanoguanine (CroG). As a supplementary tool for DNA adductomics, a DNA 
adduct database, which currently contains 123 different diet-related DNA adducts, was 
constructed. By means of the newly developed method and database, all 4 targeted DNA adducts 
and 32 untargeted DNA adducts could be detected in different DNA samples. The obtained 
results clearly demonstrate the merit of the described method for both targeted and untargeted 
DNA adduct detection in vitro and in vivo, whilst the diet-related DNA adduct database can 
distinctly facilitate data interpretation.  
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1. INTRODUCTION 
When a genotoxic chemical binds to DNA, chemically stable DNA adducts can be introduced to 
the DNA sequence. Carcinogenesis is known to arise due to a combination of both genetic and 
environmental factors, and DNA adduct formation is considered to be the first step in 
chemically induced carcinogenesis [1, 2]. Different ‘endogenous’ DNA adduct types are formed 
continuously due to normal physiological processes like oxidative stress and inflammation. The 
same and also other DNA adduct types can be formed due to exposure to environmental 
chemicals, which results in the occurrence of ‘exogenous’ DNA adduct levels [3]. It has been 
demonstrated that exogenous DNA adduct formation causally links the consumption of 
aflatoxin B1 contaminated food to hepatocellular carcinoma incidence [4] and more recently, 
researchers also established a causal link between the smoking of tobacco, the formation of 
PAH-DNA adducts and cervical cancer [5]. In consequence, research on DNA adduct related 
carcinogenesis due to certain environmental factors has gained an intelligible interest during the 
past decade.  
Colon cancer incidence is mainly influenced by the presence (or absence) of particular 
environmental factors, as literature states that up to 70 % of colon cancer cases could be 
prevented by dietary changes [6, 7]. For example, in developed (‘Western’) countries, high red 
and processed meat consumption has been linked to a significantly higher colon cancer incidence 
in both men and women.  
Different hypotheses have been put forward to substantiate this meat-cancer relationship. The 
two remaining hypotheses however, discuss the role of NOC and aldehyde formation in the 
human gut upon digestion of red and processed meat [8]. Both NOCs and aldehydes can bind to 
DNA nucleobases, resulting in the possible formation of a multitude of DNA adducts [6-9]. To 
study the role of meat consumption in particular, and the human diet and exosphere in general, 
in the initiation and progression of cancer, the development of a highly specific and sensitive 
method for the detection of diet-related DNA adducts could prove very useful. Different 
analytical methods such as immunoassays, immunohistochemistry, 32P-postlabeling, GC- or 
HPLC-ECD, HPLC-FD, GC- or (HP)LC-MS, (LC-)NMR, LM-PCR and AMS [10, 11] have 
been developed for the detection of specific or bulky DNA adducts. Although every analytical 
method has its advantages, MS may prove to be the most useful analytical method for the 
screening, detection and quantification of diet-related DNA adducts [11, 12]. The most widely 
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used DNA adduct detection technique is 32P-postlabeling, which has excellent sensitivity, but 
lacks adequate specificity [13]. Ultra-high performance liquid chromatography (UHPLC) 
combined with high resolution MS (HRMS) detection techniques on the other hand, enable 
accurate identification of analytes based on chemical composition and exact compound mass. 
Furthermore, MS techniques can also provide structural information and due to ongoing 
technical improvements, MS currently offers an excellent qualitative and quantitative tool for 
DNA adduct research [10, 14-16]. Although the advantages of HRMS are clear, it may lack 
sufficient sensitivity for quantification of low levels of DNA adducts. An alternative approach is 
the use of MS/MS, which most often brings about lower detection limits, enabling a more 
accurate quantitation. A recent advance in MS technology now combines the specificity of 
HRMS and the sensitivity of triple quadrupole MS/MS by combining both methodologies in 
‘hybrid quadrupole MS’ systems [17, 18]. In other words, MS can easily measure low DNA 
adduct levels with the highest specificity, enabling simultaneous identification and quantification 
of different compounds.  
In light of these advances, the possibilities of a hybrid HRMS/MS approach was investigated 
through the development and validation of a method capable of quantifying 4 DNA adducts that 
may be related to the meat and colon cancer hypothesis: O6-MeG, O6-CMG, M1G and CroG. 
The formation of O6-MeG and O6-CMG has been linked to NOC formation in the gut during 
meat digestion [6], while M1G and CroG can be produced when diet-related or endogenously 
formed MDA or crotonaldehyde (both LPOs) bind to guanine (G) in DNA [9]. Besides the 
described targeted approach (UHPLC-HRMS/MS), an untargeted full scan UHPLC-HRMS 
approach was explored to enable future DNA adductomics research. In addition, to facilitate 
DNA adduct research, known diet-related DNA adducts were defined and listed in an in-house 
database. 
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2. MATERIALS AND METHODS 
2.1 Reagents and chemicals 
Standards of M1G, CrodG (α-methyl-γ-hydroxy-1,N2-propano-2’-deoxyguanosine) and their 
internal standards M1G-13C3 and CrodG-13C,15N2 were obtained from Toronto Research 
Chemicals (Toronto, Canada). O6-CMdG was kindly provided by Dr. S. Moore (Liverpool John 
Moores University, UK), whilst O6-MedG, O6-d3-MedG and a guanine (G) standard were 
purchased at Sigma-Aldrich (St. Louis, USA).  
EtDA) (the precursor of KDA), crotonaldehyde (CRO) and 1,1,3,3-tetramethoxypropane (the 
precursor of MDA were obtained from Sigma-Aldrich (St. Louis, USA) as well. 
 
2.2 Preparation of stock and working solutions 
Prior to preparation of stock and working solutions, O6-CMdG, O6-MedG, O6-d3-MedG, CrodG 
and CrodG-13C,15N2 were hydrolyzed from guanosines (nucleotides) to guanines (nucleobases) in 
0.1 M formic acid at 80°C during 30 min [19]. All standards were diluted in MeOH and stored (-
20°C) in stock and working solutions of respectively 500 ng/mL and 5 ng/ mL.  
An 800 mM stock solution of KDA was synthesized through alkaline hydrolysis of EtDA [20]. 
After further dilution with phosphate buffered saline (PBS), a working solution of 20 mM KDA 
was obtained (Caution!: KDA is highly toxic and carcinogenic).  
CRO was diluted to a stock and working solution of 800 and 20 mM PBS (Caution! CRO is 
highly toxic and carcinogenic). Stock and working solutions of both KDA and CRO were stored 
in dark glass bottles at -80°C.  
The precursor of MDA; 1,1,3,3-tetramethoxypropanewas diluted in acidified (HCl, pH 2), 
deionized water and kept at 45°C during 1 h to ensure full release of MDA. Working solutions 
of MDA (20 mM) were freshly prepared prior to each experiment. 
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2.3 DNA hydrolysis and DNA adduct purification 
DNA adducts were extracted and purified according to the protocol of Vanden Bussche et al. 
[19], during which DNA samples are initially subjected to DNA hydrolysis (30 min, 80°C) in 0.1 
M formic acid to cleave both adducted and non-adducted DNA nucleobases from the DNA 
sequence. This is then followed by purification and sample cleanup by means of solid-phase 
extraction (SPE) (Oasis® HLB cartridges (1 cc, 30 mg) Waters (Milford, USA)). After SPE, the 
collected samples were evaporated to dryness under vacuum (90 min, 20°C) and resuspended in 
100 mL of mobile phase. The obtained DNA adduct samples were stored at -20°C until LC-MS 
analysis. 
 
2.4 UHPLC-HRMS(/MS) analysis 
Chromatographic separation of DNA adducts was carried out by reversed phase 
chromatography. To ensure an optimal chromatographic separation and resolution, several 
column types were tested, including Nucleodur ISIS (5 mm, 3 x 150 mm and 4 x 250 mm) and 
Pyramid (1.8 mm, 2 x 100 mm) (Machery-Nagel, Düren, Germany), Hypersil Gold (1.9 mm, 2.1 
x 100 mm, Thermo Fisher Scientific, San José, USA), Luna NH2 (5 mm, 4.60 150 mm, 
Phenomenex, Torrance, USA), Acquity BEH C18 (1.7 mm, 2.1 x 100 mm), HSS C18 (1.8 mm, 
2.1 x 100 mm) and HSS T3 (1.8 mm, 2.1 x 100 mm, Waters, Milford, MA, USA). Different 
mobile phases containing different percentages of solvent modifiers including acetic or formic 
acid and ammonium bicarbonate, and solvents i.e. water, methanol and acetonitrile were tested 
in parallel, and were pumped at 300 mL per min by an Accela 1250 pump coupled to an Accela 
Autosampler (Thermo Scientific, San José, USA).  
MS analysis was performed on a hybrid Quadrupole-Orbitrap High Resolution Accurate Mass 
Spectrometer (HRAM, Q-Exactive™, Thermo Fisher Scientific, San José, USA) coupled to a 
heated elektrospray ionization (HESI-II) source. All HESI and HRMS(/MS) parameters were 
optimized for the 4 targeted compounds and their internal standards. Chemical composition of 
the studied DNA adducts, theoretical and measured masses, observed mass deviation, monitored 
MS/MS ions and expected retention time (RT) are shown in table 1. 
General instrument control and data processing were performed with Xcalibur™ 3.0 and 
ToxID™ software (Thermo Fisher Scientific, San José, USA). 
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2.5 Validation in calf thymus DNA 
Currently, guidelines or regulations for the validation of analytical methods for the detection of 
DNA adducts in biological matrices are not available. The US Food and Drug Administration 
(FDA) did announce its intent to publish guidelines for biomarker detection methods, but a final 
draft has not yet been published [21]. Therefore, the guidelines for chemical methods described 
by the US FDA [22] and the EU Commission Directive 2002/657/EC [23] on the performance 
of analytical methods were taken into account. The described analytical method was validated by 
assessment of specificity, selectivity, linearity, precision and trueness with full scan HRMS. 
Quantification and detection limits were assessed with and for the full scan HRMS, SIM-HRMS 
and SIM-HRMS/MS method. The matrix in which all validation parameters were tested, 
consisted of the commercially available Calf Thymus DNA (CT-DNA). Lyophilized CT-DNA 
was purchased from Rockland (Gilbertsville, Pennsylvania, USA) and stored at 4°C in Tris-
EDTA buffer (1 mg/mL). 
 
2.6 DNA adducts in CT-DNA treated with genotoxic compounds 
The genotoxic compounds KDA, MDA and CRO were supplemented to CT-DNA in triplicate 
and incubated overnight (37°C) to allow interaction and subsequent DNA adduct formation. 
KDA was added to 100 mg of DNA in 3 different concentrations (1 mM, 2.5 mM and 5 mM). 
Separately, both MDA and CRO were added to 100 mg of DNA as well, but in concentrations 
of 0.1 mM, 0.25 mM and 0.5 mM. After overnight incubation, DNA adducts were extracted and 
analyzed. An equal amount of CT-DNA (100 mg), not treated with genotoxic compounds, was 
used as a negative control and to correct for intrinsically present DNA adduct levels. 
 
2.7 DNA adduct profiling in colon biopsies 
Left colon tumors were obtained during colonoscopy of 10 individuals diagnosed with colon 
cancer at the Ghent University Hospital. The average age of the patients was 74, the youngest 
being 58 and the eldest 83. The group consisted of 7 men and 3 women. All resected samples 
were poorly to moderately differentiated primary adenocarcinomas which were submerged and 
stored in 95 % of ethanol at -80°C. Two samples were retrieved in 2006 and 2007, but most 
were gathered in 2012 and 2013. 
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A Qiagen blood & tissue kit (Qiagen, Hilden, Germany) was used for the extraction of DNA 
from the tissue samples according to the protocol provided by the manufacturer. The 
concentration and purity of the extracted DNA was determined with a Nanodrop ND-1000 
spectrophotometer (Isogen Lifescience, Ijsselstein, The Netherlands). Following this, the 
obtained DNA in each sample was hydrolyzed and DNA adducts were purified according to the 
protocol described under 2.3 DNA hydrolysis and DNA adduct purification. 
 
 
3. RESULTS 
3.1 UHPLC-HRMS(/MS) settings optimization 
The Acquity BEH C18 Waters column and the use of 0.05 % of acetic acid in water and 100 % 
methanol as mobile phases provided optimal results for baseline peak separation, signal-to-noise 
ratio, peak area, peak shape and RT of all eluting targeted DNA adducts. The amount of 
methanol was increased linearly from 0.85 min, reaching 50 % after 4 min, which was then 
immediately followed by 1 min of 100 % methanol. For the remaining 2 min, the column was re-
equilibrated at 95:5 0.05 % acetic acid in water:methanol. 
 Three different MS acquisition modes were assessed: full scan MS, SIM-MS (selected ion 
monitoring) and SIM-MS/MS. Both negative and positive ionization mode (polarity switching) 
were included to not only enable the targeted analysis of the 4 targeted DNA adducts, but also 
the future analysis of all untargeted DNA adducts of interest, thus facilitating the use of this 
method as an “omics” tool. Likewise, the full MS scan range was held at 70-700 m/z to enable an 
untargeted analysis next to the targeted analysis. A scan range of 100-250 m/z was chosen for the 
targeted analysis in SIM-MS and SIM-MS/MS. Ultimately, the chosen scan resolution for full MS 
was ‘ultra high’ (100,000 FWHM (Full Width Half Maximum)), using 3 microscans. Optimal 
maximum inject time was 500 ms and the automatic gain control target was best operated in 
‘high dynamic range’ (3 x e6). Sheath gas, auxiliary gas and sweep gas flow rate were set at 35, 5 
and 2 arbitrary units. Optimal spray voltage, capillary temperature, capillary voltage and heater 
temperature were kept at 4 kV, 280°C, 40 V (positive or negative, dependent on polarity switch) 
and 330°C respectively. S-lens RF-level was set at 90 and the same settings were applied for all 
acquisition types. However, a resolution of 70,000 and 17,500 FWHM appeared sufficient for 
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respectively SIM-MS and SIM-MS/MS, whilst a maximum inject time of 250 ms was applied. 
Normalized collision energy (NCE) and monitored product ions in MS/MS for each targeted 
DNA adduct and their internal standards are shown in table 1. A chromatogram and full scan 
mass spectrum of all targeted compounds and their internal standards are presented in figure 1 
and figure 2, respectively. 
 
Figure 1. Chromatogram of O6-MeG (a), O6-d3-MeG (b), O6-CMG (c), M1G (d), 13C3-M1G 
(e), CroG (f) and 13C15N2-CroG (g) in CT-DNA with SIM-MS/MS acquisition. 
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Figure 2. Mass spectrum of O6-MeG (a), d3-MeG (b), O6-CMG (c), M1G (d), 13C3-M1G (e), 
CroG (f) and 13C15N2-CroG (g) in CT-DNA with HRMS acquisition. 
 
3.2 Validation of the full HRMS method for the targeted detection of DNA 
adducts 
3.2.1 Specificity 
The specificity of the HRMS method for the detection of O6-CMG, O6-MeG and CroG was 
assessed by analyzing over 21 blank CT-DNA samples and over 108 spiked CT-DNA samples. 
Spiked samples were fortified with a mixture of all DNA adducts, or each DNA adduct 
separately at three different concentrations levels (2.50, 5.00 and 7.50 ng/mL for O6-CMG and 
O6-MeG; 0.25, 0.50 and 0.75 ng/mL for CroG). Comparison of the obtained chromatograms of 
blank and spiked DNA samples demonstrated that the DNA matrix did not cause interference 
for O6-CMG, O6-MeG and CroG detection. In addition, spiking of O6-CMG, O6-MeG and 
CroG lead to a significant increase in peak intensity with a signal-to-noise ratio > 3. For the M1G 
DNA adduct, specificity could not be thoroughly assessed by comparison of blank and fortified 
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samples, since the matrix DNA contained endogenous levels of M1G. However, no other matrix 
substances significantly interfered with the analysis of M1G (signal-to-noise ratio > 3) and 
spiking of three different levels of M1G (0.25, 0.50 and 0.75 ng/mL) to CT-DNA did 
significantly increase the M1G peak area at the expected RT. 
 
3.2.2 Selectivity 
The methods' selectivity could be demonstrated by analyte identification based on relative RT 
(ratio of analyte RT and corresponding internal standard RT) and the accurate mass of their 
positive ions ([M+H+].). Only chromatographic peaks of interest with signal-to-noise ratios that 
exceeded 3 were taken into account and tolerance levels for relative RT and maximum mass 
deviation were established at 2.5 % and 5 ppm respectively. 
 
3.2.3 Linearity 
Linearity was assessed by deploying 2 separate calibration curves in triplicate. A first calibration 
curve was established in a low range that would enable quantification of endogenous and 
exogenous levels of DNA adducts [3, 24][3,24], whereas the second calibration curve was used to 
enable the in vitro application of this method (see 2.6 DNA adducts in CT-DNA treated with 
genotoxic compounds). For the calibration curves, the matrix DNA was fortified with 0.025; 
0.05; 0.075; 0.1; 0.125; 0.25; 0.50; 0.75; 1; 1.25; 2.5; 5; 7.5; 10 and 12.5 ng/mL O6-CMG, O6-
MeG, M1G and CroG. The obtained coefficients of determination (R2) proved to be over 0.99, 
suggesting a good to excellent linearity, which could be confirmed by means of a one-way 
ANOVA (F-test) linearity test (p > 0.05). The ANOVA model was constructed with the 
detected area ratio of each component (DNA adduct peak area/area of the internal standard) as 
the dependent variable and the calibration curve concentration levels as the independent variable 
(SPSS Statistics 21). 
 
3.2.4 Mean recovery 
To assess mean recovery of the targeted compounds, 3 series of six replicates of the earlier 
described CT-DNA samples fortified with three different spike levels were utilized. As M1G 
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appeared to be endogenously present in CT-DNA, total concentrations were adjusted to the 
measured fortified concentrations prior to calculation of the corrected mean recovery. Mean 
recovery of M1G, CroG and O6-MeG were within the narrow range of 97 and 104 % and thus 
proved to be excellent. O6-CMG mean recoveries ranged between 89 and 108 %, which is still 
well within the acceptable range of 80-120 %. 
 
3.2.5 Precision 
To evaluate precision, repeatability and intra-lab reproducibility were determined by calculation 
of the relative standard deviations (RSD %). Three sets of six fortified samples (equals the three 
fortification levels with six replicates each) were analyzed to test repeatability. One additional set 
of six samples fortified, extracted and analyzed by a different person at a different time enabled 
assessment of intra-lab reproducibility. As no detectable O6-CMG, O6-MeG and CroG levels 
appeared to be present in the matrix, and since endogenous levels in different tissues 
demonstrate a certain variation, fortification levels for O6-CMG were selected according to the 
estimated limit of detection and quantification with the full HRMS method. To establish M1G 
levels, the endogenous levels of M1G in the matrix DNA were taken into account. For CroG and 
O6-MeG, spike levels were adjusted to those of M1G and O6-CMG respectively, due to their 
analogue nature and origin. Also, for M1G, the endogenously present M1G DNA adduct levels in 
the CT-DNA were subtracted from the total measured M1G concentrations in spiked CT-DNA 
prior to calculation of the final/fortified concentration and RSD %. For M1G, CroG and O6-
MeG, repeatability appeared to be excellent since RSD % consistently proved below 4 % for 
each analyte and fortification level. In comparison, repeatability for O6-CMG was less good, but 
still below the acceptable RSD % limit of 15 with a RSD % of 9. Intra-lab reproducibility for all 
targeted compounds is good as well, with all RSD % below 9. 
 
3.2.6 Limits of detection and quantification 
LOQs were determined at a minimal signal-to-noise ratio of 10, whereas limits of detection 
(LODs) required a signal-to-noise ratio of at least 3 (table 2). LODs and LOQs with SIM-MS 
and SIM-MS/MS clearly exceeded the full HRMS LODs and LOQs for O6-CMG and O6-MeG. 
For CroG and M1G, differences in LODs and LOQs between full HRMS, SIM-MS and SIM-
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MS/MS were less pronounced. Practical assessment of LOD and LOQs for M1G is limited by 
the presence of M1G levels inherent to the CT-DNA matrix. Therefore, average LOD and 
LOQs levels for M1G were assessed based on co-chromatography of added M1G with 
endogenously present M1G in the CT-DNA matrix. For the combined detection and 
quantification of all 4 targeted DNA adducts, SIM-MS/MS would be preferred over SIM-MS 
and full MS since it combines the lowest LOQs for all 4 targeted compounds. 
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3.3 Development of a diet-related DNA adduct database to facilitate 
interpretation of untargeted DNA adductomics studies 
To construct an in-house database, literature was searched for DNA adducts of which harmful 
exogenous levels may be linked to the human diet. The main focus of the search were DNA 
adduct types originating from DNA alkylation or oxidation since these reaction types are of 
particular interest regarding the mechanisms behind colon cancer initiation and promotion by 
red and processed meat consumption [8, 25]. To this purpose, ISI Web of Knowledge and 
PubMed databases were searched for relevant papers using combinations of the grouped search 
terms (Food* OR Diet*) AND (‘DNA adduct’ OR ‘DNA damage’). Upon retrieval of papers 
documenting DNA adducts inducing foods, chemicals and/or metabolites, search terms were 
specified; e.g. ‘Meat’ AND ‘Heterocyclic amines’ AND ‘DNA adduct’ to retrieve all relevant 
papers and information on the topic at hand. The hence retrieved DNA adducts were assembled 
in a database containing 123 different diet-related DNA adducts (table 3). By means of ToxID™ 
software (Thermo Fisher Scientific, San José, USA) and the self-constructed database, the full 
scan HRMS spectra of different DNA samples could be screened for the presence of non-
targeted diet-related DNA adducts in retrospect. The considered inclusion criteria consisted of a 
minimal signal intensity of 10,000, a maximum mass deviation of 10 ppm, recurrence and stable 
RT of the DNA adduct of interest in replicate and repeat samples and a C12/C13 ratio 
approaching the natural 99:1 ratio. Detection of a certain diet-related DNA adduct with full MS 
and Tox-ID™ profiling renders chromatograms and data on measured peak area of the masses 
of interest and can thus suggest the presence of a putative DNA adduct in a sample. If believed 
relevant, exact confirmation of DNA adduct identity can be made by use of commercially 
available analyte standards. In this study, normalization of the obtained untargeted DNA adduct 
Tox-ID™ data was based on the measured signal intensity (area) of the guanine nucleobase in 
each sample by expressing DNA adduct area relative to guanine area. The identity of guanine 
was confirmed with an analytical standard. To demonstrate the possible merit and application of 
the described approach, full HRMS spectra obtained from blank CT-DNA, CT-DNA treated 
with KDA, MDA and CRO, and also tumor biopsies were interpreted by means of ToxID™ 
profiling and the self-constructed database. The results are discussed in the related sections 
below and documented in figure 3. 
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3.4 CT-DNA adducts 
The commercially available CT-DNA contained endogenous levels of M1G, whereas no 
detectable endogenous levels of O6-MeG, O6-CMG and CroG could be detected. Next to the 
targeted cyclic M1G DNA adduct, Tox-ID™ profiling indicated the possible presence of 20 
additional DNA adducts (figure 3). This includes M1A (oxopropenyl-A), M1C (oxopropenyl-C), 
1,N2-etheno-G, non-O6-carboxymethyl-G, two non-O6-methyl-Gs, carboxyethyl-G, Fapy-G 
(formamidopyrimidine-G), fapy-A (formamidopyrimidine-A), methyl-T, dimethyl-T or ethyl-T, 
carboxymethyl-T, carboxyethyl-T, methoxymethyl-C, methoxymethyl-T, butyl-G, hydroxyethyl-
G, propyl-G, trimethyl-G and hydroxyl-G DNA adducts (figure 3). 
 
3.5 DNA adducts in CT-DNA treated with genotoxic compounds 
Upon addition of different concentrations of KDA, MDA and CRO to CT-DNA, O6-MeG, O6-
CMG, M1G and CroG DNA adducts were formed during overnight incubation. O6-CMG and 
O6-MeG were formed upon addition of KDA, CroG was formed due to addition of CRO and 
M1G was produced after the addition of MDA; a clear dose-response effect was observed (figure 
4). Based on the fact that LPOs are highly reactive chemicals, and also based on practical 
assessment of the experimental setup, MDA and CRO concentration levels were adjusted to 
avoid overload of the LC and MS system. Therefore, the added MDA and CRO concentrations 
are lower than the added KDA concentrations. Addition of KDA to DNA also resulted in the 
formation of untargeted DNA adducts (figure 3). A first observation was the possible presence 
of 2 additional methyl-G compounds other than O6-MeG at RTs of 1.7 and 2.3 min. Both 
additional MeG DNA adducts were more prevalent than O6-MeG. In addition to MeG, a slight 
increase in butyl-G, methoxymethyl-C and a significant increase in methyl-T and carboxymethyl-
T could be noted after KDA treatment. During screening of CT-DNA treated with MDA by 
means of the DNA adduct database, it could be observed that not only M1G, but also M1A and 
M1C levels appeared to increase in a dose-response manner when the MDA concentration was 
raised (figure 3). In addition, just like KDA, MDA conceivably promoted the formation of 
methoxymethyl-C. Untargeted analysis of CT-DNA samples that had been treated with CRO 
revealed the probable presence of methoxymethyl-C, fapy-G, hydroxy-G and carboxy-T.  
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Figure 4. Mean (± s.d.) O6-MeG, O6-CMG, CroG and M1G DNA adduct formation in 
CT-DNA after exposure to genotoxic chemicals. Level 0 corresponds to the negative 
control samples. Level 1 represents addition of 1 mM of KDA or 0.1 mM of CRO or MDA. 
Level 2 equals addition of 2.5 mM of KDA or 0.25 mM of CRO or MDA. Level 3 
demonstrates addition of 5 mM KDA or 0.5 mM of CRO or MDA. 
 
3.6 DNA adducts in colon biopsies 
O6-CMG could be identified and quantified in 8 out of 10 tumor samples. For quantification of 
O6-CMG in each sample, the DNA adduct concentrations were adjusted according to the 
measured DNA concentration in each sample. The mean amount of O6-CMG equaled 815 
adducts per 108 nucleotides, with a relatively high inter-individual variability (range from < LOD 
to 1630 adducts per 108 nucleotides). M1G, CroG and O6-MeG could not be detected. 
Untargeted analysis of all tumor samples (T1-T10) was carried out in parallel. The list of 
observed DNA adducts includes both alkylation and oxidation DNA adducts, i.e. non-O6-CMG 
(same mass as O6-CMG, but a different RT), butyl-G, hydroxyethyl-G, carboxyethyl-A, 
carboxymethyl-A, methyl-T, dimethyl-T or ethyl-T, carboxy-T, fapy-G, fapy-A, T-glycol, 
hydroxyl-T, 1,N2-etheno-G, N2,3-etheno-G, 1,N6-etheno-A, M3C and methoxymethyl-G (figure 
3). 
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4. DISCUSSION 
A new UHPLC-HRMS/MS method was developed to enable targeted and untargeted detection 
of both known and unknown DNA adducts. A first focus was the separation and targeted 
detection of O6-CMG, O6-MeG, M1G and CroG. These DNA adducts are of particular interest 
because DNA-damaging NOCs and LPOs appear to be the two main culprits in the complex 
underlying mechanism that links red and processed meat consumption to an elevated colon 
cancer risk [8, 25]. The combined targeted detection of O6-CMG, O6-MeG, M1G and CroG is 
unique as it permits simultaneous investigation of 2 important but very different pathways. 
Furthermore, at the time, this is the only described MS-based method to combine the detection 
of O6-CMG, O6-MeG, M1G and CroG.  
DNA adductomics is an up-and-coming approach to investigate DNA adduct formation and its 
possible link to chronic disease. To elucidate supplementary meat or colon cancer related DNA 
adduct types and pathways, the use of this UHPLC-HRMS method was investigated in vitro and 
in vivo ensuring valid future clinical application in DNA adductomic studies. To the best of our 
knowledge, this paper describes 1 of only 3 high resolution MS-based DNA adductome mapping 
methods, whereas it is the first to explore and illustrate the use of Quadrupole-Orbitrap 
technology for DNA adduct profiling purposes.  
Supplementary, an in-house database that lists known DNA adducts, was constructed and 
implemented to facilitate the complex process of omics data interpretation. 
 
4.1 DNA adduct analysis with UHPLC-HRMS/MS 
All relevant performance characteristics of the MS method were in accordance with 
internationally accepted analytical criteria. However, because of the method's intended use in a 
clinical setting, most attention was paid to the achievable LODs and LOQs for the 4 targeted 
DNA adducts prior to in vitro and/or in vivo SIM-HRMS/MS method application.  
The in vivo relevance of the detection of O6-CMG has been demonstrated by its qualitative 
detection in several biological samples like blood, colon biopsies and exfoliated colonocytes [63-
65]. To the best of our knowledge, average endogenous levels of O6-CMG in human tissue have 
not yet been reported. Therefore, at present, a scientifically based statement on the applicability 
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of this method for the quantification of possibly low endogenous O6-CMG DNA adduct levels 
is not possible. Cupid et al. described the measurement of 35-80 O6-CMG DNA adducts per 108 
nucleotides in blood of volunteers consuming a high meat diet [65]. These DNA adducts levels 
were detected by means of Immunoslot Blot with an LOD of 15 adducts per 108 nucleotides, 
which confirms the competitiveness of our targeted SIM-HRMS/MS method.  
A correct quantification of endogenous levels of the O6-MeG DNA adduct with an LOQ of 2.82 
adducts per 108 nucleotides with MS/MS acquisition will depend on tissue or cell type. For 
example, Kang et al. reported the detection of less than one O6-MeG DNA adduct in 108 
nucleotides in leucocyte DNA, whereas more than two O6-MeG adducts per 108 nucleotides 
appeared to be present in hepatic DNA [3, 41]. This suggests that our current method allows 
detection and quantification of O6-MeG in a clinically relevant range. If required, the current 
LOQ and LOD could be improved by tweaking the MS and HESI settings. However, at the 
time, all settings were optimized for the simultaneous detection of all 4 targeted DNA adducts 
and for O6-CMG, demonstrating the highest LOQ and LOD, in particular.  
The retrieved LOQs for M1G and CroG (<5 adducts per 108 nucleotides) appeared to be more 
than sufficient. Indeed, according to previously reported endogenous levels of M1G and CroG in 
several tissue types, all reported DNA adduct levels exceeded 6 adducts per 108 nucleotides [3], 
which implies that our LOQs are below endogenously present M1G and CroG DNA adduct 
levels. 
 
4.2 In vitro application 
The presence of both targeted and untargeted DNA adducts were investigated in blank CT-
DNA or CT-DNA treated with genotoxic chemicals to demonstrate the in vitro application of the 
described method and the in-house constructed database.  
In blank CT-DNA samples, different DNA adducts could be retrieved. M1G appeared to be the 
sole detected targeted DNA adduct endogenously present in CT-DNA and similar amounts of 
M1G in CT-DNA have been reported before [66]. Using the untargeted HRMS approach, the 
accurate masses of 20 additional compounds (figure 3) could be linked to DNA adducts included 
in the self-constructed diet-related DNA adduct database (see table 3), resulting in a putative 
identification. The endogenous or exogenous occurrence of several of these DNA adducts in 
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DNA and their link to for example oxidative stress [35, 50], exposure to environmental 
carcinogens [40, 67] and carcinogenesis [50, 68], have been reported previously, acknowledging 
their relevance.  
Treatment of CT-DNA with KDA, MDA and CRO resulted in the formation and detection of 
the 4 targeted DNA adducts. The demonstrated dose response effect was to be expected for 
KDA, a well-known NOC, and both O6-MeG and O6-CMG, since the methylation and 
carboxymethylation of deoxyguanosine at the O6 position by nitrosated glycine derivatives have 
been documented in the past [19, 69]. The demonstrated formation of M1G in CT-DNA by 
attack of the G base by the highly reactive LPO MDA has also been reported extensively in 
literature, with M1G being the predominantly formed DNA adduct [43]. The same applies for 
CRO and CroG formation [9]. The more ‘efficient’ and pronounced interaction of MDA and 
CRO with DNA to form M1G and CroG, compared to the interaction of KDA with DNA to 
form O6-CMG and O6-MeG (lower added MDA and CRO concentrations (compared to KDA) 
yield similar DNA adduct concentrations; figure 4) can be explained by the highly reactive nature 
of LPOs [35]. 
Next to the detection of targeted DNA adducts, application of the HRMS method also enabled 
the detection of untargeted DNA adducts. Rapid putative identification of these compounds in 
retrospect was empowered by the use of the self-constructed database. In total, 25 untargeted 
DNA adducts were detected in blank CT-DNA and/or upon treatment with KDA, MDA 
and/or CRO. Several of these putatively identified DNA adducts have been detected previously 
and described in literature (table 3), acknowledging their relevance. Retrieval of these DNA 
adducts clearly emphasizes the potential of the HRMS method for DNA adductome mapping 
and the ease of putative DNA adduct identification by means of our DNA adduct database.  
Some of the untargeted DNA adducts reported above have not been investigated extensively. 
However, considering the possible detection of all these compounds after incubation of DNA 
with KDA, MDA or CRO, further investigation is warranted. After all, extensive research on the 
possible link between toxic endo- and exogenous NOCs, LPOs and disease has been conducted 
in the past and has revealed a connection to an increased cancer risk [70, 71]. 
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4.3 In vivo application 
The described DNA adductomics method has been constructed for future use in clinical studies. 
Therefore, preliminary tests for in vivo application were conducted on 10 colon tumor tissue 
samples. This resulted in the detection of the O6-CMG DNA adduct in a vast majority of colon 
tumor biopsies. The other 3 targeted compounds could not be retrieved in any of the biopsy 
samples, although they have been detected in different human tissue types before [3], thus 
suggesting that M1G, CroG and O6-MeG were either absent or no longer present above the 
LOD in the analyzed biopsies. ToxID™ screening revealed the likely presence of 17 untargeted 
DNA adducts of which some could be retrieved in all 10 biopsies, whilst others could only be 
detected in some or just one sample(s).  
Current knowledge on the stability of different DNA adducts is still limited. In consequence, 
future DNA adduct profiling should be carried out as soon as possible following tissue sampling 
to avoid DNA adduct instability issues. As these possible stability issues were not sufficiently 
taken into account during colon biopsy sample handling and storage, any conclusions obtained 
from the earlier reported results on the possible connection between observed DNA adduct 
levels and diet or disease status would be too precarious at the time being. A more extensive 
discussion on DNA adduct profiling and its link to diet and disease status will therefore be 
conducted during extensive follow-up studies. Nonetheless, the described DNA adductomics 
method already proved its usefulness as both targeted and putative untargeted diet-related DNA 
adducts were detected easily in vivo. Moreover, this is the first paper to report DNA adductome 
mapping of (tumoral) colonic tissue. 
To provide an overview, the envisioned workflow for DNA adduct profiling in future DNA 
adductomic studies by means of the reported UHPLC-HRMS(/MS) method is documented in 
the graphical abstract. 
 
4.4 The merit of a DNA adduct database 
The human diet is quite complex and person-dependent, which implies that the impact of the 
individual human diet is very hard to pin to down. As diet and lifestyle significantly contribute to 
colon cancer risk, further investigation is warranted to link dietary toxicity to chronic disease 
through DNA adduct formation. Different diet-related DNA adduct types can be formed by e.g. 
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alkylation and oxidation or mycotoxin, HCA, PAH, and acrylamide exposure. In this context, a 
total of 123 different DNA adducts have currently been listed in an in-house (diet-related) DNA 
adduct database. Most of the listed DNA adducts have already been investigated in vitro or in vivo 
in relation to one or multiple ‘suspicious’ foodstuffs (see table 3 for a more detailed account and 
references). As the currently available information concerning the genotoxic effects of different 
food constituents is quite elaborate, yet still inconclusive, and since the use of DNA adductomics 
is still under development, it may be stated that although our DNA adduct list (anno 2015; table 
3) is already quite extensive, it is not definitive. Nevertheless, due to the complex nature of the 
human diet and the long list of related research questions, the database can definitely help 
expose relevant DNA adduct types that require a more extensive investigation. 
As different heterocyclic amine, polycyclic aromatic hydrocarbon, mycotoxin and acrylamide 
generated DNA adducts were also included in the database, the untargeted UHPLC-HRMS 
approach and database can also be put to use in related research that focuses on other diet-
related chronic diseases. Furthermore, the self-constructed database includes a multitude of 
DNA adducts generated by unspecific alkylation and oxidation reactions which could be caused 
by several types of genotoxic, mutagenic and carcinogenic chemicals. 
 
 
5. CONCLUSION 
Hybrid HRMS systems yield highly specific information on compound mass, elemental 
composition and identity, whilst also enabling study of fragmentation patterns offering several 
advantages regarding structural elucidation. In consequence, such MS systems are particularly 
well suited for DNA adductomics [12, 72]. As it is our goal to implement the described method 
in the search for DNA adduct formation through dietary exposure to genotoxic chemicals in the 
meat-cancer relationship, the newly developed and successfully validated UHPLC-HRMS(/MS) 
method currently combines the simultaneous detection of 4 structurally and chemically different 
DNA adducts. The obtained LODs and LOQs for the targeted detection of O6-CMG, O6-MeG, 
M1G and CroG with SIM-MS/MS allow in vitro and in vivo application. The state-of-the-art 
hybrid MS method also showed great promise for untargeted DNA adduct detection in future 
DNA adductomic studies as the Orbitrap revealed the presence of several putatively identified 
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DNA adducts in different DNA samples. This confirms the applicability of the untargeted full 
scan HRMS approach and its envisioned use for DNA adductome mapping. The use of the in-
house DNA-adduct database in research focusing on diet and lifestyle related chronic diseases 
could expedite exposure of relevant biomarkers and provide new insights in disease etiology and 
prevention. The described adductomics methodology and database will thus serve as a basis for 
the analysis of both endogenous and exogenous DNA adducts in DNA from several tissue types 
and for a wide variety of research topics. 
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ABSTRACT 
CRC is the third most common cancer type in the world. Epidemiological research has 
demonstrated that both red and processed meat consumption significantly contribute to CRC 
risk. In this study, red meat toxicity was investigated by means of simulated gastrointestinal 
conditions, MDA analysis and UHPLC-(HR)MS(/MS) based DNA adductomics. Since dairy 
products with high calcium content are associated with a decreased CRC-risk, the possible CRC-
protective effects of calcium were assessed as well. The obtained results confirmed the earlier 
reported finding that heme-rich meat stimulates lipid peroxidation and O6-CMG DNA adduct 
formation during digestion. Calcium carbonate (CaCO3) supplementation resulted in both toxic 
and anti-toxic effects; i.e. stimulation of O6-CMG production, but reduction of MDA formation. 
DNA adductome mapping of meat digests revealed a significant interindividual variability. The 
observed DNA adduct profile also differed according to the digested meat type, uncovering 
different putative DNA adducts that seem to be associated with digestion of beef or chicken 
with or without supplemented CaCO3. Formamidopyrimidine-adenine was found to be 
discriminative for meat digests without added CaCO3, carboxyethylcytosine was significantly 
higher in beef digests and methoxymethylcytosine (or its hydroxyethylcytosine isomer) was 
found to be lower in meat digests supplemented with CaCO3. These results demonstrate that 
DNA adduct formation may be involved in the pathway that links red meat digestion to CRC 
promotion. In addition, the possible CRC-protective attributes of calcium through anti-oxidant 
actions could be documented. 
 
 
 
Keywords: 
Calcium, Cancer Risk, DNA Adductome Mapping, Malondialdehyde,  
O6-Carboxymethylguanine, Red Meat Digestion 
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1. INTRODUCTION 
With increasing age, both men and women are often afflicted with CRC, the third most common 
cancer type in men and the second most common in women [1]. The vast majority of CRC cases 
(about 90 %) and deaths (about 70 %) can be attributed to environmental factors, with diet being 
the most significant contributor [2]. Since CRC incidence is higher in economically developed 
and developing countries [3], epidemiologists have looked for evidence explaining a possible 
causal link between the consumption of typical Western foodstuffs and CRC risk. Their results 
suggest that the ‘excessive’ consumption of red and/or processed meat may involve significant 
adverse health effects [4, 5]. Although there is no mistaking that meat does provide us with 
essential nutrients, the current hypothesis on red meat carcinogenicity states that heme, which is 
more present in red meat compared to white meat, may be responsible for the increase in red 
meat associated CRC incidence due to certain indirect geno- and cytotoxic effects. The “heme 
hypothesis” states that this molecule stimulates the formation of LPOs and NOCs in the gut, 
which is why both LPOs and NOCs have been linked to the hypothesis on red meat associated 
CRC initiation and/or promotion [4, 5].  
LPOs are formed when reactive oxygen species and iron (Fe) interact with lipids like 
polyunsaturated fatty acids, resulting in the formation of different (highly) reactive electrophilic 
epoxides and aldehydes [6]. One of the major LPOs is MDA and additional examples of lipid 
peroxidation end products include acetaldehyde, hydroxynonenal and CRO [7, 8]. Several of 
these LPOs have known cyto- and genotoxic effects that may lead to mutagenesis and 
carcinogenesis via the formation of promutagenic DNA adducts [8]. Several in vivo studies have 
already demonstrated a significant increase in both LPOs and LPO derived DNA adducts in 
‘normal tissue’ due to oxidative stress and/or dietary imbalance, as well as in different human 
malignancies [6, 9].  
NOCs are potent carcinogens that can induce DNA adduct formation (e.g. O6-MeG and O6-
CMG) due to their alkylating properties [10, 11]. Diet represents the most important route of 
NOC exposure [12] although NOCs can also be formed endogenously in the stomach 
(interaction of nitric oxide or nitrite and secondary or tertiary amines) [12, 13] and large bowel 
(nitrosation of amines after microbial fermentation of proteins in the gut) [14, 15]. More 
importantly, an increase in NOC uptake has been linked to an increased consumption of red 
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meat and an increase in the levels of a specific alkylation induced DNA adduct (O6-CMG) in 
colonic tissue at least once before [11]. 
The list of different food related genotoxic compounds that may induce DNA adduct formation 
appears to be quite extensive, as is the collection of possible resulting DNA adducts [16]. Since 
attack of DNA nucleobases by environmental toxins can indeed lead to DNA mutations, 
chromosomal alterations and chemically induced carcinogenesis [17, 18], the need to investigate 
the prevalence of different types of diet-related DNA adducts in meat digests has presented itself. 
Some of our previous work confirmed a rise in (MDA and) O6-CMG DNA adduct levels upon 
digestion of heme-rich red meat [19, 20]; a process that appears to be stimulated in the event of 
digestion of overcooked meat or meat with a high fat content [21, 22]. Two complimentary 
studies by Winter et al. [23, 24] investigated the formation of hydroxyguanine (an extensively 
studied oxidative DNA adduct) and O6-MeG in mice, revealing that red meat and/or heme can 
induce a rise in the formation of those particular DNA adducts. In addition, as was already 
mentioned before, Lewin et al. [11] reported the presence of higher O6-CMG levels in human 
colonic cells after red meat consumption. To be able to investigate the current hypothesis on red 
meat induced LPO and NOC related DNA adduct formation, we aimed to further examine the 
possible genotoxic effects of red meat consumption and digestion by means of the in vitro 
gastrointestinal digestion of meat and a recently developed DNA adductomics platform [25]. 
This will allow us to analyze the presence of both targeted and untargeted diet-related DNA 
adducts in meat digests and enable a more in-depth investigation of the possible underlying 
pathway(s) of red meat associated genotoxicity, and the possible protective attributes of calcium. 
 
 
2. EXPERIMENTAL 
2.1 Meat preparations 
Four different types of meat preparations were established; beef with and without addition of 
CaCO3, and chicken with and without addition of CaCO3. Beef diaphragm (high heme iron 
content; as a model for red meat), chicken breast (low heme iron content; as a model for white 
meat) and subcutaneous pork fat were obtained from a local slaughterhouse and butcher. The 
beef and chicken samples were chopped into cubes (1 to 2 cm3) separately, and pork fat was 
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added to each of them in order to obtain a total fat content of 20 %. The meat samples were 
minced (omega T-12 (Omega Foodtech, Bologna, Italy) equipped with a 10 mm plate) and 
grounded (by means of a 3.5 mm plate) thoroughly. Subsequently, all meat preparations were 
heated for 30 min after reaching a core temperature of 90°C in a hot water bath (GFL, 
Grossburgwedel, Germany). As a final step, meat preparations were homogenized with a food 
processor and stored at -20°C. To obtain meat preparations supplemented with calcium, a 
solution of CaCO3 was freshly added (0.025 g CaCO3 per g meat) just before the start of the in 
vitro gastrointestinal digestion simulations. 
 
2.2 In vitro gastrointestinal digestion of meat 
2.2.1 Experimental setup 
In this study, two different types of experiments were set up, a first experiment to screen for 
DNA adduct formation upon in vitro beef digestion using the fecal microbiota of 5 different 
individuals and a more extensive (second) experiment to compare DNA adduct formation 
during and after digestion of different meat type preparations. The first experiment entailed 5 
separate in vitro gastrointestinal digestions of beef during which the fecal inocula (see 2.2.2 
Collection, storage and precultivation of colonic microbiota) of 5 different volunteers were used 
to simulate colonic meat digestion. In the follow-up experiment, 3 different fecal inocula 
obtained from 2 out of 5 initial volunteers (see 2.2.2 Collection, storage and precultivation of 
colonic microbiota) were employed to ferment the four meat preparations (beef without added 
CaCO3, beef with added CaCO3, chicken without added CaCO3 and chicken with added CaCO3) 
in the in vitro gastrointestinal setup in triplicate, resulting in 3 biological (by means of 3 different 
fecal inocula obtained from 2 out of 5 initial volunteers) and 3 technical replicate digestions for 
each meat preparation (all performed in separate vessels, resulting in a total of 36 separate meat 
digestions). 
 
2.2.2 Collection, storage and precultivation of colonic microbiota 
For initial screening, fresh fecal samples were obtained from 5 male volunteers on a Western-
type diet (uncontrolled and unmonitored) with no medical history of gastrointestinal disease. 
None of the volunteers had received antibiotic treatment during at least 6 months prior to 
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donation. For a follow-up experiment, 3 new fecal samples were obtained from 2 out of 5 
volunteers at different points in time (interval > 7 days). The 5 human donors of fecal material 
were recruited among the laboratory personnel through informal announcement. All volunteers 
have given their written informed consent. The obtained data and volunteer information were 
analyzed anonymously and de-identified. The research was approved by the Federal Public 
Service of Health, Food Chain Safety and Environment, Belgium, but there was no need to 
submit an application to the ethical committee due to the non-invasive nature of the voluntary 
donation of fecal samples. 
All fecal samples were processed according to a protocol adapted from Molly et al. [20, 26] Fresh 
fecal material was diluted in preheated PBS solution (1:4; w/v), to which sodium thioglycolate (1 
g/L) was added as a reducing agent. The hence obtained fecal slurry was then filtered through a 
1 mm metal sieve and stored at -80°C on a glycerol stock (20 %). After storage and prior to use 
for the gastrointestinal digestion of meat, anaerobic precultivation of fecal inocula in BHI broth 
(obtained from Oxoid Ltd, Hampshire, GB) with added cysteine (37 g/L BHI + 0.5 g/L 
cysteine) at a 1:9 ratio (v/v)) was performed at 37°C for 24 h. 
 
2.2.3 Stomach, small bowel and large bowel digestion simulation 
The in vitro gastrointestinal digestion model enabled a consecutive simulation of stomach, small 
and large bowel digestion. For the treatments with calcium, a solution of CaCO3 was freshly 
added (0.025 g CaCO3 per g meat) just prior to the in vitro digestion. During the first digestion 
step, 6 mL of simulated saliva and 12 mL of simulated gastric juice were added to 4.5 g of meat 
(beef without added CaCO3, beef with added CaCO3, chicken without added CaCO3 or chicken 
with added CaCO3). All were incubated under constant stirring (150 rpm) during 2 h at 37°C, 
after which 2 mL of bicarbonate buffer, 12 mL of simulated duodenal juice and 6 mL of 
mimicked bile juice were added to perform small bowel digestion (2 h at 37°C, stirred at 150 
rpm). Colonic fermentation (48 h, 37°C, 150 rpm) in the large bowel was simulated by addition 
of SHIME medium (22 mL) and precultivated fecal inocula (22 mL) containing the colonic 
microbiota [26]. To ensure anaerobic conditions during colonic fermentation, 30 min of N2-
flushing was performed prior to incubation [20, 26]. Samples of meat digests were taken after 
simulation of duodenal digestion (“T0” samples, whereby sampling took place immediately after 
addition of SHIME medium and the fecal inoculum) and at the end of the simulated colonic 
  
 
Chapter IV 
 
  
143 
 
  
meat digestion (“T48” samples, whereby sampling took place after 48 h incubation with SHIME 
medium and fecal inocula). Samples were stored at -80°C awaiting analysis. For technical and 
practical matters concerning this gastro-intestinal digestion model and more details on 
preparation of all mimicked gastrointestinal juices, brain heart infusion broth and SHIME 
medium, we refer to previously reported research [19]. 
 
2.3 Sample preparation for DNA adduct analysis; DNA hydrolysis and 
DNA adduct extraction 
DNA adducts in meat digests were extracted and purified according to the protocol of Vanden 
Bussche et al. [27] During the described protocol, O6-d3-methylguanine (Toronto Research 
Chemicals Inc., Toronto, Canada) was added as an internal standard, after which DNA samples 
were subjected to DNA hydrolysis (30 min, 80°C) in 0.1 M formic acid in water to cleave both 
adducted and non-adducted DNA nucleobases from all DNA sequences present. Following this, 
sample purification and cleanup was performed with SPE (Oasis® HLB cartridges (1 cc, 30 mg) 
Waters (Milford, USA)). After SPE, the collected samples were evaporated to dryness under 
vacuum (90 min, 20°C). Finally, all samples were suspended in 100 µL of 0.05 % of acetic acid in 
water and stored at -20°C until analysis. 
 
2.4 Untargeted DNA adductomics 
2.4.1 UHPLC-HRMS DNA adduct analysis 
Analysis of DNA adducts in meat digests was effectuated by ultrahigh performance liquid 
chromatography coupled to UHPLC-HRMS. In brief, chromatographic separation was achieved 
with an Acquity BEH C18 Waters column (1.7 µm, 2.1 x 100 mm; Waters Corporation, Milford, 
USA) and the use of 0.05 % of acetic acid in water and 100 % methanol as mobile phases. The 
mobile phases were pumped at 300 µL per min by an Accela 1250 pump coupled to an Accela 
autosampler (Thermo Scientific, San José, USA). HRMS analysis was performed by means of an 
Orbitrap MS (Exactive™, Thermo Fisher Scientific, San José, USA) coupled to a HESI-II 
source. All MS and HESI settings are documented in table 1. 
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Table 1. HESI and MS settings for DNA adduct analysis. 
Setting Full MS 
m/z scan range 70-700 Da 
Mass resolution 100,000 Full Width Half Maximum 
Ionization mode Polarity switching 
Maximum injection time 500 ms 
Automatic gain target 3 x e6 
Spray voltage (+/-) 4 kV 
Sheath gas flow rate 35 arbitrary units 
Auxiliary gas flow rate 5 arbitrary units 
Sweep gas flow rate 2 arbitrary units 
Capillary temperature 380°C 
Heater temperature 370°C 
Capillary voltage (+/-) 40 V 
Tube lens voltage (+/-) 70 V 
Skimmer voltage (+/-) 15 V 
 
Internal calibration of the MS system was performed daily by infusion of calibration mixtures 
prepared according to the protocol described in the operations manual (Thermo Fisher Scientific, 
San José, USA). General instrument control and initial data processing were performed with 
Xcalibur™ 2.1. 
 
2.4.2 Data processing and statistics 
2.4.2.1 ToxID™ profiling 
By means of an in-house DNA adduct database25 and the use of ToxID™ software (Thermo 
Fisher Scientific, San José, USA), the full scan HRMS spectra of the meat digestion samples were 
screened for the possible presence of known diet-related DNA adducts. The inclusion criteria 
consisted of a minimum signal intensity of 10 000, a maximum mass deviation of 10 ppm, 
recurrence and stable retention time (RT) of the DNA adduct of interest in replicate samples and 
a C12/C13 ratio approaching the natural 99:1 ratio. 
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2.4.2.2 Sieve™ data processing 
2.4.2.2.1 Chromatographic peak selection with database lookup 
To screen for the presence and significance of known DNA adducts in the different digested 
meat samples, two sample differential analysis was performed with the database lookup function 
of Sieve™ 2.1 (Thermo Fisher Scientific, San José, USA). This approach allows pairwise 
comparison of DNA adduct levels in different meat preparations and correct statistical 
interpretation and evaluation of the obtained results. Combining the spectral data obtained from 
all three biological replicate digestion samples from the second experiment assured repeatability 
of the obtained results in different technical and biological replicates of different individuals. The 
chosen parameter settings enabled retention of ions demonstrating an m/z value between 70 and 
700 Da, also demonstrating an RT between 0.7 and 5.5 min (of chromatographic analysis). A 
mass deviation up to 10 ppm was allowed and the maximum peak width consisted of 0.5 min. 
Positive and negative ions were analyzed separately. The maximum number of frames and 
minimal peak intensity was set at 50 000 and 35 000 (frame number and arbitrary units 
respectively) for positive ion mode and 50 000 and 20 000 (frame number and arbitrary units, 
respectively) for negative ion mode. After automated processing, Sieve™ reported the m/z value 
and RT for each detected ion, also documenting on the signal abundance in each sample. In a 
subsequent step, the ‘Database Lookup’ and an in-house diet-related DNA adduct database were 
used for putative identification of the detected and selected ions. 
 
2.4.2.2.2 Chromatographic peak selection in preparation of Simca™ analysis 
In preparation of statistical analysis by means of Simca™, Sieve™ can be operated to select all 
detected chromatographic peaks. To this purpose, the same Sieve™ settings as described in 
2.4.2.2.1 Chromatographic peak selection with database lookup, were applied, although the 
database lookup function was not enabled and the maximum number of frames and the minimal 
peak intensity (in arbitrary units) were both set at 35 000. 
 
2.4.2.3 Simca™: orthogonal partial least squares discriminant analysis 
Simca™ 13 (Umetrics AB, Umeå, Sweden) software can be implemented for Orthogonal Partial 
Least Squares Discriminant Analysis (OPLS-DA) of multivariate omics data of which the 
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number of variables (X) exceeds the number of observations. During this type of analysis, a 
linear regression model that can fit a certain sample into a certain category (categorical Y) based 
on its X-variables, is constructed.  
In this study, OPLS-DA was performed by the combined analysis of all raw data obtained from 
all 3 follow-up digestions for both selected test subjects separately, thus combining the data of all 
technical replicates (every experiment was performed in triplicate) for each biological replicate (3 
per test subject; n = 9) for selected test subject 1 (P1) on the one hand and selected test subject 2 
(P2) on the other.  
After logarithmic data transformation (to ensure normal data distribution) and Pareto scaling (to 
limit large differences concerning the range of the different X-variables without leveling off), 
Simca™ allowed automated data modelling. The validity of the obtained OPLS-DA model was 
checked by CV-ANOVA (p < 0.05) and assessment of R2 (must approach 1 (= perfect fit) and is 
used to assess the goodness of fit, representing the explained variation in X) and Q2 (= cross-
validated R2, used to assess the predictive ability of the method and operated with a minimal 
threshold of 0.5). Discriminative/predictive ions were selected based on a Variable Importance 
in Projection-score (VIP score) > 0.8. The VIP score reflects the relative importance of X-
variables in predicting the Y-variable. A VIP > 1 has a high influence, a VIP < 1, but > 0.8 has a 
moderate influence and a VIP < 0.8 has a low influence [28, 29]. 
 
2.5 Targeted analyses 
2.5.1 O6-carboxymethylguanine and O6-methylguanine 
Targeted analysis of the O6-CMG and O6-MeG DNA adducts was performed by means of 
UHPLC-MS/MS using a triple quadrupole MS (TSQ Vantage) coupled to a HESI-II source, an 
Accela pump and Accela autosampler (Thermo Fisher Scientific, San José, USA) [27]. 
Identification of O6-CMG and O6-MeG was achieved based on matching fragments and RT, 
derived from corresponding analytical standards. O6-CMG was kindly provided by Dr. S. Moore 
(Liverpool John Moores University, Liverpool, UK), whilst O6-MeG was purchased from Sigma-
Aldrich (St Louis, MO, USA). Correct quantification was performed by means of a 12-point 
calibration curve in calf thymus DNA (Rockland, Gilbertsville, Pennsylvania, USA) [27]. 
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Instrument control and data processing were performed with Xcalibur™ 2.1 (Thermo Fisher 
Scientific, San José, USA). 
 
2.5.2 Malondialdehyde 
MDA concentrations in meat digests were determined colorimetrically according to the protocol 
described by Van Hecke et al. [21], i.e. a slightly altered version of the TBARS protocol 
documented by Grotto et al. [30] MDA was allowed to react with 2-thiobarbituric acid in an acid 
environment, resulting in the formation of TBARS. After extraction of the formed TBARS by 
means of 1-butanol, the absorbance of the TBARS complexes was measured at 532 nm (G10S 
UV–Vis, Thermo Fisher Scientific, San José, USA). Quantification was enabled by means of an 
8-point calibration curve (0 to 50 nmol of MDA per mL, constituted after acid and thermal lysis 
of 1,1,3,3-tetramethoxypropane (Sigma-Aldrich, St Louis, MO, USA)). 
 
2.5.3 Statistics 
Statistical analysis of the results obtained by means of all targeted analyses was performed with 
SAS enterprise guide 6 (SAS Institute Inc., Cary, North Carolina, USA), applying a type I error 
probability of 5 %. 
 
 
3. RESULTS 
3.1 DNA adduct profiling of in vitro beef digests using 5 different fecal 
inocula 
Per test subject, individual in vitro gastrointestinal digestions of beef preparations were performed 
by adding its proper fecal inoculum to the colonic compartment. Samples for DNA adduct 
profiling purposes were collected directly after addition of pre-cultivated fecal inocula, but 
before colonic incubation (T0), and also after 48 hours of colonic digestion (T48), enabling 
assessment of interindividual differences over time.  
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Untargeted HRMS analysis was performed on the meat digests for all 5 test subjects. The 
acquired T0 and T48 sample spectra and chromatograms were screened for DNA adducts 
included in the diet-related database, thereby using ToxID™ data processing. This resulted in 
the putative identification of 46 untargeted DNA adducts, which were present at T0 and/or T48. 
To clearly visualize the increase or decrease of DNA adduct levels during in vitro colonic 
digestion of beef (difference in measured DNA adduct levels in T48 samples compared to T0 
samples), measured putative DNA adduct signal intensities at T0 were subtracted from T48 
DNA adduct signal intensities and visualized in a heat map (figure 1). In this heat map, positive 
values are colored red; meaning that the respective T48 signal intensity (for that compound and 
test subject) was higher than the T0 signal intensity, implying that DNA adduct levels increased 
during colonic digestion, whilst negative values are colored blue; meaning that T0 values were 
higher than T48 values, and that DNA adduct levels decreased during colonic digestion.  
The detected levels of different putatively identified DNA adduct types increased during colonic 
digestion of beef, whilst others declined. None demonstrated a steady state. The detected DNA 
adduct types were somewhat similar for all tested fecal inocula, although significant 
interindividual differences could be noted in their intensity levels, both before (T0) and after 
(T48) colonic digestion of beef. 
 
3.2 DNA adductomics in digests of different meat preparations 
A second in vitro experiment was conducted using the fecal inocula of 2 out of the 5 previously 
employed volunteers. These particular volunteers (P1 & P2) were selected since their fecal 
inocula demonstrated a noticeable increase of O6-CMG levels (RT 1.58 min) upon colonic 
digestion of beef. The production of O6-CMG was of particular interest in this study since the in 
vivo occurrence of O6-CMG has been linked to red meat digestion and may be involved in the 
development of CRC [11].  
Meat preparations of beef and chicken, both with or without added CaCO3, were subjected to 3 
separate in vitro digestions as described in the Experimental section. Targeted O6-CMG analysis 
and untargeted HRMS analysis was performed on the obtained samples at T0 and T48 to 
evaluate the effect of in vitro gastrointestinal digestion of different meat preparations on DNA 
adduct profile.  
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Figure 1. Heat map 
displaying rank transformed 
data (ToxID™) on increase 
(light to dark red) or 
decrease (light to dark blue) 
of DNA adduct levels 
(different isomers marked 
with *(*)(*)(*)) during 48 
hours of colonic beef 
digestion (after stomach and 
small intestinal digestion) 
utilizing the fecal inocula of 
5 different test subjects (P1, 
P2, P3, P4 and P5). To 
facilitate comparison, DNA 
adduct levels in T0 samples 
were subtracted from DNA 
adduct levels in T48 samples, 
rendering positive values to 
be red, and negative values 
to be blue. Darker shades 
document larger differences 
in DNA adduct signal 
intensity. White boxes 
represent DNA adducts that 
were not detected, 
Regarding the abbreviations 
in the DNA adduct names; 
G equals guanine, C equals 
cytosine, T equals thymine, 
A equals adenine and U 
stands for uracil; ‘M’ 
represents an adduct type 
originating from the 
reaction of a nucleobase 
with 1 or more MDA 
molecule(s). RT is 
expressed in min. 
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As this paper aims to further unravel the hypothesis on red meat related CRC risk, only 
tentatively identified DNA adduct types that were higher in red vs. white meat digests will be 
discussed in detail. Since calcium is believed to have CRC-protective attributes, the same applies 
for putative DNA adducts that appeared to be lower upon digestion of CaCO3 supplemented 
meat. 
 
3.2.1 DNA adduct profiling in digests of different meat preparations 
The results of the DNA adduct analysis of digests of different meat preparations encompass the 
detection of several putatively identified DNA adducts. Figure 2 shows the DNA adduct types 
and levels in meat digests that were sampled after small intestinal digestion (= T0 samples). In 
figure 3, DNA adduct levels in digestive samples obtained after complete in vitro gastrointestinal 
digestion of all different meat preparations are compared (= T48 samples). The results 
demonstrate that certain DNA adduct types appear to be more prevalent in chicken digests 
compared to beef, whilst others were more common in beef digests. Inclusion of CaCO3 in meat 
preparations induced a similar effect, resulting in higher or lower DNA adduct levels in those 
particular meat digests. Both figure 2 and figure 3 are heat maps that allow comparison of DNA 
adduct levels in different meat digests for a certain test subject (P1 or P2) by means of a color 
code. To enable this, the measured signal intensity for that particular DNA adduct in a specific 
meat digest type was subtracted from the measured signal intensity in a different meat digest type. 
An example, ‘P1: B-C’ allows comparison for DNA adduct levels in beef (B) and chicken (C) 
digests for test subject 1 (P1) as the detected signal intensity in chicken was subtracted from the 
observed signal intensity in beef. Since positive values in this heat map are marked red, and 
negative values are marked blue, a blue box would indicate that the obtained DNA adduct levels 
in chicken digests were higher compared to beef (B-C < 0). In contrast, a red box would signal 
higher DNA adduct levels in beef digests compared to chicken digests (B-C > 0). 
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Figure 2. Heat map 
displaying rank 
transformed data 
(ToxID™) on average 
putatively detected DNA 
adduct levels (different 
DNA adduct isomers 
marked with *(*)(*)(*)) in 
T0 digestive samples by 
means of 3 separate in 
vitro setups utilizing 3 
different fecal inocula of 2 
different test subjects (P1 
and P2) to compare DNA 
adduct levels and types in 
different meat preparation 
digests. White boxes 
imply the absence of that 
DNA adduct type in said 
sample. Red indicates 
higher putative DNA 
adduct levels in 
comparison (average 
DNA adduct level in the 
first noted meat digest 
minus the average DNA 
adduct level in the second 
noted meat digest). Blue 
represents lower putative 
DNA adduct levels in 
comparison. “B” 
represents beef digests, 
“C” represents chicken 
digests and “Ca” 
indicates the addition of 
CaCO3 to the considered 
meat preparation that was 
digested. Concerning the 
DNA adduct name abbreviations; G equals guanine, C equals cytosine, T equals 
thymine, A equals adenine and U stands for uracil; ‘M’ represents an adduct type 
originating from the reaction of a nucleobase with 1 or more MDA molecule(s). RT is 
expressed in min. 
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Figure 3. Heat map 
displaying average rank 
transformed ToxID™ data of 
putatively detected DNA 
adduct levels (different 
isomers marked with 
*(*)(*)(*)) in colonic 
digestive samples (T48) by 
means of 3 separate in vitro 
setups utilizing 3 different 
fecal inocula of 2 test subjects 
(P1 and P2) to compare DNA 
adduct levels and types in 
meat digests. White boxes 
represent the absence of 
measurable DNA adduct 
levels. Light to dark red 
represents higher putative 
DNA adduct levels in 
comparison (average DNA 
adduct level in the firstly 
mentioned digested meat 
preparation minus the 
average DNA adduct level in 
the secondly mentioned meat 
preparation digest). Light to 
dark blue represents lower 
putative DNA adduct levels 
in comparison. “B” stands for 
beef, “C” stands for chicken, 
and “Ca” stands for added 
CaCO3. With regard to DNA 
adduct name abbreviations; 
G equals guanine, C equals 
cytosine, T equals thymine, A 
equals adenine and U stands 
for uracil; ‘M’ represents an 
adduct type originating from 
interaction with 1 or more 
MDA molecule(s). RT is 
expressed in min. 
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3.2.2 Two sample differential analysis by means of Sieve™ database 
lookup: DNA adducts in different meat preparations pre- and 
post-colonic digestion 
DNA adduct types that were retrieved by means of two sample differential analysis of meat 
digest samples obtained after colonic digestion (at T48) are presented in table 2. Hereby, 7 
different DNA adducts appeared to be significantly higher or lower in beef digests compared to 
chicken digests. Addition of CaCO3 to beef or chicken did also result in a shifted DNA adduct 
profile. Just prior to colonic digestion (at T0), over 20 different DNA adduct types with 
significantly higher or lower levels in beef or chicken digests could be retrieved, whilst addition 
of CaCO3 to chicken or beef also induced a significant increase or decrease in certain DNA 
adduct levels (compared to those in chicken or beef without added CaCO3) (see table 3 and table 
4). In the context of red meat genotoxicity, the putatively identified DNA adducts of interest are 
the ones with a significantly higher prevalence in beef digests. Regarding the possible CRC-
protective attributes of calcium, investigation of the putatively identified DNA adducts that are 
lower in meat preparation digests with added calcium in comparison to digests of meat 
preparations without added calcium are prioritized. DNA adducts of interest that were retrieved 
at T0 are presented in table 3, whereas additional DNA adducts are documented in table 4. 
 
3.2.3 Simca™ modelling; discrimination between digested meat 
preparations 
OPLS-DA modelling of T48 sample composition did not reveal any discriminating DNA 
adducts for beef vs. chicken or added CaCO3 vs. no added CaCO3. However, 2 putative DNA 
adducts could be retained as discriminating factors for digestion of meat with added CaCO3 in 
T0 samples. The putatively identified M3C (diformyldihydromethano-oxazocinyloxopyrimidine, 
RT of 4.58 min and m/z of 300.0991 in negative ionization mode), a DNA adduct type resulting 
from the interaction of MDA and cytosine, was found to be discriminative for digestion of meat 
with added CaCO3 (vs. meat without added CaCO3) for P1. In contrast, fapy-A (4,6-diamino-5-
formamidopyrimidine, RT of 1.14 min and m/z of 154.0723 in positive ionization mode), an 
oxidative adenine lesion, appeared to be predictive for the lack of CaCO3 addition to meat 
preparations prior to in vitro digestion in P2 samples. The tentatively identified M3C 
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demonstrated a VIP score of 0.732 in chicken digests and 0.815 in beef digests. Fapy-A 
demonstrated a VIP score of 1.78 in chicken digests and 2.70 in beef digests. 
 
Table 2. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts in colonic meat digests (T48) after two sample differential analysis by means of 
Sieve™ database lookup.  
Discriminating for DNA adduct RT 
(min) 
Beef vs. Chicken Carboxyethyl-C 0.82 
 Dimethyl-T or Ethyl-T 0.70 
 M3C (Diformyldihydromethano-
oxazocinyloxopyrimidine) 
4.12 
Chicken vs. Chicken + CaCO3 Methoxymethyl-C 0.78 
 Methoxymethyl-C 0.80 
 Methoxymethyl-C 1.03 
 Methoxymethyl-C 1.30 
 Methoxymethyl-C 1.59 
 Methoxymethyl-C 1.84 
 Methoxymethyl-C 2.18 
Beef + CaCO3 vs. Beef 3,N4-etheno-C (*) 0.79 
 Carboxymethyl-T (*) 0.74 
 M3C (Diformyldihydromethano-
oxazocinyloxopyrimidine) (*) 
1.07 
 Methyl-G or Hydroxymethyl-A 1.45 
 Methyl-T or Ethyl-U (*) 2.46 
 Methyl-T or Ethyl-U 3.19 
 Tetramethyl-C 1.16 
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Table 3. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts of interest (relevant to the hypothesis) in precolonic meat digests (T0) after two 
sample differential analysis by means of Sieve™ database lookup. 
Discriminating for  DNA adduct RT 
(min) 
Beef vs. Chicken 1,N6-etheno-A 3.73 
 Dimethyl-T or Ethyl-T 0.70 
 Dimethyl-T or Ethyl-T 0.76 
 Dimethyl-T or Ethyl-T 1.01 
 Dimethyl-T or Ethyl-T 1.27 
 Dimethyl-T or Ethyl-T 2.62 
 Dimethyl-T or Ethyl-T 2.95 
 Dimethyl-T or Ethyl-T 3.23 
 Dimethyl-T or Ethyl-T 3.31 
 Dimethyl-T or Ethyl-T 3.65 
 Dimethyl-T or Ethyl-T 3.81 
 Dimethyl-T or Ethyl-T (*) 4.37 
 Ethyl-G or Dimethyl-G or Methoxymethyl-A 0.84 
 M2G (MDA dimer guanine DNA adduct) 1.14 
 M2G (MDA dimer guanine DNA adduct) (*) 3.73 
 M3C (Diformyldihydromethano-
oxazocinyloxopyrimidine) 
2.99 
 Methoxymethyl-C 3.98 
 Methoxymethyl-T 2.10 
 Methyl-U 3.18 
Chicken vs. Chicken + CaCO3 Ethyl-G or Dimethyl-G or Methoxymethyl-A 0.85 
 Hydroxy-A 3.16 
 Methoxymethyl-C 3.64 
 Methyl-C 2.68 
 Methyl-C 2.98 
 Methyl-C 3.24 
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Table 4. Significantly higher levels (p < 0.05 or p < 0.10 (*)) of putatively identified DNA 
adducts (not relevant to hypothesis) in pre-colonic meat digests (T0) after two sample 
differential analysis by means of SieveTM database lookup.  
Discriminating for DNA adduct RT 
(min) 
Chicken vs. Beef Carboxy-G (*) 0.81 
 Heptenaletheno-G 4.01 
 Hydroxy-A 3.22 
 Hydroxy-A 3.48 
 Hydroxy-A (*) 2.64 
 Hydroxy-PhIP-G (Hydroxy-
aminomethylphenylimidazopyridine-G) (*) 
3.75 
 Hydroxynonenal-A 2.65 
 Hydroxynonenal-A 2.84 
 IQ-G (Aminomethylimidazoquinolone-G) 1.29 
 M1A (MDA dimer guanine DNA adduct) 0.86 
 M1G (Pyrimidopurinone) 4.36 
 M3C (Diformyldihydromethano-oxazocinyloxopyrimidine) 1.05 
 MeIQ-G (Aminodimethylimidazoquinolone-G) 5.08 
 Methoxymethyl-C 0.77 
 Methoxymethyl-T 3.62 
 Methyl-A (*) 1.13 
 Methyl-C 1.39 
 Methyl-C 2.68 
 Methyl-C (*) 3.80 
 Methyl-T or Ethyl-U 3.16 
 Methyl-T or Ethyl-U 3.84 
 Methyl-T or Ethyl-U (*) 1.17 
 PhIP-G (Aminomethylphenylimidazopyridine-G) 1.41 
 ST-G (Sterigmatocystin-G) 1.72 
 Tetramethyl-C 0.86 
Chicken + CaCO3 vs. 
Chicken 
1,N6-etheno-A 
Dimethyl-T or Ethyl-T 
1.54 
1.02 
 Dimethyl-T or Ethyl-T 1.04 
 Dimethyl-T or Ethyl-T 1.27 
 Dimethyl-T or Ethyl-T 2.62 
 Dimethyl-T or Ethyl-T 3.80 
 Dimethyl-T or Ethyl-T 4.11 
 Dimethyl-T or Ethyl-T 4.23 
 Methoxymethyl-C 3.05 
 Methoxymethyl-T 2.05 
 Methyl-T or Ethyl-U 2.10 
 Methyl-T or Ethyl-U 2.50 
 Nitro-C 3.29 
Beef + CaCO3 vs. Beef Dimethyl-T or Ethyl-T 
Dimethyl-T or Ethyl-T 
0.71 
1.02 
 Dimethyl-T or Ethyl-T 1.28 
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Table 4 continued. 
Discriminating for DNA adduct RT (min) 
Beef + CaCO3 vs. Beef Dimethyl-T or Ethyl-T 1.62 
 Dimethyl-T or Ethyl-T 2.87 
 Dimethyl-T or Ethyl-T 2.70 
 Dimethyl-T or Ethyl-T 4.22 
 Hydroxynonenal-C 1.30 
 Hydroxymethylhydantion (*) 2.80 
 Diformyldihydromethano-oxazocinyloxopyrimidine 
(M3C) 
3.93 
 Methoxymethyl-T 2.10 
 Methyl-C (*) 2.89 
 Methyl-T or Ethyl-U 2.51 
 Methyl-U 2.42 
 Methyl-U 3.90 
 Nitro-C 2.76 
 Nitro-C 3.29 
 
 
3.3 UHPLC-MS/MS analysis of O6-carboxymethylguanine and O6-
methylguanine in digests of different meat preparations 
O6-CMG could be detected upon digestion of all studied meat preparations, utilizing all fecal 
inocula obtained from both selected test subjects (P1 & P2), demonstrating a clear rise in O6-
CMG levels after 48 h of colonic digestion. The detected O6-CMG levels at T0 did not surpass 
the limit of quantification, but the obtained O6-CMG levels at T48 are shown in figure 4. O6-
MeG could not be detected in any of the samples.  
Overall, the highest levels of the O6-CMG DNA adduct were retrieved in digestive samples of 
test subject 1 (P1). Combining the results from all replicates (3 technical replicates x 3 biological 
replicates per test subject) from P1 demonstrated that O6-CMG levels were significantly higher 
upon digestion of beef compared to chicken (p < 0.05), and that addition of CaCO3 resulted in 
higher DNA adduct levels for both beef and chicken (p < 0.05). For test subject 2 (P2), the same 
results could be observed; O6-CMG formation upon digestion of beef was significantly higher 
compared to chicken (p < 0.05), and addition of CaCO3 did also result in a significant increase in 
O6-CMG levels (p < 0.05). Combined statistical analysis of P1 and P2 data confirmed the earlier 
observed trend for beef vs. chicken across individuals; beef consumption increased O6-CMG 
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levels overall (p < 0.05) (data not shown). This was not the case for CaCO3 addition as it did not 
significantly affect O6-CMG levels overall (p > 0.05) (data not presented). 
 
Figure 4. Formation of the O6-CMG DNA adduct (mean concentration ± s.e.m.) during 
colonic digestion of chicken without added CaCO3, chicken with added CaCO3, beef 
without added CaCO3 and beef with added CaCO3 by means of the fecal inocula of test 
subject 1 and 2 (significant differences (p < 0.05) documented with different letters). 
 
3.4 Malondialdehyde in digests of different meat preparations 
The digestive samples were also subjected to MDA analysis. The formation of MDA upon 
digestion of beef was significantly higher compared to chicken individually and overall (p < 0.01). 
Addition of CaCO3 to meat preparations rendered a significantly lower amount of MDA for P1 
(p < 0.05), but not for P2 (p > 0.05) prior to colonic digestion (= in T0 samples). After colonic 
digestion, MDA levels in CaCO3 meat digests were significantly reduced compared to digests of 
meat preparations without added CaCO3 (p < 0.05) for both P1 and P2 (table 5 and 6). 
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4. DISCUSSION 
This study focused on the detection of diet-related DNA adducts in meat digests. Different 
putatively identified DNA adducts could be detected in vitro and several DNA adduct types were 
found to be more prevalent upon digestion of a particular meat type; e.g. levels of O6-CMG and 
the putatively identified carboxyethyl-C were higher in beef vs. chicken digests, whilst both were 
also influenced by CaCO3 supplementation. The latter also applies for the tentatively identified 
fapy-A and methoxymethyl-C (or its hydroxyethyl-C isomer) DNA adducts, which appeared to 
be discriminative for or significantly higher in meat that was not supplemented with CaCO3. The 
lipid peroxidation product MDA increased upon digestion of beef compared to chicken, whereas 
CaCO3 supplementation reduced its formation.  
When comparing the concentrations of different food metabolites and DNA adduct levels in 
different meat type digests, the major compounds of interest in this study are the ones that are 
higher in beef compared to chicken since these types of molecules may help explain the link 
between red meat consumption and CRC incidence. Untargeted UHPLC-HRMS analysis 
revealed that the colonic microbiota of 3 out of 5 of the initial test subjects induced O6-CMG 
formation upon digestion of meat. More in-depth targeted UHPLC-MS/MS analysis of P1 and 
P2 meat digest samples revealed the presence of the O6-CMG DNA adduct in pre- and post-
colonic digests with all 4 meat preparations. O6-CMG levels were not quantifiable (< LOQ of 50 
pmol per mg of DNA) prior to colonic digestion, but increased during the colonic digestion 
phase. The earlier reported finding that O6-CMG levels were higher upon digestion of beef 
(heme-rich meat) compared to chicken (low heme content) [20] were confirmed in the present 
study. The red meat-CRC hypothesis suggests that the formation of NOCs in the gut is involved 
in the initiation and/or development of CRC. NOCs are known to have DNA-alkylating 
properties, rendering them to be a very likely precursor of O6-CMG formation. This has already 
been investigated and demonstrated in vivo in humans as well, thus supporting the NOC 
hypothesis that links red meat consumption to CRC development [11].  
An additional red meat-CRC hypothesis is the LPO hypothesis, in which LPOs are believed to 
stimulate initiation and/or promotion of CRC. In this study, MDA levels were higher in beef 
digests compared to chicken at all times, attesting to the pro-oxidative attributes of heme-rich 
meat [20, 22, 31]. In vitro MDA formation notably differed from O6-CMG DNA adduct 
formation as MDA levels were higher after small bowel digestion of meat, demonstrating an 
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abiding decrease during colonic digestion. This decrease suggests active or passive degradation 
(through e.g. oxidation [32]) during colonic digestion although interaction with fibers [33], 
proteins [34] and/or DNA [8] is possible as well. However, the most prominent MDA-induced 
DNA adduct (M1G) [8] could not be retrieved in this study. The interaction of MDA with 
proteins and/or fibers may thus be more prominent than DNA adduct formation although 
instability of the M1G DNA adduct in digestive samples may also be the underlying cause of the 
lack of M1G detection. Additional research should be conducted to support these statements.  
To enable further investigation of the NOC and LPO hypothesis, meat preparations were 
supplemented with CaCO3 since consumption of calcium-rich dairy products has been 
associated with a decreased CRC-risk [35, 36]. In this study however, addition of CaCO3 
stimulated O6-CMG formation. It is however likely that calcium exerts its protective effect 
through a different route. After all, the CRC-protective attributes of calcium have been ascribed 
to its possible (concentration-dependent) anti-oxidative properties [5, 37, 38]. In support of this, 
we observed a decrease in MDA upon digestion of meat with added CaCO3, distinctly suggesting 
that addition of CaCO3 to meat reduces lipid peroxidation and MDA formation during digestion. 
This is an observation that has been documented before by Pierre et al. [39] who also measured 
TBARS levels after calcium supplementation to beef-fed rats. The finding that CaCO3 addition 
stimulated O6-CMG formation in this study may be linked to the composition and activity of the 
microbiota. In a previous study, we were able to demonstrate that O6-CMG formation has a 
bacterial origin since inactivation of the microbiota completely abolished O6-CMG production 
[20]. Stimulation of the bacteria that are responsible for O6-CMG production may be the 
underlying cause of the CaCO3 induced increase of O6-CMG levels since varying dietary calcium 
levels can affect the microbial composition of the gut [40]. Some of the gut colonizing bacteria 
are able to perform enzymatic N-nitrosation reactions or reduce pH levels to induce acidic N-
nitrosation, explaining the microbially induced formation of NOCs and alkylation DNA adducts 
[41, 42]. This could also explain the interfering role of CaCO3. As such, future studies on red 
meat carcinogenicity should include characterization of the fecal microbiome to gather more 
knowledge on the possible involvement of specific gut microbes in the formation of (NOCs 
and) alkylation-induced DNA adducts. After all, previous research has already demonstrated that 
red meat and dietary fiber significantly alter O6-MeG DNA adduct levels and the composition of 
the fecal microbiome [43]. 
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Research on the composition of the human microbiome and metabolome has revealed a 
significant interindividual and intra-individual variability [44, 45]. Due to the highly variable and 
person-dependent bacterial composition in the colon and the resulting scope of metabolism 
activities, different metabolites – including DNA adducts or their precursors – can be present in 
the gut of different individuals at various points in time. Isolation of the diverse microbial 
community in the fecal inocula from different healthy volunteers could probably explain the 
notable interindividual variation in O6-CMG levels and the obtained DNA adduct profile of P1 
to P5 meat digests in this study. In pre-colonic digestion samples, DNA adducts can be present 
due to the active formation of genotoxic molecules during enzymatic (small intestinal) digestion 
of beef, followed by interaction with DNA (most likely from bacterial origin, as this type of 
DNA will be most abundantly present at the time). Alternatively, some DNA adducts may 
already be present in the pre-cultivated fecal inoculum [20]. Previous research demonstrated that 
the O6-CMG DNA adduct (that could be detected in beef digests), and its unknown precursor, 
were not present after small bowel digestion but originated from the fecal inoculum of certain 
individuals. In addition, it was shown that the colonic microbiota significantly contributed to the 
formation of O6-CMG during the simulated colonic digestion of both beef and chicken, 
demonstrating a clear rise of O6-CMG in T48 samples [20]. However, these findings cannot be 
extrapolated for all other DNA adduct types and their respective precursors. Nevertheless, the 
presence of DNA adducts in pre-colonic meat digestion samples directs towards the presence of 
DNA-reactive molecules in the gut during or after digestion of food. In agreement, scientific 
literature suggests that (microbial) gut metabolism is not always beneficial to human health as it 
affects several physiological processes like inflammation, DNA damage and cell apoptosis. 
Especially some of the bacterially produced detrimental gut metabolites have potentially harmful 
alkylating and oxidant activities (e.g. NOCs and LPOs). Hence, evidence of the active 
contribution of these (microbially produced) gut metabolites like MDA and O6-CMG to the 
development of chronic diseases is accumulating [15].  
After UHPLC-HRMS DNA adductomics of all pre-colonic meat digests, ToxID™ analysis 
demonstrated that certain untargeted DNA adducts types were more prevalent in beef digests 
compared to digests of beef with added CaCO3 or chicken digests. The same applies for chicken 
digests compared to digests of chicken without CaCO3 for both test subjects. However, none of 
these ToxID™ retrieved DNA adduct types appeared to be significantly higher according to 
Sieve™ or Simca™. Simca™ analysis did however reveal the presence of a DNA adduct that 
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was discriminative for meat digests without added CaCO3, and which was putatively identified as 
fapy-A, an oxidative DNA lesion with in vivo relevance [46]. Lower fapy-A levels in samples from 
CaCO3 supplemented meat preparations could be due to the anti-oxidant nature of calcium in 
certain concentrations [37, 38], possibly explaining the CRC-protective characteristics of dairy 
(with high calcium levels) [36].  
In post-colonic meat digests, Simca™ did not reveal any discriminant DNA adduct types, 
although both ToxID™ and Sieve™ did. One putatively identified DNA adduct type appeared 
to be significantly higher for beef compared to chicken in Sieve™ as well as ToxID™; i.e. 
carboxyethyl-C eluting at 0.82 min. Carboxyethyl-C is a DNA adduct type that can result from 
DNA alkylation, but has not been studied extensively or retrieved in vivo (to the best of our 
knowledge). Stimulation of the production of carboxyethyl-C during heme-rich meat digestion 
aligns with the earlier discussed results concerning the increased production of O6-CMG upon 
digestion of beef, indicating a similar underlying pathway. Several potential isomers of 
methoxymethyl-C, also including hydroxyethyl-C, appeared to be higher in chicken digests 
without added CaCO3 compared to chicken digests with supplemented CaCO3. ToxID™ data 
analysis confirmed this for the methoxymethyl-C isomer eluting at 0.80 min. Since the formation 
of methoxymethyl-C or hydroxyethyl-C appears to be reduced upon CaCO3 addition, this 
compound may be involved in the LPO hypothesis (just like MDA and fapy-A), although further 
identification and research are required to support this statement. To the best of our knowledge, 
both methoxymethyl-C and hydroxyethyl-C have not previously been detected in vivo. 
Definite positive identification of the fapy-A, carboxyethyl-C and methoxymethyl-C (or 
hydroxyethyl-C) DNA adducts requires confirmation of co-chromatography by means of an 
analytical standard. Unfortunately, these 3 types of DNA adduct standards are not commercially 
available (at affordable rates), impairing confident compound identification. However, the fact 
that all compounds could be retrieved after specific sample preparation steps (DNA hydrolysis 
and DNA adduct extraction) and analytical analysis by means of an UHPLC-HRMS method that 
was developed for the detection of DNA adduct molecules specifically, makes it more likely that 
these compounds are indeed DNA adducts. In any case, all compounds that were determined to 
be higher in this study for one particular digested meat type can be defined as relevant food 
metabolites. 
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In this study, different ways of untargeted data processing were applied; i.e. ToxID™, Sieve™ 
and Simca™. However, Sieve™ and Simca™ did not indicate that O6-CMG could be of any 
importance. Nonetheless, targeted O6-CMG analysis and statistical interpretation of the results 
did reveal some interesting findings. This indicates that the obtained output of results very much 
depends on the applied software and parameter settings. In retrospect, we concluded that O6-
CMG signal intensities did not reach the minimal signal intensity that was set in Sieve™, 
excluding O6-CMG from further multivariate data processing. However, this does not render the 
O6-CMG data to be less important, keeping in mind that the initial untargeted detection of O6-
CMG was performed by means of an Orbitrap. An Orbitrap is very well suited for untargeted 
‘omics’ applications, but is surpassed by triple quadrupoles regarding sensitivity [47]. In 
consequence, targeted UHPLC-MS/MS analysis by means of a triple quad enabled more in-
depth investigation of O6-CMG levels. This emphasizes that DNA adductomics applications can 
be very useful for preliminary biomarker screening, but also demonstrates the benefits of 
specialized data processing and/or complimentary analyses.  
In this study, meat digestion was performed by means of an in vitro digestion system that offers 
several advantages due to its flexibility and lack of ethical restraints [19]. Unfortunately, its use is 
quite labor-intensive, which is reflected in the fact that the microbiota of only 5 different 
individuals could be screened and that only 2 were selected for a more in-depth investigation of 
meat-related DNA adduct formation. In addition, the in vitro setup may not truly reflect the in 
vivo situation since the in vitro system mainly mimics luminal DNA adduct formation, which may 
not translate directly into luminal and mucosal DNA adduct formation in vivo. Future in vitro 
studies in line with this study, and future in vivo studies in humans should document dietary 
habits (e.g. make use of food frequency questionnaires, 24-hour recalls, etc.) to be able to link 
this information on exposure to the variation in detected DNA adduct levels. Furthermore, 
complimentary analyses to measure the actual intake of nutrients, as well as assessment of non-
digested nutrients and digestion metabolites (e.g. with fecal metabolomics [48]) may offer some 
relevant information to help elucidate the red meat-CRC link. 
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5. CONCLUSION 
This study was able to confirm that heme-rich meat stimulates lipid peroxidation and O6-CMG 
formation. It also demonstrated that CaCO3 can suppress MDA formation, acknowledging the 
CRC-protective potential of calcium ingestion via the reduction of lipid peroxidation. In contrast, 
CaCO3 appeared to stimulate alkylation of guanine (O6-CMG formation), which is believed to be 
procarcinogenic [11]. Digestion of different meat types revealed that both meat digestion and 
CaCO3 supplementation influences the DNA adductome. The presence of the fapy-A, 
carboxyethyl-C and methoxymethyl-C DNA adducts in meat digests does however require 
further investigation. Since all putatively identified DNA adduct types in this meat digestion 
study originate from DNA alkylation, DNA oxidation or attack of DNA nucleobases by LPOs 
[25], further DNA adduct profiling and identification is definitely warranted to allow thorough 
investigation of the LPO and NOC pathway in red meat related carcinogenicity. This will be 
enabled by future in vitro and in vivo DNA adductome studies. To the best of our knowledge, this 
is one of very few studies to implement a state-of-the-art DNA adductomics platform. Moreover, 
to date, it is the only study that employed this approach to investigate DNA adduct formation 
during food digestion. 
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ABSTRACT 
In 2015, the WHO and IARC issued that the consumption of red meat is ‘probably carcinogenic 
to humans’, primarily focusing on the observed link between red meat consumption, as a part of 
the Western diet, and CRC incidence. Different hypotheses have been put forward to explain 
this causal relationship but the heme hypothesis, which states that heme iron present in red meat 
stimulates the formation of toxic NOCs and LPOs, has received the most attention and support. 
Although we know that NOCs as well as LPOs can exert DNA damaging effects, the exact 
underling mechanisms of red meat and heme iron genotoxicity requires further elucidation. By 
means of DNA adductomics, chemically induced DNA adduct formation can be mapped in 
relation to e.g. dietary exposures. In this study, this state-of-the-art methodology was used to 
investigate alkylation and (lipid per)oxidation induced DNA adduct formation in in vitro red vs. 
white meat digests. In doing so, 90 DNA adduct types could be (tentatively) identified, 
encompassing several known alkylation and (lipid per)oxidation induced DNA adducts. The 
retrieved DNA adduct types and levels demonstrate a clear interindividual variation. Overall, the 
increased formation of 26 DNA adduct types could be related to red meat (and heme iron) 
digestion (as opposed to white meat digestion). More specifically, hydroxymethylhydantion, 
diformyldihydromethano-oxazocinyloxopyrimidine (M3C), hydroxyethylthymine (or 
methoxymethylthymine), carboxyethylthymine, methylthymine, ethylthymine, 
hydroxymethylthymine, tetramethylthymine and 3,N4-ethenocytosine were singled out as 
potential heme-rich meat digestion markers. Since those particular DNA adduct types originate 
from DNA alkylation and/or oxidation processes, this is in support of the heme, NOC and LPO 
hypothesis. As a result, it has become clear that DNA adduct formation may indeed contribute 
to red meat related CRC risk, arguing further investigation. 
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1. INTRODUCTION 
The vast majority of cancer cases are not hereditary in origin, but are caused by the (chronic) 
exposure to certain environmental factors. This encompasses exposure to genotoxic chemicals 
from multiple and highly diverse sources; e.g. HCAs in meat cooked at high temperatures, 
mycotoxins in molded food and feed, PAHs in tobacco smoke, diesel exhaust, and grilled meat 
[1]. Such chemicals can contribute to cancer initiation and development individually and/or 
synergistically. Moreover, the hence induced DNA adduct formation appears to be key in 
chemically induced carcinogenesis; covalent binding of genotoxic chemicals to DNA 
nucleobases can alter genes and induce mutations [2]. 
In 2015, the IARC and the WHO issued that red meat is ‘probably carcinogenic to humans’ 
(group 2B) “based on limited evidence that the consumption of red meat causes cancer in 
humans and strong mechanistic evidence supporting a carcinogenic effect” [3]. One of the main 
hypothetical mechanisms underlying the epidemiological link between red meat consumption 
and CRC is explained by the ‘heme hypothesis’. This hypothesis states that heme, which is 
intrinsically more present in red meat compared to white meat, stimulates (lipid per)oxidation 
and NOC formation in the gut besides effecting direct toxicity [4, 5]. NOCs, heme, as well as 
several known oxidative metabolites (e.g. ROS and LPOs) exert genotoxic effects via alkylation 
and/or oxidation of DNA, as such contributing to chemically induced DNA adduct formation 
[6-8].  
NOC exposure can occur via different routes; dietary intake and endogenous formation in the 
gut [9, 10]. More specifically, nitrosamines and nitrosamides can be formed in the stomach due 
to the interaction of nitric oxide or nitrite from metabolism, food, saliva and pharmaceutical 
drugs [10, 11]. In the large bowel, microbial fermentation of proteins can lead to the production 
of amines, which can then be transformed to NOCs by means of nitrosation [12]. Several studies 
have demonstrated that dietary heme iron, but not inorganic iron and/or meat protein, 
significantly increases fecal NOC-levels of human volunteers consuming a red meat diet [13-16]. 
Hence, it appears that heme iron catalyzes NOC-formation upon red meat digestion. More 
specifically, it has been hypothesized that heme can capture NO (e.g. after release by S-
nitrosothiols under alkaline conditions in the small bowel), resulting in the formation of nitrosyl 
heme. Thus, since nitrosyl heme can act as a nitrosating agent, heme iron can promote 
  
 
 
 
Chapter V 
 
  
175 
 
 
endogenous NOC formation [17]. Because NOCs exert DNA-alkylating properties, increased 
NOC formation can lead to the accumulation of alkylation-induced DNA adducts [6, 18]. 
The heme hypothesis also stipulates a direct and indirect heme iron induced increase of oxidative 
stress and lipid peroxidation. Through the Fenton reaction, heme iron can stimulate the 
formation of ROS and LPOs [19], leading to a cascade of oxidative reactions and resulting in the 
oxidation of e.g. DNA nucleobases. As such, red meat digestion can increase CRC risk in a 
twofold manner; i.e. through the induction of oxidative stress and/or by DNA adduct formation 
[4, 5, 20, 21]. 
DNA adduct formation due to red meat consumption could be an important step in the 
pathophysiology underlying CRC. However, to date, the exact etiology of red meat induced CRC 
initiation, promotion and progression lacks full elucidation. This study aimed to further unravel 
the genotoxic effects of red meat consumption via alkylation and/or oxidation induced DNA 
adduct formation. To this purpose, gastrointestinal digestion of beef diaphragm (a model for red 
meat) was simulated in vitro, and compared to the digestion of chicken breast (a model for white 
meat). Analysis of any resulting DNA adduct formation was performed by means of a state-of-
the-art DNA adductomics platform based on the use of high resolution mass spectrometry, and 
an in-house DNA adduct database listing all currently known diet-related alkylation and (lipid 
per)oxidation related DNA adducts [6, 22]. In addition, to gain a more profound insight into the 
underlying mechanisms, additional experiments were performed to assess the possible interfering 
role of myoglobin, i.e. the heme iron containing protein that is intrinsically more present in red 
compared to white meat [20]. 
 
 
2. MATERIALS AND METHODS 
2.1 Reagents and chemicals 
O6-CMdG was kindly provided by Dr. S. Moore from Liverpool John Moores University (UK). 
Deoxyguanosine (dG), O6-MedG and O6-d3-MedG (internal standard for both O6-MedG and 
O6-CMdG) were purchased from Sigma-Aldrich (St. Louis, USA). Analytical standards for M1G 
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and its internal standard M1G-13C3 were obtained from Toronto Research Chemicals (Toronto, 
Canada).  
O6-CMdG, O6-MedG, O6-d3-MedG, and dG were hydrolyzed to their nucleobase form in 0.1 M 
formic acid over the course of 30 min at 80°C. All standards were diluted in methanol to obtain 
stock and working solutions of 500 ng/mL and 5 ng/mL, respectively.  
Myoglobin was obtained from Sigma-Aldrich (St-Louis, Missouri, USA). A stock solution of 10 
mg/mL for myoglobin was prepared in ultrapure water (UP) (Millipore, Brussels, Belgium) and 
stored at -20°C. 
Solvents were of analytical grade (VWR International, Merck, Darmstadt, Germany) when used 
for extraction and purification steps, and of Optima LC/MS grade for LC−MS application 
(Fisher Scientific UK, Loughborough, UK). 
 
2.2 Meat preparations 
Beef diaphragm, chicken breast and subcutaneous pork fat (lard) were obtained from a local 
slaughterhouse and butcher. The beef and chicken meat were chopped into cubes (1 to 2 cm3), 
after which lard was added to obtain a total fat content of 20 %. The meat preparations were 
minced (with an Omega T-12 (Omega Foodtech, Bologna, Italy) equipped with a 10-mm plate) 
and ground (with a 3.5-mm plate) thoroughly. Subsequently, the meat preparations were heated 
in a hot water bath (GFL, Grossburgwedel, Germany) for 30 min after reaching a core 
temperature of 90°C. As a final step, the meat preparations were homogenized with a food 
processor, after which they were stored at -20°C. 
 
2.3 In vitro gastrointestinal digestion of meat preparations 
2.3.1 Collection, storage and pre-cultivation of colonic microbiota 
Fresh fecal samples were obtained from 7 male and 3 female volunteers (age ranging from 22 to 
75 yrs. old) without any medical history of gastrointestinal disease. None of the solicited 
volunteers underwent antibiotic treatment during at least 6 months prior to donation. All 10 
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human donors of fecal material were recruited among the laboratory personnel and their family 
members through informal announcement, after which all participating volunteers gave their 
written informed consent. The obtained data and volunteer information were analyzed 
anonymously and de-identified. The research was approved by the Federal Public Service of 
Health, Food Chain Safety and Environment, Belgium, but there was no need to submit an 
application to the ethical committee due to the non-invasive nature of the voluntary donation of 
fecal samples.  
Fresh fecal samples were processed according to a protocol adapted from Molly et al. [23, 24] as 
has been described previously [25]. In short, fresh fecal material was diluted in preheated PBS 
solution (1:4; w/v) to which sodium thioglycolate (1 g/L) was added as a reducing agent. 
Subsequently, the fecal slurry was filtered (through a 1 mm metal sieve) and stored at -80°C on a 
glycerol stock (20 %). Prior to the gastrointestinal digestion of meat, the fecal inocula was pre-
cultivated anaerobically for 24 h at 37°C in BHI broth (obtained from Oxoid Ltd, Hampshire, 
GB) with added cysteine (37 g/L BHI + 0.5 g/L cysteine) at a 1:9 ratio (v/v)). 
 
2.3.2 Simulated gastrointestinal digestion of meat preparations 
The use of a well-established in vitro gastrointestinal digestion model enabled simulation of 
stomach, small and large bowel digestion of beef and chicken meat preparations. The utilized 
model has been described on multiple occasions. Therefore, for all details on the utilized in vitro 
digestion model and the prior preparation of all mimicked gastrointestinal juices, brain heart 
infusion broth and SHIME medium, we refer to previous work [25].  
For this study, 4.5 g of beef or chicken meat preparations were digested in vitro in triplicate, using 
10 different fecal inocula (n = 2 x 3 x 10 simulated meat digestions). Samples were taken after 
simulation of duodenal digestion (“T0” samples, whereby sampling took place immediately after 
addition of SHIME medium and the fecal inoculum; i.e. just prior to colonic fermentation) and 
at the end of the simulated colonic meat fermentation (“T48” samples, whereby sampling took 
place after 48 h incubation with SHIME medium and fecal inocula; i.e. after the colonic 
fermentation). All meat digestion samples were stored at -80°C until analysis.  
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To investigate the role of heme iron in red meat induced genotoxicity, an additional experiment 
involving myoglobin addition was performed. The following digestions were performed in 
triplicate; 4.5 g of beef meat preparation (produced as described previously; 2.2 Meat 
preparations) without added myoglobin, 4.5 g of beef meat preparation with 5 mg of added 
myoglobin, 4.5 g of beef meat preparation with 50 mg of added myoglobin, 50 mg of myoglobin 
(without meat or lard), and 4.5 g of lard with 50 mg of added myoglobin. Samples were obtained 
at “T0” and “T48” and stored at -80°C. The fecal inoculum used to perform the colonic 
fermentation was selected at random (P5). 
 
2.4 DNA adductomics analysis 
2.4.1 Sample preparation 
DNA adducts in meat digests were extracted and purified according to a protocol described by 
Vanden Bussche et al. [26] and Hemeryck et al. [22]. At first, 3 internal standards (O6-d3-MeG and 
M1G-13C3) were added to each sample. Then, DNA was hydrolyzed in 0.1 M formic acid in UP 
(30 min, 80°C) to cleave both adducted and non-adducted DNA nucleobases from all DNA 
sequences present in the meat digestion samples. Subsequently, sample purification and cleanup 
was performed by means of SPE (Oasis® HLB cartridges (1 cc, 30 mg) Waters (Milford, USA)), 
after which the eluted samples were evaporated to dryness (90 min under vacuum, 20°C). Finally, 
the dried residue was re-suspended in 100 µL of 0.05 % of acetic acid in UP and stored at -20°C 
awaiting analysis. 
 
2.4.2 UHPLC-HRMS analysis 
Analysis of DNA adducts in meat digests was enabled by ultrahigh performance liquid 
chromatography coupled to high resolution mass spectrometry (UHPLC-HRMS) [22]. In brief, 
chromatographic separation was performed with an Acquity BEH C18 Waters column (1.7 µm, 
2.1 x 100 mm; Waters Corporation, Milford, USA). The mobile phases consisted of 0.05 % of 
acetic acid in UP and 100 % methanol. The flow of the mobile phases (300 µL per min) and 
injection of samples was accomplished with a Dionex Ultimate 3000 pump and autosampler 
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(Thermo Scientific, San José, USA), and HRMS DNA adduct analysis was performed by means 
of a hybrid Quadrupole-Orbitrap High Resolution Accurate Mass Spectrometer (HRAM, Q-
Exactive, Thermo Fisher Scientific, San José, USA) coupled to a heated electrospray ionization 
(HESI-II) source. Internal calibration of the MS system was performed daily by infusion of 
calibration mixtures that were prepared according to the protocol described in the operations 
manual (Thermo Fisher Scientific, San José, USA). General instrument control and initial data 
processing were performed with Chromeleon Xpress and Xcalibur™ 3.0. 
 
2.4.3 Data processing and statistics 
2.4.3.1 ToxFinderTM profiling  
The use of ToxFinder™ 1.0 software (Thermo Fisher Scientific, San José, USA) and an in-house 
DNA adduct database allowed screening of the full scan HRMS spectra of meat digestion 
samples for alkylation and/or (per)oxidation induced DNA adducts. Only DNA adducts 
demonstrating a minimum signal intensity of 20,000, a maximum mass deviation of 10 ppm, 
recurrence and stable RT in replicate samples, and the presence of the naturally occuring C13 
isotope were retained. The hence obtained output was visualized by means of Morpheus 
software (https://software.broadinstitute.org/morpheus). Student’s t-test was used for statistical 
interpretation of the detected DNA adduct levels. Tentative identification based on accurate 
mass was checked manually for each compound. The identities of O6-MeG, O6-O6-CMG and 
M1G were confirmed by means of analytical standards. 
 
2.4.3.2 Sieve™ pre-processing 
To screen digested meat samples for known alkylation and/or oxidation induced DNA adducts, 
control compare trend analysis was performed using the database lookup function of Sieve™ 2.2 
(Thermo Fisher Scientific, San José, USA). Combining the spectral data obtained from the three 
technical replicate digestion samples assured repeatability of the obtained results. Only ions with 
an m/z between 70 and 700 Da, and eluting between 0.7 and 5.6 min of chromatographic 
analysis were considered. A mass deviation up to 10 ppm was allowed, whilst the maximum peak 
width consisted of 0.5 min. Chromatographic peak selection was executed for positive and 
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negative ions separately. The maximum number of frames and minimal peak intensity were set at 
200,000 and 20,000 arbitrary units, respectively. After automated processing of all raw files, the 
database lookup function was enabled to match the retrieved matrix features to DNA adduct 
identities listed in an in-house diet-related DNA adduct database, enabling tentative DNA 
adduct identification.  
 
2.4.3.3 Simca™ multivariate statistics 
Simca™ 14 software (Umetrics AB, Umeå, Sweden) was used for multivariate statistics, starting 
with the importation of the output of Sieve™ pre-processing. Overall, data analysis was 
performed combining the data of all 3 technical replicates at all times to ensure robustness and 
repeatability. 
At first, Principal Component Analysis (PCA) was performed to enable preliminary data 
exploration and detection of possible outliers. Subsequently, logarithmic data transformation and 
Pareto scaling were performed, followed by automated OPLS-DA data modelling. The validity 
of the obtained OPLS-DA model was checked with permutation testing (n = 100), CV-ANOVA 
(p < 0.05), and assessment of R2 (must approach 1 (= perfect fit)) and Q2 (=cross-validated R2, 
operated with a minimal threshold of 0.5 to ensure correct prediction). For valid models, 
discriminative ions were selected based on a VIP score > 0.8 because a VIP > 1 demonstrates a 
high influence, a VIP > 0.8 (but < 1) demonstrates a moderate influence, but a compound with a 
VIP < 1 merely demonstrates a low influence [27, 28]. 
 
 
3. RESULTS 
3.1 DNA adduct profiling of red vs. white meat digests 
Chicken and beef digests (T0 as well as T48 samples) were screened for the presence of 
alkylation and/or oxidation induced DNA adducts by means of ToxFinder™ and the in-house 
DNA adduct database, enabling comparison of the levels of the retrieved DNA adduct types in 
different sample types.  
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3.1.1 Formation or degradation of DNA adducts during colonic 
fermentation 
The detected concentrations of some DNA adduct types increased during colonic fermentation, 
whilst others declined. In figure 1, the levels of several tentatively identified DNA adduct types 
in T48 samples are compared to those in T0 samples by means of a heat map. Comparison was 
enabled by subtracting T0 DNA adduct levels from T48 DNA adduct levels (peak areas) after 
correction for individual sample guanine content, and displaying the difference by means of a 
color scheme; higher T48 levels (compared to T0) are displayed in red (the result of the T48 - T0 
subtraction is positive), whilst lower T48 levels (compared to T0) are displayed in blue (the result 
of the T48 - T0 subtraction is negative). The heat map in figure 1 displays significant as well as 
non-significant differences. In figure 2, only significant differences are shown. 
 
3.1.2 The effect of beef digestion in comparison to chicken digestion 
3.1.2.1 At the start of the colonic fermentation (T0) 
In figure 3, the difference in DNA adduct levels in T0 beef digests is compared to T0 chicken 
digests. To enable straightforward comparison, measured DNA adduct levels (peak areas 
corrected for the amount of guanine in each sample) in chicken digests were subtracted from 
those in beef digests. When DNA adduct levels in beef digests were higher in comparison to 
chicken digests, this is displayed in red, whilst when DNA adduct levels in chicken digests were 
higher than those in beef digests, this is displayed in blue. The heat map in figure 3 displays 
significant as well as non-significant differences. Figure 4 only shows significant differences.
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Figure 1. Heat map displaying the mean rise (light to dark red) or decrease (light to dark 
blue) of putative DNA adduct levels (different DNA adduct isomers marked with 
*(*)(*)) during 48 hours of colonic beef (‘B’) or chicken (‘C’) digestion utilizing the fecal 
inocula of 10 different test subjects (P1 – P10). To facilitate comparison, DNA adduct 
levels in T0 samples were subtracted from DNA adduct levels in T48 samples, rendering 
positive values (T48 > T0) to be red, and negative values (T0 > T48) to be blue. Darker 
shades document larger differences in DNA adduct signal intensity. White boxes 
represent a difference close to 0, whilst grey boxes represent non-detection of that 
specific DNA adduct in those specific samples. RT is expressed in min. G, C, T, A and 
U respectively represent guanine, cytosine, thymine, adenine and uracil. After each DNA 
adduct name, the ionization mode is indicated; (+) or (-). 
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Figure 1 continued. 
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Figure 2. Heat map displaying the significant (p < 0.10) rise (red) or decrease (blue) of 
mean putative DNA adduct levels (different isomers marked with *(*)(*)) during 48 
hours of colonic beef (‘B’) or chicken (‘C’) digestion utilizing the fecal inocula of 10 
different test subjects (P1 – P10). To facilitate comparison, DNA adduct levels in T0 
samples were subtracted from DNA adduct levels in T48 samples, rendering positive 
values to be red, and negative values to be blue. Grey boxes represent non-significant 
differences. RT is expressed in min. G, C, T, A and U represent guanine, cytosine, 
thymine, adenine and uracil respectively. After the DNA adduct names, the charge of 
each detected compound is indicated; (+) means that that specific DNA adduct type 
was detected in positive ionization mode, whilst (-) means that specific DNA adduct 
type was detected in negative ionization mode. 
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Figure 2 continued. 
 
 
 
  
 
 
 
Chapter V 
 
  
186 
 
 
 
Figure 3. Heat map displaying the difference in putatively detected DNA adduct levels 
(isomers marked with *(*)(*)) for chicken vs. beef digestion in T0 and T48 digestive 
samples of 10 different test subjects (P1 – P10). DNA adduct levels in chicken digests 
were subtracted from those in beef digests to enable straightforward comparison. Red 
indicates higher putative DNA adduct levels in beef digests compared to chicken digests 
(i.e. concentration in beef > chicken). Blue represents lower putative DNA adduct levels 
in comparison (subtraction has a negative outcome; i.e. chicken > beef). White boxes 
represent a difference close to 0, whilst grey boxes represent the fact that that specific 
DNA adduct was not detected in those specific samples. RT is expressed in min. G, C, T, 
A and U stand for guanine, cytosine, thymine, adenine and uracil respectively. After each 
DNA adduct name, the ionization mode is indicated; (+) or (-). 
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Figure 3 continued. 
 
  
 
 
 
Chapter V 
 
  
188 
 
 
 
Figure 4. Heat map displaying significant (p < 0.10) differences in putatively detected 
DNA adduct levels (isomers marked with *(*)(*)) for chicken vs. beef digestion in T0 
and T48 digestive samples by of 10 different test subjects (P1 – P10). DNA adduct levels 
in chicken digests were subtracted from those in beef digests to enable straightforward 
comparison. Red indicates significantly higher DNA adduct levels in beef digests 
compared to chicken digests (subtraction has a positive outcome; beef > chicken). Blue 
indicates significantly lower putative DNA adduct levels in comparison (subtraction has 
a negative outcome; chicken > beef). Grey boxes represent non-significant differences. 
RT is expressed in min. G, C, T, A and U stand for guanine, cytosine, thymine, adenine 
and uracil respectively. After each DNA adduct name, the charge of the detected 
compound is indicated; (+) for positive, (-) for negative. 
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Figure 4 continued. 
 
3.1.2.2 After colonic fermentation (T48) 
Differences in DNA adduct formation in T48 beef digests compared to T48 chicken digests are 
on display in figure 2 as well. DNA adduct levels (peak areas corrected for the amount of 
guanine in each sample) in chicken digests were subtracted from DNA adduct levels in beef 
digests. Again, when DNA adduct levels in beef digests were higher compared to chicken digests, 
this is displayed red, but when DNA adduct levels in chicken digests were higher compared to 
those in beef digests, this is displayed in blue. 
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3.2 Multivariate statistics to compare DNA adduct profile in red vs. white 
meat digests 
Simca™ analysis was performed to see whether multivariate statistics could be used to 
discriminate between T0 and T48 samples on the one hand, and beef and chicken digests on the 
other, as such also enabling the selection of discriminating DNA adduct types.  
PCA-X modelling of negative as well as positive ion features revealed a distinct grouping of T0 
vs. T48 samples (figures 5 and 6), followed by a clear grouping according to test subject. A valid 
OPLS-DA model discriminating between T0 and T48 samples could be constructed for each test 
subject separately and all test subjects combined.  
 
 
Figure 5. Clustering of T0 (orange) vs. T48 (blue) digestion samples in the PCA-X plot 
according to negative ion features. 
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Figure 6. Clustering of T0 (orange) vs. T48 (blue) digestion samples in the PCA-X plot 
according to positive ion features. 
 
During OPLS-DA analysis of positive ion features, a valid model could be constructed to 
discriminate beef digests from chicken digests overall (for T0 and T48 samples of all 10 test 
subject digestions), and in T0 samples. This was however not the case for T48 samples. In 
addition, beef digests could not be discriminated from chicken digests for each test subject 
separately (data from T0 and T48 samples combined as well as separately), based on information 
contained in positive as well as negative ion features. With regard to negative ion feature OPLS-
DA modelling (using the raw data from all 10 test subject digestions), discrimination between 
beef vs. chicken digests was somewhat clear in T0 samples, but did not suffice to construct a 
valid OPLS-DA model that met all previously set criteria. OPLS-DA modelling could not be 
performed for T48 samples either. An overview of the obtained OPLS-DA model characteristics 
is provided in table 1. 
 
   T
ab
le
 1.
 O
PL
S-
D
A 
m
od
el
 c
ha
ra
ct
er
is
tic
s. 
M
od
el
  
Ch
ar
ge
 
N
um
be
r o
f c
om
po
ne
nt
s 
R
2 X
 
R
2 Y
 
Q
2  
CV
-A
N
O
VA
  
Pe
rm
ut
at
io
n 
te
st
 
T0
 vs
. T
48
 (b
ee
f +
 c
hi
ck
en
 sa
m
pl
es
) 
+
 
1+
3+
0 
0.
72
4 
0.
98
3 
0.
96
3 
p 
=
 0
 
E
xc
ell
en
t 
T0
 vs
. T
48
 (b
ee
f +
 c
hi
ck
en
 sa
m
pl
es
) 
- 
1+
3+
0 
0.
76
0 
0.
97
1 
0.
95
7 
p 
=
 0
 
E
xc
ell
en
t 
Be
ef
 vs
. c
hi
ck
en
 (T
0 
+
 T
48
 sa
m
pl
es
) 
+
 
1+
9+
0 
0.
83
0 
0.
95
9 
0.
75
0 
p 
<
 0
.0
1 
G
oo
d 
Be
ef
 vs
. c
hi
ck
en
 (T
0)
 
+
 
1+
6+
0 
0.
71
5 
0.
98
6 
0.
94
5 
p 
<
 0
.0
1 
G
oo
d 
Be
ef
 vs
. c
hi
ck
en
 (T
48
) 
+
 
1+
3+
0 
0.
29
6 
0.
98
4 
0.
61
5 
p 
<
 0
.0
1 
G
oo
d 
Be
ef
 vs
. c
hi
ck
en
 (T
0 
+
 T
48
 sa
m
pl
es
) 
- 
1+
2+
0 
0.
24
4 
0.
80
0 
0.
23
6 
p 
<
 0
.0
1 
G
oo
d 
Be
ef
 vs
. c
hi
ck
en
 (T
0)
 
- 
1+
5+
0 
0.
24
5 
0.
99
5 
0.
63
3 
p 
<
 0
.0
1 
G
oo
d 
Be
ef
 vs
. c
hi
ck
en
 (T
48
) 
- 
1+
2+
0 
0.
20
3 
0.
88
0 
0.
25
5 
p 
=
 0
.0
14
 
Su
ffi
cie
nt
 
 
  
 
 
 
Chapter V 
 
  
193 
 
 
The valid OPLS-DA model constructed to discriminate between beef and chicken digests in T0 
samples (based on positive ion feature data) rendered 4 DNA adduct types with marker potential. 
These compounds of interest are listed in table 2. 
 
Table 2. DNA adducts discriminating between beef vs. chicken digests prior to colonic 
fermentation. 
DNA adduct name RT 
(min) 
Charge ∆ ppm Discriminative for VIP 
score 
Dimethyl-T or ethyl-T 0.72 + 2.92 Beef digests 1.95 
Hydroxymethyl-T 0.77 + 3.00 Beef digests 0.89 
Methyl-G 1.46 + 3.40 Beef digests 1.23 
Tetramethyl-T 2.74 + 3.03 Beef digests 1.66 
 
 
3.3 The effect of myoglobin digestion on DNA adduct profile  
In total, 5 different experiments were set up to decipher the interfering role of myoglobin in red 
meat genotoxicity. ToxFinder™ profiling was performed for each sample; average putative 
DNA adduct levels in T0 as well as T48 samples are shown in figure 7. Figure 8 enables correct 
statistical interpretation of the observed differences. 
 
Next page:  
Figure 7. Heat map displaying average putatively detected DNA adduct levels (different 
isomers are marked with *(*)(*)) in T0 and T48 digestive samples of different digestion 
experiments. Darker shades of red indicate higher signal intensities. Grey boxes 
represent the absence of DNA adduct detection in those specific samples. RT is 
expressed in min. G, C, T, A and U respectively represent guanine, cytosine, thymine, 
adenine and uracil. After each DNA adduct name, the observed ionization mode is 
indicated; (+) or (-). “Myo” is short for myoglobin. 
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Figure 7 continued. 
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Next page: 
Figure 8. Heat map displaying significant (p < 0.10) differences in putatively detected 
DNA adduct levels (different isomers marked with *(*)(*)) in samples from the different 
experimental setups. Red indicates significantly higher DNA adduct levels in the first 
compared to the second group mentioned in the observed column. Blue indicates 
significantly lower putative DNA adduct levels in the first compared to the second group 
mentioned in the observed column. Grey boxes represent non-significant differences. RT 
is expressed in min. G, C, T, A and U stand for guanine, cytosine, thymine, adenine and 
uracil, respectively. After each DNA adduct name, the observed ionization mode is 
indicated; (+) or (-). “Myo” is short for myoglobin. 
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Figure 8 continued. 
 
 
  
 
 
 
Chapter V 
 
  
199 
 
 
4. DISCUSSION 
This study aimed to further unravel the genotoxic effects of red meat consumption due to DNA 
alkylation and/or oxidation in light of the current hypotheses on the link between red meat 
consumption and CRC development. It has previously been demonstrated that red meat 
digestion can promote colon carcinogenesis dependent on heme concentration [29]. The exact 
underlying mechanisms have not been elucidated yet, but it was hypothesized that heme iron 
readily catalyzes the formation of genotoxic NOCs and LPOs [4]. To measure the hence induced 
DNA adduct formation, the in-house DNA adductomics methodology [22] was implemented. 
The application of this state-of-the-art DNA adductomics platform is highly innovative, allowing 
us to take the field of DNA adduct research to the next level. 
DNA adduct profiling demonstrated a clear inter-individual variability with regard to the types 
and levels of alkylation and/or oxidation induced DNA adducts at the start as well as shortly 
after in vitro colonic meat fermentation. This was reflected by ToxFinder™ profiling as well as 
Simca™ modelling, and is perfectly in line with previous findings [24, 30]. Prior to the start of 
each colonic fermentation, a fecal inoculum is added, resulting in the cultivation of a certain 
individual’s colorectal microbiota in order to mimic colonic meat fermentation after enzymatic 
stomach and small bowel digestion. As such, a pre-colonic digestive sample (T0) can contain 
DNA adducts because of (a) the interaction between the added fecal DNA (from human, 
bacterial or dietary origin) and genotoxic molecules formed during the small intestinal digestion 
of meat, or (b) their presence in the (pre-cultivated) fecal inoculum itself due to prior in vivo 
formation [24]. For example, we have previously demonstrated that the presence of O6-CMG, an 
alkylation induced DNA adduct, in meat digests can be linked back to the fecal donor. In other 
words, some fecal inocula contain and/or lead to the active production of O6-CMG prior to 
and/or during colonic fermentation, whilst others simply do not [24, 30]. A rise in DNA adduct 
levels during colonic fermentation suggests active formation of its precursor molecules by the 
colonic microbiota (e.g. O6-CMG does no longer rise if the fecal microbiome is neutralized due 
to autoclavation [24]), whilst a decrease indicates active or passive degradation. Indeed, it has 
become indisputable that the gut microbiome exerts beneficial as well as detrimental effects on 
gut and overall human health. With regard to CRC, it has become clear that the gut microbiome 
actively contributes to cell proliferation, apoptosis, differentiation, and DNA damage. As a result, 
the gut microbiome, and its metabolic products, strongly influence whether someone develops 
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CRC, or not [12, 31]. However, due to the complexity of host-diet-microbiome interactions, a lot 
of questions still remain [31], especially concerning gut microbiome induced DNA adduct 
formation. 
In this study, several oxidation and/or alkylation induced DNA adducts could be detected prior 
to colonic fermentation (at ‘T0’) as well as at the end of digestion (at ‘T48’). The number of 
putatively identified DNA adducts that significantly increased during colonic meat fermentation 
exceeds 60, and e.g. includes Methyl-T (RT 1.09 min) in test subjects 3, 4, 5, 6 and 9; and 
Methyl-G (or its Hydroxymethyl-A isomer, RT 1.44 min) in all 10 test subjects. In contrast, over 
40 tentatively identified DNA adduct types demonstrate a significant decline during colonic 
fermentation. The latter DNA adducts types are not of specific interest in T48 samples, but 
could be relevant due to their natural in vivo occurrence and/or in vitro formation following small 
intestinal meat digestion (in T0 samples). Therefore, specific attention should be given to DNA 
adduct types that are more prevalent in beef digests compared to chicken digests if present in T0 
samples overall, and T48 samples if the DNA adduct of interest rises during colonic 
fermentation.  
DNA adduct types demonstrating a significantly higher formation due to the digestion of beef 
compared to chicken are of specific interest because those specific DNA adduct types could be 
of importance with regard to CRC initiation through N-nitrosation and lipid peroxidation 
processes during red meat digestion. However, since not all DNA adduct types are (as) 
promutagenic and/or procarcinogenic (e.g. 7-MeG is not mutagenic, whilst O6-MeG is [32]), the 
reported in vitro observations require linkage to (intermediate) effects and/or disease outcome in 
vivo. Unfortunately, the DNA adductomics methodology/technology has not yet been 
implemented in in vivo CRC studies. Hence, at the time being, information on in vivo DNA 
adduct formation in relation to CRC is quite limited. Nevertheless, it has e.g. previously been 
demonstrated that normal colonic tissue of CRC patients contains significantly higher DNA 
adduct levels compared to colonic tissue from healthy controls [33].  
To the best of our knowledge, O6-CMG is the only DNA adduct type that has directly been 
associated with red meat consumption in vivo, which we have been able to confirm in vitro in this 
and in previous studies; i.e. O6-CMG significantly rises upon red meat digestion and myoglobin 
addition [24]. Since we already know that O6-CMG is actively formed by the colonic microbiota 
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during colonic meat fermentation [24], the results of this study are able to confirm and 
emphasize the relevance of O6-CMG formation in relation to red meat digestion in the (human) 
colon.  
Apart from O6-CMG, we were able to detect several other putatively identified DNA adduct 
types that could be related to red meat digestion in vitro as well as in vivo. However, in-depth 
discussion of each individual DNA adduct type is not feasible. Therefore, we will focus on the 
most prominent significant findings.  
Multivariate statistics delivered dimethyl-T (or ethyl-T), hydroxymethyl-T and tetramethyl-T and 
methylguanine (MeG) as potential DNA alkylation (and also oxidation in case of hydroxymethyl-
T) red meat digestion markers. MeG DNA adducts are among the most commonly studied 
alkylation DNA adduct types. In contrast to our previous in vitro meat digestion studies, we were 
able to detect O6-MeG in pre- and post-colonic meat digests. More specifically, O6-MeG 
significantly increased during colonic meat digestions performed with 4 out of 10 fecal inocula. 
A clear trend with regard to red vs. white meat digestions could however not be observed. We 
were also able to detect 3 methylated G residues besides O6-MeG; MeG isomers eluting at 1.44, 
1.67 and 2.41 min respectively. The first isomer (RT 1.44 min) is most striking since it could be 
detected for all 10 test subjects. At first glance, there was no distinct pattern according to 
digested meat type. Addition of myoglobin to beef digestion seemed to increase the 
concentration of this specific MeG isomer, although not significantly (p > 0.10). Nevertheless, 
multivariate statistics labeled this MeG isomer as a discriminative molecule for beef digestion 
across all 10 test subjects. Because this MeG isomer demonstrated the highest signal intensities, 
it most likely corresponds to 7-MeG, the most prominently formed DNA alkylation lesion that 
has previously been detected in vivo, but is not promutagenic [7, 32]. On the other hand, DNA 
methylation does regulate gene expression, whilst the presence of 7-MeG in a DNA sequence 
can also prematurely end DNA replication [7], demonstrating the in vivo relevance of 7-MeG as a 
DNA alkylation marker. Information on the in vivo as well as in vitro formation of dimethyl-T (or 
Ethyl-T), hydroxymethyl-T and tetramethyl-T in the context of food digestion and/or cancer 
development is negligible at the time being, apart from dimethyl-T, which can alternatively 
correspond to ethyl-T. More specifically, e.g. O4-ethylthymine (O4-eT) has previously been 
detected in vivo and linked to the daily exposure to ethylating agents [34, 35]. We know that O4-
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eT can induce DNA miscoding, rendering O4-eT to be a compound of interest in the context of 
cancer initiation [7]. Huh et al. furthermore documented that this compound was significantly 
more present in malignant liver tumors compared to non-tumoral tissue [34]. Hence, the 
retrieved dimethyl-T or ethyl-T adduct definitely is a compound of interest. 
Based on ToxFinderTM screening it could be observed that the hydroxymethylhydantion and 
malondialdehyde-3x-C DNA adducts were significantly higher (p < 0.05) in T0 beef digests 
compared to chicken digests for at least 6 test subjects. Hydroxymethylhydantion, a ROS 
induced T alteration [36], appeared to be significantly higher after small bowel digestion of beef 
in comparison to chicken for all 10 test subjects but P1, suggesting that small bowel beef 
digestion induced oxidative stress and ROS production. In contrast, myoglobin addition did not 
significantly increase hydroxymethylhydantion levels. A DNA adduct type with a highly similar 
behavioral pattern is malondialdehyde-3x-C (M3C, eluting at 4.26 min); i.e. M3C was significantly 
higher in T0 beef digests for 6 test subjects. M3C is a cytosine analogue formed due to the 
interaction with 3 MDA molecules, whilst MDA itself is a well-known LPO [37, 38]. In previous 
work, we were able to demonstrate that (lipid) peroxidation primarily occurs prior to colonic 
fermentation [24, 39]. Therefore, the retrieval of ROS and/or LPO induced DNA adducts in 
pre-colonic digestion samples is perfectly in line with expectations. A similar trend for 
hydroxymethylhydantion, malondialdehyde-3x-C or any other DNA adduct types could not be 
observed in T48 samples.  
In total, 34 different alkylation and/or oxidation induced DNA adduct types significantly (p < 
0.10) increased in pre-colonic digestion samples upon addition of (5 mg of) myoglobin (observed 
by means of ToxfinderTM data processing). Of these specific DNA adduct types, hydroxyethyl-T 
(or methoxymethyl-T), carboxyethyl-T and 3,N4-etheno-C, demonstrated significant potential as 
heme-rich meat digestion markers. Hydroxyethyl-T (eluting shortly after 1 min), which might 
alternatively correspond to methoxymethyl-T, appeared to be higher in digests of beef compared 
to chicken for 5 different fecal inocula (p > 0.10 for 4 out of 5 and p = 0.0003 for 1 out of 5), 
and significantly increased due to addition and digestion of myoglobin; p = 0.034 for 5 mg of 
added myoglobin, and p = 0.007 for 50 mg of added myoglobin. The same trend could be 
observed for carboxyethyl-T (eluting shortly after 1 min) and 3,N4-etheno-C (RT of  3.83 min). 
Carboxyethyl-T was higher (p > 0.10) in T0 beef digestion samples (compared to chicken) for 6 
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out of 10 test subjects, and furthermore significantly rose upon myoglobin addition (p = 0.056 
for 5 mg of myoglobin, p = 0.004 for 50 mg of myoglobin). 3,N4-etheno-C was higher (p < 0.10) 
in beef digests using 4 out of 10 fecal inocula, and also significantly increased due to the 
digestion of added myoglobin (p= 0.003 for 5 mg, and p = 0.098 for 50 mg). For certain fecal 
inocula/test subjects, these particular DNA adduct types were also (significantly) higher (p < 
0.10) in post-colonic beef digests (compared to chicken), although myoglobin addition did not 
significantly influence post-colonic DNA adduct levels. Carboxyethyl-T, formed by alkylation of 
T, has not previously been detected in vivo, but has been synthetized in vitro [40]. Hydroxyethyl-T, 
or its methoxymethyl-T analogue, is best known for its potential antiviral properties [41] but has, 
to the best of our knowledge, never been linked to in vivo environmental genotoxicity. In contrast, 
hydroxyethyl-G has previously been detected in vivo, and is furthermore known to originate from 
several possible sources including lipid peroxidation [7]. Hydroxyethyl-T may very well have a 
similar origin. 3,N4-etheno-C is a known lipid peroxidation induced DNA adduct type that has 
previously been detected in vivo and has furthermore been associated with oxidative stress, base 
pair substitution mutations and an increased cancer risk [7]. Hence, the retrieval of these DNA 
adduct types is in support of the heme hypothesis, furthermore providing clues with regard to 
the underlying pathways. 
Throughout this study, the genotoxic effects of beef seemed to be more pronounced in pre-
colonic digests in comparison to post-colonic digests. We notice that this is most likely due to a 
larger variety in catabolic as well as anabolic reactions in the (simulated) large bowel. After all, 
the large bowel is a reaction vessel, subject to a highly diverse range of microbiotic activities [12], 
whilst digestion in the stomach and small bowel mainly consist of purely mechanical and 
chemical reactions and interactions, which are furthermore assumed to be identical throughout 
the entire experimental setup in this study. As a result, overall variation is considerably lower in 
pre-colonic meat digestion samples compared to post-colonic digestion samples, attributing to 
the fact that the genotoxicity of beef could not always be confirmed in post-colonic meat 
digestion samples. 
In conclusion, it has been demonstrated that the use of a DNA adductomics platform, 
furthermore implementing an in-house DNA adduct database, allowed mapping of diet-related 
DNA adducts in red vs. white meat digests. Different NOC- and LPO-related DNA adduct types 
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could be tentatively identified. More importantly, these specific DNA adduct types could be 
relevant with regard to red meat and/or heme genotoxicity, and the hence associated CRC risk. 
Unfortunately, the available information on the in vivo occurrence of a large variety of these 
DNA adduct types and their relevance in the context of cancer risk, is mostly lacking at the time. 
Therefore, the in vivo relevance of the in this study retrieved DNA adduct types and levels awaits 
further confirmation. Nevertheless, the results of this study have aided with the exploration of 
red meat and/or heme induced genotoxicity, and can furthermore be used as future reference for 
in vivo DNA adduct profiling studies. 
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ABSTRACT 
Digestion of red and processed meat has been linked to the formation of genotoxic NOCs and 
LPOs in the gut. In this study, rats were fed a meat based diet to compare the possible genotoxic 
effects of red vs. white meat, and the interfering role of dietary fat. To this purpose, liver, 
duodenum and colon DNA adductome were analyzed with UHPLC-HRMS. The results 
demonstrate that the consumed meat type alters the DNA adductome; the levels of 22 different 
DNA adduct types significantly increased upon the consumption of beef (compared to chicken) 
and/or lard supplemented beef or chicken. Furthermore, since the retrieved DNA adduct types 
originate from DNA alkylation, nitrosation and/or oxidation, their formation may be linked to 
the formation of NOCs and LPOs upon red (and processed) meat digestion, which is in line 
with the current hypotheses on the causal link between red and processed meat consumption 
and the development of colorectal cancer. 
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1. INTRODUCTION 
DNA adduct formation is the result of the attack of nucleophilic sites in DNA by endo- or 
exogenous electrophilic molecules. As such, the DNA building blocks, i.e. the guanine (G), 
cytosine (C), adenine (A) and thymine (T) nucleobases can be altered both structurally and 
functionally. In the absence of a timely detoxification of the initiating genotoxin and/or repair of 
the resulting DNA adduct, DNA adduct formation can lead to mutations and chemically 
induced carcinogenesis [1]. Hence, investigation of DNA adduct formation can provide valuable 
information on exposure to both environmental and endogenous chemicals with genotoxic, 
mutagenic and/or carcinogenic properties on the one hand, and their possible adverse health 
effects on the other. For example, DNA adduct formation is believed to be an intermediate step 
in hepatocarcinogenesis due to chronic aflatoxin B1 exposure. Aflatoxin B1 is a known human 
carcinogen that is formed as a secondary metabolite by food and feed contaminating fungi. Its 
uptake results in the formation of different types of DNA adducts and also leads to a correlated 
increase in liver cancer risk [2]. Accordingly, DNA adduct analysis can be very useful to 
investigate the underlying pathways of several non-hereditary cancers, which actually 
comprehends the vast majority of cancer cases [3]. 
One of the most prevalent cancer types that mainly occurs due to environmental factors (e.g. 
diet and lifestyle) is colorectal cancer (CRC). CRC is the third and second most common cancer 
type in men and women worldwide , and important influencing factors include adoption of the 
Western dietary pattern with the excessive consumption of fat and red and processed meat [3]. 
With regard to the observed increase in CRC risk due to red and processed meat consumption, 
different research groups have investigated the proposed underlying pathways. Currently, there 
are several intertwined hypotheses that are still under investigation. A prominent hypothesis 
states that heme stimulates the formation of both LPOs and NOCs in the gut besides its own 
direct (cyto)toxicity [4]. The heme molecule is intrinsically more present in red (e.g. beef) than 
white (e.g. chicken) meat in the form of myoglobin, which renders this molecule a very potent 
candidate to help explain the toxicity of red but not white meat. Both exo- and endogenous 
NOCs may contribute to red and processed meat toxicity. Several types of NOCs (e.g. 
nitrosamines and nitrosamides) have known carcinogenic properties [5], and the most common 
route of exposure to NOCs indeed occurs via Western type foodstuffs [6]. However, certain 
NOCs, i.e. nitrosamines and nitrosamides, can also be formed in the gut during digestion of 
food. What further supports the NOC hypothesis is the fact that exposure to NOCs has already 
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been linked to an increase in tumor development [5]. The same reasoning actually applies for 
LPOs; LPOs can originate from both exo- and endogenous processes and possess known cyto- 
and genotoxic effects that have been linked to carcinogenesis [7, 8]. 
In previous studies, we were able to link red meat digestion to the increased formation of LPOs 
(e.g. MDA), as well as LPO- and NOC-related DNA adducts (e.g. O6-CMG), [9, 10]. The current 
study aimed to further explore the possible genotoxic effects of red meat consumption in vivo 
since (a) both NOCs and LPOs are prone to DNA adduct formation [8] and (b) a shift in DNA 
adduct profile after beef digestion has been demonstrated previously in vitro [10].  
A state-of-the-art DNA adductomics methodology [11], based on accurate mass measurements 
(HRMS), was employed to map the diet-related DNA adduct profile in tissue from rats on a 
meat diet. The use of an in-house DNA adduct database and specialized omics software further 
enabled a focused investigation of possibly relevant diet-related DNA adducts [11]. 
 
 
2. MATERIAL AND METHODS 
2.1 Rat feeding trial 
2.1.1 Meat based diets 
Four different diets, based on lean chicken (LFCh), fat chicken (lean chicken with added lard; 
HFCh), lean beef (LFBe) or fat beef (lean beef with added lard; HFBe), were prepared in 
advance. To this purpose, the m. pectoralis profundus of chicken, as a model for white meat, and the 
m. pectoralis profundus of beef, as a model for red meat, were purchased, chopped, minced and 
ground. Then, the meat (and added lard) was cooked at 70°C during 70 min in a hot water bath 
(cooked to the core, but not overcooked to avoid interference from the formation of genotoxic 
heterocyclic amines and polycyclic aromatic hydrocarbons), followed by homogenization in a 
food processor. After this, the 4 different meat based diets were manufactured as is documented 
in table 1, vacuum packed and stored at – 20°C. 
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2.1.2 Rat experiment 
For this rat trial (ECD 14/58 (Ghent, Belgium)), 24 male Sprague-Dawley rats (± 150 g) were 
purchased from Janvier laboratories (France). The rats were housed in groups of 4 upon arrival 
and given a standard laboratory diet (Ssniff R/M-H pellets from Ssniff, Soest, Germany) and 
water at libitum during the first 10 days. After this adaptation period, all rats were divided ad 
random in 4 groups and housed individually. Then, during 14 consecutive days, each group 
received a different diet (provided ad libitum and refreshed daily), i.e. a diet based on lean chicken 
(= ‘low fat chicken diet’ or ‘LFCh’), chicken with added lard (= ‘high fat chicken diet’ or ‘HFCh’), 
lean beef ((= ‘low fat beef diet’ or ‘LFBe’) or beef with added lard ((= ‘high fat beef diet’ or 
‘HFBe’). The exact composition of these meat-based diets is documented in table 1. Dietary 
nutrients were estimated and calculated based on the known macronutrient content of lean meat 
(22 % protein, 1 % fat), lard and all other utilized ingredients (as listed on the 
wrapping/packaging). Energy content was calculated using the Atwater system.  
Following 14/15 days on the experimental diets, all rats were anesthetized with 5 % isoflurane 
gas and euthanized by terminal blood collection from the abdominal aorta, after which the 
different organs were harvested. Rats were euthanized on 6 consecutive days; one rat of each 
dietary treatment was sacrificed in a random order each day (a more detailed account of this 
experiment is provided by Van Hecke et al., 2016 [12]. For this particular study, the liver, 
duodenal mucosae and colonic mucosae were sampled from each individual rat. Tissues were 
rinsed with a 0.9 % saline solution and stored in 95 % of ethanol at -80°C until further sample 
processing. 
All applicable international, national, and/or institutional guidelines for the care and use of 
animals were followed. All procedures performed in studies involving animals were in 
accordance with the ethical standards of the institution or practice at which the studies were 
conducted. Furthermore, the local ethical committee granted approval for this particular study 
(ECD 14/58 (Ghent, Belgium)). 
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Table 1. Composition of the diets (LFCh = low fat chicken diet, HFCh = high fat 
chicken diet, LFBe = low fat beef diet; HFBe = high fat beef diet). 
 LFCh  HFCh LFBe HFBe 
Ingredients     
Meat (g/kg) 650 650 650 650 
Chicken muscle (g/kg)  650 550 - - 
Beef muscle (g/kg) - - 650 550 
Lard (g/kg)  - 100 - 100 
Sucrose (g/kg) 200 200 200 200 
Corn starch (g/kg)  79.2 79.2 79.2 79.2 
Cellulose (g/kg) 22 22 22 22 
Safflower oil (g/kg) 20 20 20 20 
AIN76 mineral mix (low 
Ca: TD.79055) (g/kg) 20 20 20 20 
AIN76 vitamin mix (g/kg) 6.3 6.3 6.3 6.3 
Calcium phosphate (g/kg) 1.3 1.3 1.3 1.3 
Choline bitartrate (g/kg) 1.2 1.2 1.2 1.2 
Calculated nutrients      
Protein (%)  13.7 11.6 13.7 11.6 
Fat (%)  2.7 12.5 2.7 12.5 
Carbohydrates (%)  30.1 30.1 30.1 30.1 
Meat/powder diet ratio 65/35 65/35 65/35 65/35 
Calculated Energy 
(kcal/g FM) 2.0 2.8 2.0 2.8 
 
 
2.2 DNA extraction, DNA hydrolysis and DNA adduct extraction 
DNA from liver tissue, duodenal mucosae and colonic mucosae was extracted by means of the 
NucleoSpin Tissue Machery Nagel DNA extraction kit (Machery Nagel GmbH & Co., Düren, 
Germany) according to the protocol described by the manufacturer. DNA concentration and 
purity in each sample were determined with a Nanodrop ND-1000 spectrophotometer (Isogen 
Lifescience, Ijsselstein, The Netherlands).  
The obtained DNA in each individual sample was then subjected to an earlier reported and 
validated DNA adduct extraction protocol [13]. In brief, all DNA samples were hydrolyzed in 
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0.1 M formic acid at 80°C during 30 min Ensuing this, sample purification and cleanup was 
performed with solid-phase extraction (SPE) (Oasis® HLB cartridges (1cc, 30 mg) Waters 
(Milford, USA)), after which all eluates were evaporated to dryness under vacuum at room 
temperature. In the final step, all samples were suspended in 100 µL of 0.05 % of acetic acid in 
water and stored at -20°C until analysis. 
 
2.3 DNA adduct analysis 
2.3.1 Reagents and chemicals 
Analytical standards for M1G, CrodG and their respective internal standards; M1G-13C3 and 
CrodG-13C,15N2, were purchased from Toronto Research Chemicals (Toronto, Canada). O6-
MedG and O6-d3-Me-dG (internal standard for both O6-MedG and O6-CM-dG) were obtained 
from Sigma-Aldrich (St. Louis, USA). O6-CMdG (O6-carboxymethyl-2’-deoxyguanosine) was 
kindly provided by Dr. S. Moore from Liverpool John Moores University (UK).  
O6-CMdG, O6-MedG, O6-d3-MedG, CrodG and CrodG-13C,15N2 were hydrolyzed to their 
nucleobase form in 0.1 M formic acid at 80°C during 30 min. All standards were diluted in 
methanol and stored at -20°C in stock and working solutions of 500 ng/mL and 5 ng/mL 
respectively. 
 
2.3.2 UHPLC-HRMS analysis 
A robust, validated UHPLC-HRMS method [11] enabled targeted and untargeted DNA adduct 
analysis. Analysis was performed on a hybrid Quadrupole-Orbitrap HRAM (Q-ExactiveTM, 
Thermo Fisher Scientific, San José, USA) coupled to a HESI-II source as described by 
Hemeryck et al [11]. Internal calibration of the MS detector was performed daily by infusion of 
calibration mixtures prepared according to the protocol described in the operations manual 
(Thermo Fisher Scientific, San José, USA). Instrument control was performed with Chromeleon 
Xpress and Xcalibur™ 3.0. 
Targeted analysis included the detection and quantification of O6-MeG, O6-CMG, M1G and 
CroG. Untargeted DNA adduct analysis was enabled by full scan MS acquisition at 100,000 
FWHM in a range of 70 to 700 Da. 
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2.4 Data processing 
2.4.1 XcaliburTM 
O6-MeG, O6-CMG, M1G and CroG were identified by means of an analytical standard and 
quantified based on a 10-point calibration curve (5, 10, 25, 50, 100, 200, 300, 400 and 500 
pg/mL). XcaliburTM Quan enabled data processing. 
 
2.4.2 ToxFinderTM profiling and GENE-E marker selection 
The use of ToxFinder™ software (Thermo Fisher Scientific, San José, USA) and an in-house 
DNA adduct database [11] allowed screening of the full scan HRMS spectra of each sample for 
the possible presence of known diet-related DNA adducts based on m/z. The considered 
inclusion criteria consisted of a minimum signal intensity of 10,000; a maximum mass deviation 
of 10 ppm, and the presence of a C13 isotope. Visualization of the obtained output from 
ToxFinderTM data processing was enabled by GENE-E matrix 
(http://www.broadinstitute.org/cancer/software/GENE-E/). Hierarchical clustering of 
samples was performed by means of ‘one minus pearsons correlation’, whilst the GENE-E 
marker selection tool (all possible permutations) was used to search for potential markers. 
Student’s t-test was used for statistical interpretation of DNA adduct levels in tissue samples 
from rats on a different diet (n = 6 per group). 
 
2.4.3 SieveTM chromatographic peak selection with database lookup 
SieveTM 2.1 (Thermo Fisher Scientific, San José, USA) was implemented to screen for the 
presence and significance of known diet-related DNA adducts in the different DNA samples. All 
ions eluting between 0.7 and 5.5 min (of chromatographic analysis) with an m/z value between 
70 and 700 Da were retained. The maximum peak width consisted of 0.5 min and maximum 
mass deviation was set at 10 ppm. Positive and negative ions were selected in separate 
experiments. The maximum number of frames was 200,000, whilst minimal peak intensity was 
set at 50,000 (arbitrary units). After automated processing, SieveTM reported the m/z value, RT 
and abundance of each detected ion. The database lookup function was used to putatively 
identify the detected and selected ions by matching the theoretical m/z values of the diet-related 
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DNA adducts in the in-house database to the m/z values of the detected ions. To be able to 
select DNA adducts that are (significantly) higher or lower in tissue from rats that received a 
different diet, SieveTM pairwise comparison experiments were executed for each tissue type 
separately in both the negative and positive ionization mode. Tissue DNA adduct levels were 
compared for the HFBe and LFBe diet, the HFCh and LFCh diet, the HFBe and HFCh diet, 
and the LFBe and LFCh diet, resulting in 24 different SieveTM experiments. 
 
2.4.4 SimcaTM: Orthogonal Partial Least Squares Discriminant Analysis 
SieveTM was used to select all chromatographic peaks in all samples (= 3 tissue types x 24 rats) 
simultaneously with the exact same settings as described above (= 2 separate SimcaTM 
experiments, 1 for positive ions, 1 for negative ions). SimcaTM 13 (Umetrics AB, Umeå, Sweden) 
was used to enable processing of multivariate omics data by means of OPLS-DA. Automated 
SimcaTM data modeling was performed after correction for the amount of DNA in each sample, 
logarithmic data transformation and Pareto scaling. R2 was assessed to ensure goodness of fit 
(minimal threshold of 0.5) and Q2 was used to assess the predictive ability of the method 
(minimal threshold of 0.5). Discriminative/predictive ions were selected based on their excentric 
position in the S-plot and a VIP score above 1. A VIP above 1 demonstrates a high influence; a 
VIP below 1, but above 0.8 demonstrates a moderate influence, and a VIP below 0.8 reflects a 
low influence. 
 
 
3. RESULTS 
The average initial and final body weight of the rats did not differ among the dietary treatments 
(a more detailed account is provided by Van Hecke et al., 2016 [12]. Rats on the diets with added 
lard had a significantly lower feed intake (-25 %) compared to rats on the diets without added 
lard, but there was no difference (p = 0.751) in metabolizable energy intake (data published 
previously by Van Hecke et al., 2016 [12]. 
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Overall, several diet-related DNA adducts could be retrieved in DNA obtained from rat liver, 
duodenal and colonic mucosae by means of UHPLC-HRMS(/MS), which will be discussed in 
detail below. 
 
3.1 O6-CMG, O6-MeG, M1G and CroG DNA adduct levels (XcaliburTM 
Quan) 
The O6-CMG DNA adduct could not be retrieved in any of the samples under investigation. 
M1G could be detected (levels < limit of quantification) in DNA obtained from the duodenal 
mucosa of 1 rat on a HFBe diet, and in a DNA sample obtained from the colonic mucosa of a 
rat on a HFCh diet. The O6-MeG adduct could be quantified in 6 out of 24 liver samples, 2 out 
of 24 duodenal samples and 3 out of 24 colon samples. The CroG DNA adduct could be 
detected and quantified in 1 duodenum sample, 2 liver samples and 3 colon samples. There was 
no clear distinction according to diet although both O6-MeG and CroG DNA adduct levels 
appeared to be lower in liver tissue in comparison to duodenal and colonic mucosal tissue after 
correction for the amount of DNA in each sample (table 2 and 3). 
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Table 2. Obtained amount of DNA (ng/µL) for each sample. 
Rat ID Liver Duodenum Colon 
1 83.04 46.36 45.70 
2 98.62 69.64 100.62 
3 87.96 39.40 39.04 
4 55.16 39.58 20.06 
5 76.76 35.76 29.56 
6 89.86 72.22 28.16 
7 84.76 34.16 12.38 
8 64.32 31.16 29.64 
9 81.86 24.66 24.92 
10 69.00 51.30 35.46 
11 81.82 22.26 27.10 
12 94.06 35.06 32.04 
13 82.90 32.24 59.46 
14 64.90 43.34 24.08 
15 107.8 30.44 14.04 
16 74.06 34.34 9.24 
17 69.40 52.34 21.06 
18 80.24 43.02 42.86 
19 66.28 53.80 25.62 
20 81.28 37.54 38.06 
21 83.54 67.72 33.32 
22 76.50 34.26 19.92 
23 99.04 68.18 66.16 
24 75.36 37.72 45.96 
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Table 3. Targeted DNA adduct levels (in 100 µg of DNA) obtained from liver (L), 
duodenum (D) and colon (C); LFCh = low fat chicken diet, HFCh = high fat chicken 
diet, LFBe = low fat beef diet, HFBe = high fat beef diet; N.D. = not detected, N.Q. = 
detected below quantification limit. 
  O6-MeG (pg/mL) M1G (pg/mL) CroG (pg/mL) 
Rat 
ID Diet L D C L D C L D C 
1 LFCh 13 N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
2 HFCh 7 N.D. N.D. N.D. N.D. N.Q. N.D. N.D. N.D. 
3 LFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
4 HFBe 11 530 222 N.D. N.D. N.D. N.D. N.D. 8 
5 LFCh N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
6 HFCh N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
7 LFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
8 HFBe N.D. N.D. N.D. N.D. N.Q. N.D. N.D. N.D. N.D. 
9 LFCh N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
10 HFCh N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
11 LFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
12 HFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
13 LFCh N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
14 HFCh N.D. N.D. 489 N.D. N.D. N.D. N.D. N.D. N.D. 
15 LFBe N.D. 539 230 N.D. N.D. N.D. N.D. N.D. 11 
16 HFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
17 LFCh 14 N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
18 HFCh N.D. N.D. N.D. N.D. N.D. N.D. 2 25 N.D. 
19 LFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
20 HFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
21 LFCh 11 N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
22 HFCh N.D. N.D. N.D. N.D. N.D. N.D. 2 N.D. 11 
23 LFBe 8 N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
24 HFBe N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. N.D. 
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3.2 ToxFinderTM DNA adduct profiling 
An overview of the results of ToxFinderTM data processing and GENE-E clustering (pearsons 
correlation) is presented in the heat map (figure 1). Only DNA adduct types that could be 
retrieved in a vast majority of DNA samples (present in ≥ 4 out of 6 samples) were included in 
the heat map. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Next page: 
 
Figure 1. Heat map of average (n=6 for each sample type) DNA adduct types and levels 
in liver, duodenal and colon DNA after correction for the amount of DNA per sample. 
Darker shades of blue represent higher average DNA adduct levels. HF indicates a high 
fat content in the diet, LF indicates a low fat content in the diet, Ch stands for chicken 
and Be stands for beef. RT is expressed in min, an asterix marks a different isomer of a 
certain DNA adduct that had already been detected at an earlier RT (different RT = 
different isomer), and a grey box represents the total absence of DNA adduct detection 
in those particular samples. The ionization mode in which each DNA adduct type was 
detected, is provided between brackets after each DNA adduct name.  
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3.3 Significantly higher or lower DNA adduct levels according to SieveTM 
peak integration and database lookup 
Different putatively identified DNA adducts could be detected in all tissue types and samples. 
Two sample differential analysis enabled pairwise comparison of DNA adduct levels in each 
tissue type according to diet. DNA adduct types that appeared to be distinctly higher in beef vs. 
chicken are of particular interest to this study due to their possible role in the unknown 
underlying pathways that causally link red meat consumption and CRC. The same applies for 
DNA adducts that appear to be higher upon digestion of a ‘high fat’ (HF) diet vs. a ‘low fat’ (LF) 
diet. Therefore, only those types of DNA adducts are presented in table 4, 5 and 6, and 
discussed further on. All other DNA adduct types can be consulted in table 7, 8 and 9, but will 
not be discussed. 
 
Table 4. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (relevant to hypothesis) in colonic mucosae samples after two sample 
differential analysis by means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
Δ ppm 
HFCh vs. LFCh Trimethyl-G + 0.79 5.10 
 N2,3-etheno-G + 2.10 4.11 
 Butyl-G (*) + 2.16 6.18 
 Methoxy-A (*) + 4.70 8.85 
HFBe vs. LFBe Hydroxyethyl-T (*) + 1.01 7.19 
 Carboxyethyl-T (*) + 1.10 6.04 
 Carboxymethyl-T or Carboxyethyl-U (*) + 1.10 4.22 
 M1G (*) + 1.15 8.86 
 Methyl-C-glycol (*) + 1.37 4.16 
 Hydroxynonenal-G (*) + 1.51 0.89 
 Oxohexenal-A (*) + 4.00 0.57 
HFBe vs. HFCh M1-C (*) - 1.36 1.92 
LFBe vs. LFCh 1,N6-etheno-A (*) + 0.71 9.70 
 Carboxy-T (*) - 0.72 2.42 
 M1-C (*) - 1.42 2.66 
 U-glycol (*) - 1.89 4.38 
 T-glycol (*) + 2.16 3.60 
 Formamidopyrimidine-A + 4.86 8.05 
 Hydroxynonenal-G + 5.34 4.08 
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Table 5. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (relevant to hypothesis) in duodenal mucosae samples after two sample 
differential analysis by means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
Δ ppm 
HFCh vs. LFCh Glyoxal-G - 1.17 0.69 
 Hydroxy-A + 1.35 3.33 
 Heptenaletheno-C + 2.43 9.46 
 Methoxymethyl-G or Hydroxyethyl-G + 2.77 7.62 
 M2-acetaldehyde-A + 2.83 5.52 
 Dihydro-T (*) + 3.97 3.99 
HFBe vs. LFBe Crotonaldehyde-G + 0.99 0.71 
 Octenal-G (*) + 4.33 6.01 
HFBe vs. HFCh Carboxyethyl-T + 0.71 5.42 
 Trimethyl-G (*) - 0.86 8.40 
 Pentenal-G  - 0.94 4.71 
 Crotonaldehyde-G + 0.96 0.71 
 Heptenaletheno-C + 0.99 2.39 
 Oxohexenal-A (*) + 1.04 5.25 
 Hydroxybutyl-C (*) + 1.07 3.29 
 Dimethyl-T or Ethyl-T + 1.40 7.91 
 Nitro-U + 2.04 2.16 
 Butyl-G + 2.18 6.55 
 Oxohexenal-G + 2.38 6.31 
 Butyl-G (*) + 3.63 6.62 
 M2-acetaldehyde-A (*)  - 4.18 2.78 
 Oxohexenal-G + 5.03 3.89 
 Oxohexenal -G (*) + 5.50 4.50 
LFBe vs. LFCh 1,N2-propano-G (*) - 1.04 7.17 
 Hydroxyhydro-C (*) - 4.12 4.77 
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Table 6. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (relevant to hypothesis) in liver samples after two sample differential analysis by 
means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
Δ ppm 
HFCh vs. LFCh Methoxy-A (*) - 1.5 2.86 
 M1-acetaldehyde-G (*) + 2.94 5.36 
 Methoxy-U + 3.52 3.45 
 Nitro-T (*) - 3.79 9.44 
 Hydroxybutyl-C (*) - 4.29 6.63 
 M1-acetaldehyde-G - 4.85 5.97 
 Pentenal-G (*) + 5.11 1.38 
HFBe vs. LFBe Carbamoylhydroxyethyl-G + 0.82 1.86 
 Formyl-U (*) + 1.29 2.15 
 Methyl-C (*) + 1.49 3.48 
 M1-C - 3.01 3.77 
 Carboxymethyl-C + 3.88 2.51 
 Heptenal-G + 3.94 1.15 
 Pentenal-G + 5.31 4.75 
 Trihydroxybutyl-T + 5.33 8.49 
HFBe vs. HFCh Butyl-G (*) + 0.71 5.00 
 Formamidopyrimidine-A (*) + 5.00 9.25 
 Oxohexenal-C (*) + 5.11 0.51 
LFBe vs. LFCh Methoxy-U (*) + 1.21 2.37 
 Carboxymethyl-T or Carboxyethyl-U + 1.35 1.72 
 Heptenaletheno-A (*) - 1.39 3.22 
 Heptenaletheno-A + 4.11 4.10 
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Table 7. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (not relevant to current hypothesis) in liver samples after two sample differential 
analysis by means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
LFCh vs. HFCh Nitro-A (*) - 2.81 
 Malondialdehyde-acetaldehyde2-A (*) - 4.57 
LFBe vs. HFBe Hydroxybutyl-T (*) + 0.93 
 MethoxymethylG or HydroxyethylG (*) + 1.49 
 Nitro-A (*) + 1.6 
 Hydroxybutyl-A + 3.69 
 Butyl-G (*) + 3.75 
 Hydroxyhydro-C (*) - 3.79 
 Hydroxybutyl-G + 3.8 
 Hydroxybutyl-G (*) - 3.84 
 Octenal-G (*) + 5.39 
HFCh vs. HFBe /   
LFCh vs. LFBe Carboxymethyl-T or Carboxyethyl-U (*) - 0.75 
 Carbamoylethyl-G + 0.76 
 Dimethyl-A or Ethyl-A (*) + 0.76 
 Carbamoylhydroxyethyl-G (*) + 0.82 
 M3-C (*) + 1.93 
 Carbamoylethyl-G (*) - 2.17 
 Oxohexenal-A (*) + 3.88 
 
 
Table 8. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (not relevant to current hypothesis) in duodenal mucosae samples after two 
sample differential analysis by means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
LFCh vs. HFCh Hydroxyethyl-T + 0.71 
 Hydroxyethyl-A + 0.74 
 Butyl-G + 0.96 
 Octenal-G (*) - 5.41 
LFBe vs. HFBe Heptenaletheno-G - 4.79 
HFCh vs. HFBe Glyoxal-G - 1.17 
 Trihydroxybutyl-G (*) + 1.96 
 Heptenaletheno-C + 3.88 
 Hydroxybutyl-G (*) - 4.09 
LFCh vs. LFBe Glyoxal-G (*) - 1.14 
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Table 9. Significantly higher levels (p < 0.05 or (*) p < 0.10) of putatively identified DNA 
adducts (not relevant to current hypothesis) in colonic mucosae samples after two 
sample differential analysis by means of SieveTM database lookup analysis. 
Higher in DNA adduct Charge RT 
(min) 
LFCh vs. HFCh Hydroxydihydro-T (*) - 1.22 
 Carboxyl-A + 1.65 
 Hydroxydihydro-T - 2.14 
 Heptenaletheno-G + 4.06 
 Methyl-C-glycol + 4.22 
 Hydroxyethyl-A + 4.86 
 Hydroxy-A (*) + 4.92 
 Carboxy-T - 5.30 
LFBe vs. HFBe Heptenaletheno-A (*) - 5.35 
HFCh vs. HFBe Heptenaletheno-A - 4.85 
LFCh vs. LFBe Dimethyl-T or Ethyl-T - 0.72 
 Methoxy-C - 0.89 
 M2-G (*) + 1.10 
 Heptenaletheno-A (*) + 4.45 
 Hydroxybutyl-A (*) - 5.46 
 
3.3.1 Influence of fat content in the diet  
Different putative DNA adduct types appeared to be higher in rats on a HF diet compared to a 
LF diet, as is documented in tables 4 to 6. None of the DNA adduct types that were significantly 
(p < 0.05) or borderline significantly higher (p < 0.10) in one of the three tissue types under 
investigation also appeared to be (borderline) significantly higher (p < 0.10) in one of the other 
two tissue types. 
 
3.3.2 Effect of beef vs. chicken meat digestion  
Digestion of a beef diet resulted in a significantly different DNA adduct profile in liver, 
duodenum and colon (see tables 4 to 6). The formyl-U DNA adduct (RT of approximately 1.90 
min) was significantly higher in both liver (p < 0.05) and duodenal (p < 0.10) DNA. A 
significantly higher level (p < 0.10) of both methyl-C (RT of approximately 1.96) and dimethyl-A 
or ethyl-A (RT of approximately 4.86) could be retrieved in the small and large bowel. 
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3.4 Discriminating DNA adducts (SimcaTM modeling) 
An acceptable OPLS-DA model that enables a clear distinction between samples from rats in 
different dietary groups could not always be constructed. DNA adducts in colon and liver 
samples could not be modeled according to diet, although samples from different tissue types 
could easily be distinguished and modeled at all times (figure 2 & 3). DNA adducts in duodenal 
DNA could be modeled under certain conditions; the effect of the HFBe diet could be modeled 
vs. the HFCh diet in positive ionization mode. The same applies for samples from rats on a 
HFCh diet vs. rats on a LFCh diet. In negative ionization mode, the beef diet could be modeled 
vs. the chicken diet regardless of fat content, whilst the HFBe diet vs. the LFBe diet could be 
modeled with the retained negative ions as well. Different putative DNA adducts demonstrated a 
high VIP score (> 1) and an excentric position in the corresponding S-plot (S-plots of valid 
models are provided in figures 4 to 8). Table 10 provides an overview of the potentially 
discriminating DNA adducts of interest (that could be retrieved with SimcaTM). When calculating 
the true positive (= sensitivity) and true negative rate (= specificity) of the potential 
discriminants, none of the retrieved DNA adduct types allowed a perfect discrimination 
according to the consumption of a specific meat type. 
 
3.5 Selection of DNA adduct types relevant to the proposed red meat 
hypotheses 
Table 11 contains a selection of the obtained ToxFinderTM, GENE-E, SieveTM and SimcaTM 
output. DNA adduct types were selected if they were retrieved with ToxFinderTM and (1) 
demonstrated significantly higher or lower levels (significant if p < 0.05 or borderline significant 
if p < 0.10) for a certain diet according to the student’s t-test or (2) demonstrated significantly 
higher or lower levels (significant if p < 0.05 or borderline significant if p < 0.10) for a certain 
diet according to SieveTM or (3) were singled out as a potential marker by the GENE-E marker 
selection tool or (4) were singled out as a potential marker by SimcaTM. All listed DNA adduct 
types could be retrieved in liver, duodenum as well as colon DNA (except for M2G (RT 3.66), 
which could not be detected in liver DNA). 
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Figure 2. OPLS-DA scatter plot demonstrating a clear grouping of samples according to 
(the retrieved DNA adduct profile in each) tissue type in positive ionization mode; Li = 
liver samples (purple), Sb = duodenum samples (orange), Co = colon samples (yellow). 
 
 
Figure 3. OPLS-DA scatter plot demonstrating a clear grouping of samples according to 
(the retrieved DNA adduct profile in each) tissue type in positive negative ionization 
mode; Li = liver samples (purple), Sb = duodenum samples (orange), Co = colon 
samples (yellow). 
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Figure 4. Valid OPLS-DA model S-plot with highlighted potential discriminating 
markers for high fat chicken (lower left quadrant; red) vs. high fat beef (upper right 
quadrant, blue). 
 
 
 
Figure 5. Valid OPLS-DA model S-plot with highlighted potential discriminating 
markers for low fat chicken (lower left quadrant; red) vs. high fat chicken (upper right 
quadrant, blue). 
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Figure 6. Valid OPLS-DA model S-plot with highlighted potential discriminating 
markers for high fat beef (lower left quadrant; red) vs. low fat beef (upper right quadrant, 
blue). 
 
 
 
Figure 7. Valid OPLS-DA model S-plot with highlighted potential discriminating 
markers for high fat chicken (lower left quadrant; red) vs. high fat beef (upper right 
quadrant, blue). 
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Figure 8. Valid OPLS-DA model S-plot with highlighted potential discriminating 
markers for low fat chicken (lower left quadrant; red) vs. low fat beef (upper right 
quadrant, blue). 
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4. DISCUSSION 
Red meat and animal fat intake related genotoxicity were assessed in male Sprague-Dawley rats. 
The red meat associated formation of a limited number of diet-related DNA adduct types (e.g. 
hydroxyguanine (an oxidative DNA lesion) and O6-MeG (alkylation DNA adduct)) has been 
previously investigated in a small number of rodent and human studies [14-16]. However, up to 
date, there are no (published) untargeted in vivo DNA adductomics studies that investigate the 
possible genotoxic effects of the consumption of red vs. white meat (with or without added lard), 
rendering this study to be the first in its kind. 
 
4.1 Liver vs. duodenum vs. colon  
The described untargeted application of applied UHPLC-HRMS method enabled extensive 
DNA adduct profiling. As could be expected due to differences in tissue composition and 
physiology, and also digestion and metabolisation related differences in exposure to (different 
levels of) diet-related toxins, a different DNA adduct profile could be retrieved in each tissue 
type. SimcaTM analysis allowed modeling of DNA adduct types and levels according to tissue type. 
In accordance, GENE-E demonstrated a clear clustering of liver samples, duodenal samples and 
colon samples, also distinctly clustering all bowel samples and thus reflecting a larger 
resemblance in the obtained DNA adduct profile in duodenum and colon DNA vs. liver DNA. 
DNA adduct types that are higher in colonic DNA could be relevant to the red meat CRC-
hypothesis due to the fact that red meat consumption has primarily been linked to the 
development of cancer of the colon but not liver and/or duodenum. Hence, DNA adduct types 
that are higher in colon vs. duodenum or liver may reveal important clues on the underlying 
mechanism. Unfortunately, the relevance (rate of (potential) mutagenic and carcinogenic actions) 
of the retrieved DNA adduct types cannot be compared objectively at the time being; i.e. some 
DNA adduct types are highly mutagenic, some are repaired spontaneously, and some occur 
endogenously whilst others are or do not [8]. Therefore, the DNA adduct types that were 
distinctly higher or lower in liver, duodenum and/or colon were not explored further in this 
chapter. 
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4.2 The effect of meat type and fat content in the diet on the DNA 
adductome  
Differences in DNA adduct levels according to diet were investigated for each tissue type 
separately. Three out of four targeted DNA adducts could be detected (O6-MeG, CroG and 
M1G) in rat liver, duodenum and colon. Due to the fact that the total amount of DNA in each 
sample was rather low, we were unable to confirm or refute any possible relation between O6-
MeG, M1G or CroG levels and meat type or fat content in the diet. The fourth DNA adduct; i.e. 
O6-CMG, could not be retrieved in this study although its presence has previously been reported 
in both rats and humans [8, 14, 17]. In the current study, the amount of DNA in the samples 
could have been too low to detect O6-CMG although the detection limit of the utilized method 
may have been a limiting factor as well [11]. Alternatively, since rats do not possess an 
enterosalivary cycle of nitrate and the meat diets did not contain relevant amounts of nitrite, the 
formation of O6-CMG adducts via the formation of the hypothesized NOC precursors could 
have been negligible [18]. Nevertheless, in future studies, the amount of DNA per sample should 
be increased (≥ 100 µg) to be able to thoroughly assess the influence of a specific diet on the 
presence and levels of O6-MeG, O6-CMG, CroG and M1G DNA adducts. Even more so since 
previous research has already pointed out their potential in vivo relevance in relation to diet [7, 8, 
14, 16, 19].  
Extensive data processing by means of different omics software packages enabled us to single 
out 22 different putative DNA adduct types that were higher in rat colon, duodenum or liver 
after digestion of a beef based diet (compared to a diet with chicken) and/or a HF diet 
(compared to a LF diet); 14 DNA adduct types appeared to be significantly higher after 
consumption of beef (vs. consumption of chicken), 3 DNA adduct types demonstrated an 
increase upon daily HF consumption (vs. LF), and 5 DNA adducts demonstrated an increase 
after the consumption of a diet with a high fat content (compared to the corresponding LF diet) 
as well as a beef diet (compared to the consumption of a chicken diet). Since all 22 selected 
DNA adduct types originate from alkylation, nitrosation and/or oxidation processes, a more in-
depth investigation of the retrieved DNA adduct types is highly relevant to the red meat-CRC 
hypothesis; i.e. NOCs and LPOs rise upon red meat and high fat intake, and are prone to form 
DNA adducts [4, 8]. 
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It should be noted that low fat and high fat meat diets slightly differed in macronutrient as well 
as energy content. This may have influenced DNA adduct levels, but was inherent to the 
experimental setup, and thus unavoidable. The addition of lard to, and the simultaneous 
reduction of meat in high fat diets directly resulted in an increased fat and energy content, whilst 
also reducing protein and water content in high fat meat diets compared to low fat meat diets. 
Shifts in the DNA adductome due to the digestion of a high fat meat diet in this study may thus 
alternatively be related to a higher energy and/or lower protein intake. If so, the observed DNA 
adduct changes due to digestion of high vs. low fat meat diets may not be relevant to the red (and 
processed) meat CRC hypothesis since previous research has not been able to link total energy 
and protein intake to CRC risk [20, 21]. All of the above does however not interfere with the 
correct interpretation of DNA adductomic differences due to red vs. white meat digestion since, 
in order to assess red vs. white meat genotoxicity, the effect of a low fat beef diet was only 
compared to that of a low fat chicken diet, whilst the same applies for high fat diets. 
 
4.3 DNA adducts that increased after the daily consumption of beef  
Trihydroxybutyl-U (RT of 0.72), carboxyl-A (RT of 1.85 min), methyl-C, oxohexenal-C, 1,N2-
propano-G, nitro-C, M2-acetaldehyde-A (observed at two different RTs), M2G (RT of 3.66 min), 
hydroxyhydro-C (observed at two different RTs), heptenal-G, hydroxyethyl-C (or 
methoxymethyl-C) and carbamoylhydroxyethyl-G DNA adducts appeared to be higher in beef 
fed rats compared to chicken fed rats. 
Of these DNA adduct types, only methyl-C, M2G and carboxyl-A demonstrate a significant 
increase in colon DNA, the major tissue type of interest. Methylation of C at its 5th carbon atom 
induces the formation of 5-methyl-C. 5-Methyl-C, also known as the ‘6th base’ of the mammalian 
genome, plays an important role in gene expression, genomic imprinting and suppression of 
transposable elements, and is therefore of specific interest in the field of epigenetics [22]. 
However, the methyl group in the methyl-C compound that could be detected in this study (and 
was singled out as a discriminative DNA adduct type for all tissue types according to GENE-E), 
may be positioned elsewhere, which means the retrieved methyl-C molecule could just as well 
correspond to N3-methyl-C, N4-methyl-C or O2-methyl-C [23]. Direct or indirect addition of a 
carboxyl group to the adenine nucleobase is an unspecific reaction type that cannot easily be 
linked to a specific precursor. The gut microbiome may be able to induce the formation of 
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carboxyl-A directly or indirectly (e.g. via NOC formation) although this is merely speculative. 
Carboxyl-A has not been studied extensively but its C analogue (carboxyl-C) has been detected in 
vivo (genomic DNA of mouse embryonic stem cells and mouse organs) and has been linked to 
the enzyme mediated demethylation of 5-methyl-C [22]. Since demethylation of methyl-A has 
been described as well (=DNA repair pathway) [24], the mode of action may be similar, possibly 
resulting in the in vivo formation of carboxyl-A. The major MDA DNA adduct is an important 
LPO) is the monomeric M1G DNA adduct although multimeric DNA adducts - like the 
putatively detected M2G - can also be formed after polymerization of 2 or more MDA molecules. 
The formation of multimeric MDA DNA adducts does not occur as fast or frequent as 
monomeric MDA DNA adduct formation under physiological conditions and is relatively slow 
at neutral pH. However, according to Marnett et al. [7], multimeric MDA DNA adduct types can 
occur in certain - unspecified - in vivo circumstances.  
Oxohexenal-C and heptenal-G appeared to be significantly higher in liver DNA after daily beef 
consumption, and for heptenal-G, the effect was observed for both the LF and HF beef diet. 
Oxohexenal and heptenal are products of lipid peroxidation. Shorter chain LPOs like acrolein 
and crotonaldehyde are more reactive towards biomacromolecules than the longer chain LPOs 
like heptenal and oxohexenal, but acrolein and crotonaldehyde primarily originate from ω-3 fatty 
acids, whilst the longer chain enals appear to originate from ω-6 fatty acids exclusively [25]. Since 
dietary ω-6 polyunsaturated fatty acids have been linked to colon tumorigenesis in F344 rats [26], 
the retrieval of oxohexenal-C and heptenal-G could be of particular interest. 
The tentatively identified trihydroxybutyl-U, 1,N2-propano-G, nitro-C, M2-acetaldehyde-A, 
hydroxyhydro-C, hydroxyethyl-C (or methoxymethyl-C) and carbamoylhydroxyethyl-G DNA 
adducts were exposed as discriminating DNA adducts for beef vs. chicken digestion in duodenal 
DNA. The trihydroxybutyl-U molecule has hardly been studied and could just as well 
correspond to an isomer with the exact same mass (like e.g. trihydroxypropyl-T). Both 1,N2-
propano-G and M2-acetaldehyde-A are products of lipid peroxidation derived DNA adduct 
formation. 1,N2-propano-G is formed due to exposure of G to acrolein [25], an ubiquitous and 
highly reactive LPO, while M2-acetaldehyde-A can be derived from the interaction of A and a 
malondialdehyde-acetaldehyde conjugate consisting of 2 MDA molecules and 1 acetaldehyde 
molecule [27]. The possible in vivo formation of M2-acetaldehyde protein adducts was confirmed 
by Tuma et al. [28], although this might be the first time that the in vivo formation of (2 different) 
M2-acetaldehyde DNA adducts is suggested. Nitro-C, hydroxyhydro-C, hydroxyethyl-C (or 
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methoxymethyl-C) and carbamoylhydroxyethyl-G are formed upon nitrosation, oxidation 
and/or alkylation of C and G, which are very unspecific ways of DNA adduct formation that 
cannot easily be retraced to its exact origin/precursor. At the time, more detailed information on 
nitro-C is not available since it appears that nitro-C has hardly been studied. The available 
information on hydroxyhydro-C is scarce as well, although this compound has previously been 
identified in mammalian DNA [29]. To the best of our knowledge, hydroxyethyl-C and/or 
methoxymethyl-C have never been detected in vivo. Carbamoylhydroxyethyl-G formation on the 
other hand, has been linked to exposure to acrylamide (used in industry, present in cigarettes and 
foods processed at high temperatures) in rats although acrylamide exposure in this study is not 
very likely [30]. However, nothing in its chemical structure suggests that carbamoylhydroxyethyl-
G formation is strictly limited to the occurrence of acrylamide exposure since the added 
chemical group is not highly specific; i.e. carbamoylation and alkylation of macromolecules can 
also be induced by e.g. nitrosourea compounds (a specific group of NOCs) [31]. The latter 
hypothesis is far more likely following the consumption of beef and the subsequent increased 
exposure to the NOC formation promoting heme molecule [4]. 
 
4.4 DNA adducts that increased due to the intake of a high fat diet  
Hydroxybutyl-A, hydroxymethyl-A (or methyl-G or methoxy-A) and hydroxybutyl-G 
significantly increased in liver or duodenal DNA after the daily consumption of a HF meat diet. 
Airoldi et al. [32] already documented the in vivo formation of hydroxybutyl-G in urothelial and 
hepatic DNA after administration of a single dose of N-nitrosobutyl(4-hydroxybutyl)amine, a 
carcinogenic NOC, to rats. A similar mechanism may likewise be applicable for hydroxybutyl-A, 
although additional research is required to support this statement and confirm the detection of 
hydroxybutyl-A in rat liver DNA. The mass that corresponds to hydroxymethyl-A, methyl-G or 
methoxy-A could not be identified as O6-MeG or N7-methyl-G by means of analytical standards 
(O6-MeG elutes at 2.83 min [11] and N7-methyl-G elutes at 1.50 min (unpublished data)). 
According to literature, N7-methyl-G is the predominantly formed methyl-G isomer, whilst O6-
MeG occurs far less frequently (e.g. 400 N7-methyl-G molecules compared to 1 O6-MeG 
molecule by the S-adenosylmethionine enzyme, a methyl group donor that contributes to 
physiological DNA methylation) [8]. Alternative options for identification include N1-, and N3-
methyl-G [33] or  a methoxy-A [34] or hydroxymethyl-A [35] isomer. 
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4.5 DNA adducts associated with the intake of a beef as well as a high fat 
diet  
The putatively identified carboxyl-A (RT of 0.96 min), CroG (RT 0.96 min), carboxymethyl-G 
(or glyoxal-G), carboxyethyl-G (or carboxyhydroxyethyl-A or methylglyoxal-G) and M2-
acetaldehyde-A (RT of 5.50 min) were higher in rat DNA after digestion of a beef diet as well as 
a meat diet with added fat.  
In colon DNA, an increase of carboxymethyl-G (or glyoxal-G) and carboxyethyl-G (or 
carboxyhydroxyethyl-A or methylglyoxal-G) occurred due to the consumption of a HF (chicken) 
diet (in comparison to a LFCh diet). The carboxymethyl-G compound could not be identified as 
O6-CMG since it did not co-elute with an O6-CMG standard (which has a RT of 1.54 min [11]). 
However, two very likely alternatives are N7-carboxymethyl-G or glyoxal-G for the reason that 
(a) nitrosated bile salts predominantly form N7-carboxymethyl-G during reaction with DNA [8], 
and (b) glyoxal-G formation by NOCs has been documented previously [36], and (c) the glyoxal 
molecule, an endogenously occurring metabolite that is formed during degradation of glucose, 
glycated proteins and lipid peroxidation, is known to readily react with DNA [37, 38]. The latter 
also applies for methylglyoxal, which is a probable precursor of the methylglyoxal-G DNA 
adduct; the molecule that may equally correspond to carboxyethyl-G, or carboxyhydroxyethyl-A. 
Regardless, N7-carboxymethyl-G [8], glyoxal-G [36], methylglyoxal-G [39], carboxyethyl-G [40] 
as well as carboxyhydroxyethyl-A [41] have all been studied and detected in vitro and/or in vivo in 
previous DNA adduct studies, rendering all of these DNA adduct types to be valid options for 
tentative identification. 
The carboxyethyl-G (or carboxyhydroxyethyl-A or methylglyoxal-G) and carboxymethyl-G (or 
glyoxal-G) DNA adducts could also be retrieved in liver DNA where they significantly increased 
after beef as well as high fat consumption. M2-acetaldehyde-G also increased upon beef and high 
fat consumption in liver DNA, plus also demonstrated a significant increase in duodenal DNA 
in relation to beef consumption. As was discussed earlier on for its A analogue (M2-acetaldehyde-
A, in 4.3 DNA adducts that increased after the daily consumption of beef), M2-acetaldehyde-G 
could originate from the interaction of G and a malondialdehyde-acetaldehyde conjugate, but has 
also never formerly been detected in vivo. 
The remaining DNA adducts; carboxyl-A and CroG, were discriminating for beef vs. chicken and 
HF vs. LF beef in the rat duodenum. As was already discussed above, carboxyl-A has not 
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previously been detected in vivo although it may be of importance by analogy with carboxyl-C (in 
relation to methyl-A and 5-methyl-C respectively) [22]. Since CroG eluted at RT 0.96 min and 
not at RT 3.46 min [11], we can be certain that this compound does not match with the 
commercially available CroG standard that was purchased beforehand. The retrieved CroG 
molecule could be an isomer since CroG does occur in different configurations [42]. 
The identity of the putatively identified DNA adducts that were discussed above, were not 
confirmed by means of analytical standards, which is in part because the currently commercially 
available number of DNA adduct standards is limited. Nevertheless, there are several valid 
arguments that can be raised in support of the putative identification of all DNA adduct types; 
(a) DNA purity was tested and confirmed for each sample after DNA extraction from liver, 
duodenum and colon tissue samples, (b) DNA was hydrolyzed (in acid at high temperature) and 
DNA adducts were extracted by means of SPE, (c) DNA adducts were separated by means of a 
UHPLC method that was optimized for DNA adduct separation, and (d) Q-Exactive MS 
analysis allows highly accurate mass measurements. Nevertheless, the findings of this study 
should be validated by independent follow-up studies. 
 
 
5. CONCLUSION 
In the past, animal DNA adduct studies have allowed researchers to gain a more thorough 
understanding of the role of DNA adducts in mutation and carcinogenesis. Even today, animal 
model studies represent one of the best options to study the relation between dietary exposure to 
directly or indirectly harmful chemicals, gastro-intestinal formation of genotoxic chemicals, 
metabolisation (resulting in activation or inactivation) and excretion of genotoxic chemicals, 
related DNA adduct formation and the onset of disease. This study demonstrated that beef and 
high fat intake (in comparison with chicken and low fat meat intake) stimulate the formation of 
certain types of DNA adducts that may be relevant to the red-meat-CRC hypothesis since the 
DNA adduct types that were studied and retrieved in liver, duodenum and/or colon are the 
result of DNA alkylation, nitrosation and/or oxidation processes. Nevertheless, the exact 
relevance of these DNA adduct types in relation to the red meat-CRC hypothesis needs to be 
assessed further in follow-up studies. 
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1. MAIN RESEARCH FINDINGS AND SCIENTIFIC 
CONTRIBUTIONS 
 
Figure 1. Schematic overview of the workflow and scientific contributions of this thesis. 
 
1.1 Development and application of a DNA adductomics methodology to 
study diet-related genotoxin exposure 
Exposomic studies comprise both external and internal exposure assessment in order to 
correctly link exposure to effect [1], which also applies to DNA adductomic studies. The most 
common tool used to study environmental exposure to toxins are questionnaires. However, the 
major flaw of questionnaires in light of exposome mapping, is the fact that they can only focus 
on a limited number of environmental factors and pollutants. Furthermore, questionnaires do 
not take unknown exposure into account, and are often subject to participant or response bias [1, 
2]. Therefore, an in-depth exposure assessment requires a multi-disciplinary approach that can 
tackle these issues. 
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Focussing on the more detailed assessment of genotoxin exposure by means of analytical 
chemistry, two different types of studies or approaches can be distinguished; the bottom-up 
(targeted) and the top-down (untargeted) approach. The bottom-up approach envisions 
summing up all known exposure types or groups in order to characterize the exposome. The 
downside to this most commonly used approach is the fact that unknown exogenous and also 
endogenous environmental factors may be overlooked [1, 3]. The alternative strategy on the 
other hand; the top-down approach, reflects both known and unknown exogenous and 
endogenous exposures [1]. Although the latter sounds very appealing, it requires specialized 
untargeted “omics” technologies and methodologies, and embodies extensive data processing by 
means of specialized software. Nevertheless, independent experts in the field have suggested that 
“omics” is the present and future of (cancer) epidemiology, despite its expense and complexity [1, 
4]. Therefore, application of these approaches to the field of adductomics, via the use of 
appropriately designed studies and analytical methodologies, is of high importance.  
The study of DNA adduct types and levels in human tissue offers an interesting tool in several 
fields of research, including toxicology and cancer epidemiology. Over the years, a range of 
techniques and methods have been developed to study the formation of endo- and exogenous 
DNA adducts in different biological matrices, ranging from those based on antibodies and 
labeling such as immunoassays, immunohistochemistry and 32P-postlabeling to advanced 
instrumental techniques. The latter invariably use chromatographic separation coupled with 
various detection methods e.g. GC-ECD, HPLC-FD, GC- or (HP)LC-MS, (LC-)NMR, and 
AMS [5, 6]. However, for the simultaneous detection, identification and quantification of both 
known and unknown DNA adducts, MS is deemed to be the most promising technique and the 
gold standard for DNA adduct detection [5, 7, 8].  
Different research groups have explored triple quadrupole MS/MS [9, 10], ion trap MS [11, 12], 
TOF (time-of-flight) HRMS [13, 14] and orbitrap HRMS [15] for DNA adductomics purposes. 
Up until now, triple quad and ion trap technology have been applied most frequently as MSn 
accommodates the need for low level DNA adduct measurements [16, 17]. However, for 
untargeted omics applications, HRMS is the more rational choice since accurate mass 
measurements simplify compound identification [16]. A relatively recent trend in MS technology 
is the more widely spread and commercial use of hybrid MS instruments that combine the 
accuracy of HRMS with the specificity and sensitivity of MSn [18]. Accordingly, these hybrid MS 
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instruments currently bring the best to the world of MS DNA adductomics, although additional 
work is required to further optimize the use of MS for DNA adductome mapping.  
The number of published DNA adductomics methods that make use of hybrid HRMS/MS is 
very limited. In fact, Balbo et al. were the first – and up until now, only ones - to implement 
hybrid HRMS/MS technology for DNA adductomics purposes [15]. However, in light of this 
PhD, a new HRMS-based DNA adducomics methodology was developed and optimized. The 
potential application of the newly developed method is twofold; i.e. the presence and levels of 
four DNA adduct types, i.e. O6-MeG, O6-CMG, M1G and CroG, can be assessed by means of a 
targeted HRMS/MS approach, whilst screening of unknowns is enabled via an untargeted full 
scan HRMS approach. The described analytical method was validated successfully through 
assessment of specificity, selectivity, linearity, precision and accuracy. In addition, the in vitro and 
in vivo application of the newly developed methodology demonstrated highly promising results 
and future prospects with regard to the investigation of DNA adduct formation following dietary 
exposure to genotoxic chemicals in the meat-cancer relationship. Furthermore, the developed 
methodology can also be implemented for other environmental carcinogenesis related research 
topics. 
In parallel, to facilitate data interpretation and compound identification, an in-house diet-related 
DNA adduct database was established. At the time, and to the best of my knowledge, there is no 
publically available DNA adduct database. Furthermore, it appears that very few DNA adduct 
compounds are included in existing chemical databases like e.g. ChemSpider and the Human 
Metabolome Database. In addition, despite the inclusion of certain DNA adduct compounds in 
the above-mentioned databases, the provided information is mostly limited (e.g. no 
fragmentation spectra). The self-constructed in-house DNA adduct database currently contains 
over 180 diet-related DNA adduct types, mostly including alkylation and oxidation induced 
DNA adducts. Moreover, based on existing and newly published literature, the database is 
updated continuously ensuring up-to-date and state-of-the-art research. 
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1.2 Assessment of N-nitroso compound and lipid peroxidation product 
formation, metabolic activity and cytotoxicity 
Within the previously mentioned DNA adduct database, DNA adduct types formed due to 
alkylation, oxidation or attack of DNA by LPOs are included. As such, in this work, the 
formation of genotoxic compounds with alkylating or oxidising properties could be assessed in 
an indirect manner. Direct assessment of the formation of (alkylating) NOCs or LPOs was only 
performed on occasion, and the same applies for the determination of metabolic activity and 
cytotoxicity.  
In chapter II, the metabolic activity and cytotoxicity of red vs. white meat digests was assessed, 
specifically focussing on the digestion of chicken, pork and beef. Metabolic activity was 
determined by measuring short chain fatty acid, indol, phenol, p-cresol and ammonia production, 
whilst cytotoxic effects were monitored by evaluating changes in Caco-2 cell viability. Both 
cytotoxicity and metabolic activity did not significantly differ between red and white meat 
digestion. In the same experimental setup, ATNC analysis was performed on stomach, small and 
large bowel meat digests. The results demonstrated that no ATNC levels could be detected in 
small and large bowel digests, despite the formation of the NOC-related O6-CMG DNA adduct 
during colonic meat digestion. In contrast, NOC-derived NO could be detected in stomach 
samples, with a trend towards higher ATNC levels upon the digestion of beef. However, due to 
technical malfunctions during analysis, the validity of these results can be questioned. Even more 
so since others have previously documented the presence of ATNCs in ileal and fecal samples, 
moreover reporting a significant increase in ATNC levels following red meat digestion [19, 20]. 
However, if the non-detection of ATNCs in small and large bowel digests cannot be attributed 
to technical malfunctions, we must consider the possibility that O6-CMG formation does not 
necessarily originate from the production of NOCs during (red) meat digestion. If so, the 
formation of O6-CMG (and other potential alkylation induced DNA adducts) could originate 
from the gastrointestinal production of other DNA alkylating metabolites that are yet to be 
identified.  
MDA is a naturally occurring product of lipid peroxidation with mutagenic and carcinogenic 
properties [21]; MDA can induce DNA cross-links, frameshift mutations, and base pair 
substitutions [22, 23]. During several experiments set up over the course of this PhD, the in vitro 
gastrointestinal formation of MDA was monitored on multiple occasions (as described in 
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chapters II, IV and V). The obtained results were highly consistent; i.e. MDA formation was 
significantly higher upon red meat (i.e. beef) digestion in comparison to white meat (i.e. chicken) 
digestion. In addition, the supplementation of myoglobin to beef digestions resulted in a dose-
response increase of MDA. We were also able to demonstrate that the addition of calcium 
carbonate to meat preparations resulted in a decreased formation of MDA (as described in 
chapter IV). The obtained results align with the heme hypothesis; i.e. heme iron in red meat 
stimulates the formation of reactive oxygen species and LPOs, including MDA, through the 
Fenton reaction. Calcium on the other hand, is hypothesized to capture and precipitate heme 
iron [24], and as such limit the heme iron induced formation of ROS and LPOs. Of course, this 
is of particular interest since the consumption of calcium-rich dairy products is inversely 
correlated to CRC risk [25]. 
 
In summary, we were able to document that: 
1. Red meat digestion results in a significant increase in lipid peroxidation under the form 
of MDA formation. 
2. Addition of myoglobin to meat preparations increases lipid peroxidation under the form 
of MDA formation. 
3. Addition of calcium to meat preparations reduces lipid peroxidation under the form of 
MDA formation. 
4. The earlier reported increased formation of NOCs due to red meat digestion (in 
comparison to white meat digestion) could not be confirmed. 
5. Red meat digestion does not significantly alter (Caco-2) cell viability or metabolic activity 
(under the form of short chain fatty acid, indol phenol, p-cresol and ammonia 
production). 
 
1.3 Person-dependent patterns in the in vitro digestion DNA adductome  
With regard to the in vitro simulation of digestion, the cultivation of the fecal microbiome of 
human donors to mimic colonic digestion was indispensable. Moreover, it soon became clear 
that the composition and metabolic activity of the gut microbiome plays a very dominant role in 
the colonic digestion and concomitant DNA adduct formation. For example, as was described in 
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chapter II, colonic metabolic activity (i.e. the formation of SCFAs indol phenol, p-cresol and 
ammonia production) was very much dependent on the fecal donor, as was O6-CMG formation. 
Later on, mapping of the in vitro DNA adductome also reflected this interindividual variability; i.e. 
there were significant differences when comparing ‘individual’ DNA adductomes.  
The decribed interindividual DNA adductomic differences are the result of differences in 
metabolic activity, which stems from the fact that each individual’s microbiome is in fact unique 
[26, 27]. The composition of the microbiome is mostly shaped in early life, but nevertheless 
modified due to environmental factors like diet, lifestyle social interactions, etc. throughout life 
[26, 27]. The gut microbiome exerts various physiological functions that are mutually beneficial 
to the host and microbiome. The gut microbiome is, for example, responsible for the metabolic 
conversion and uptake of dietary components, competition with pathogens, and regulation of 
host immune function [28]. However, since the composition and activities of the gut 
microbiome seem to directly influence cancer (and other chronic disease) susceptibility, it has 
also become clear that the gut microbiome can just as well exert adverse health effects [28]. More 
specifically, the gut microbiome can produce detrimental metabolites as a result of mere 
physiological food metabolisation or actively contribute to the transformation and activation of 
environmental pollutants [29]. 
The observed interindividual variations in overall metabolic activity and the DNA adduct 
forming potential of the gut microbiome may play an important part in interindividual 
differences in cancer susceptibility. A specific example concerning possible bacterial involvement 
in DNA adduct formation, that is relevant to the heme hypothesis, concerns the interindividual 
difference in bacterial N-nitrosation and the hence induced formation of NOCs. Several 
(facultative) anaerobic bacteria can induce NOC formation via nitroreductase and nitrate 
reductase, and as such lead to NOC-induced DNA adduct formation [28, 30, 31]. In agreement, 
it has already been demonstrated that nitrate reductase is upregulated in obese individuals as well 
as inflammatory bowel disease patients [32], which are indeed more susceptible to CRC [25]. 
Therefore, assessment of nitroreductase and nitrate reductase activity in relation to NOC as well 
as alkylation induced DNA adduct formation could provide useful insights into individual CRC 
risk and etiology. This was not assessed in light of this PhD, but should be investigated in 
follow-up research. Whether or not heme iron can directly or indirectly interfere with bacterial 
N-nitrosation is of specific interest as well. Since diet shapes the gut microbiome, dietary heme 
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iron may be a contributing factor and/or directly promote the person-dependent rate of nitrate 
reductase induced NOC formation. 
By analogy, individual gut microbiome variability may also contribute to the observed 
interindividual differences in DNA adduct formation due to the attack of DNA by ROS and/or 
LPOs. Oxidation and ROS production are inherent to both mammalian and bacterial energy 
metabolism. Hence, differences in the composition of the gut microbiota can contribute to shifts 
in ROS and LPO formation, as well as the gastrointestinal DNA adductome [31, 33]. 
To conclude, it can be stated that it is very likely that the individual gut microbiome actively 
drives the person-dependent formation of several (diet-related) DNA adducts. Therefore, future 
work in line with this PhD project should provide a detailed account of the composition and 
activity of the gut microbiome (by e.g. metagenomics and metatranscriptomics, respectively) in 
relation to red and processed meat intake, and the gastrointestinal or fecal DNA adductome. In 
addition, when conducting in vitro experiments using human fecal samples or human in vivo 
experiments, dietary patterns, habits, and other relevant lifestyle factors of the human volunteers 
should be controlled and/or monitored since this could provide relevant information with 
regard to interindividual variability. 
 
1.4 Diet-induced shifts in the in vitro and in vivo DNA adductome  
The DNA adductome associated with the digestion of beef significantly differed from that of 
chicken in vitro as well as in vivo. Due to the causal link between red meat, but not white meat, 
consumption and CRC, only DNA adduct types that appeared to be significantly higher in beef 
vs. chicken digests were indeed of specific interest. This can be explained by the fact that not all 
DNA adduct types are mutagenic and/or carcinogenic, and certain DNA adduct types are readily 
repaired by DNA repair mechanisms [34]. Hence, DNA adduct formation does not necessarily 
contribute to cancer risk. Whether or not this is the case for red meat induced DNA adducts is 
the point at issue.  
Two independent in vitro and one in vivo experiment were set up to assess red meat induced DNA 
adduct formation. A significant shift in the DNA adductome due to red meat digestion (in 
comparison to white meat) could be observed throughout. As a result, the increased formation 
of several putatively detected DNA adduct types could be linked to red meat digestion. In 
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addition, it was also demonstrated that meat calcium and fat content can induce significant shifts 
in the DNA adductome, documenting their potential role as modulating factors. As a result, it 
was confirmed that diet in general, and red meat in particular, can induce DNA damage in the 
form of DNA adduct formation. 
The interindividual variability in the DNA adduct forming potential of the gut microbiome 
however somewhat impeded straightforward interpretation of DNA adduct data and discovery 
of DNA adduct biomarkers associated with red meat digestion. Nevertheless, several DNA 
adduct types could be singled out as they were detected on multiple occasions; i.e. independently 
throughout both in vitro and in vivo experimental setups. 7 DNA adduct types could repeatedly 
and consistently be associated with red meat digestion. These specific DNA adducts of interest 
are listed in table 1, and discussed briefly below.  
O6-CMG, methyl-G and dimethyl-T (or ethyl-T) are formed due to DNA alkylation, which may 
occur due to endogenous as well as exogenous exposure to alkylating chemicals like NOCs [34]. 
In vivo as well as in vitro methylation and ethylation of G and T has previously been documented, 
but only O6-CMG was previously linked to red meat consumption [34, 35]. Malondialdehyde-2x-
G (M2G) and Malondialdehyde-3x-C (M3C) are DNA adduct types that originate from the 
interaction between MDA and DNA [21, 36]. The earlier discussed finding that beef digestion 
promotes MDA formation, supports these results. In addition, the formation of heptenal-G also 
corresponds to the documented increase of lipid peroxidation since heptenal is another well-
known LPO [37]. Carbamoylhydroxyethyl-G has previously been detected in vivo in association 
with acrylamide exposure [38]. Nevertheless, nothing about the carbamoylhydroxyethyl-G 
structure suggests that the formation of this DNA adduct type is strictly limited to the attack of 
the G nucleobase by acrylamide; i.e. other diet-related genotoxins, including NOCs and/or 
LPOs, may be able to contribute to its formation.  
The retrieval of these alkylation and/or oxidation induced DNA adduct types in relation to red 
meat digestion, is in support of the heme, NOC and lipid peroxidation hypotheses. It 
furthermore suggests that DNA adduct formation may contribute to red meat consumption 
related CRC risk, which should definitely be further investigated. 
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1.5 Critical Notes 
1.5.1 In vitro model vs. in vivo situation 
In Chapter II, IV and V, red vs. white meat digestion experiments were performed by means of a 
static in vitro digestion model, sequentially exposing the meat to simulated mouth, gastric, small 
and large intestinal digestion. Said in vitro model is very versatile and as such ideally suited for 
mechanistic explorative work. Furthermore, the use of an in vitro model is preferred over the use 
of an in vivo (e.g. rodent) model due to ethical considerations, whilst the first is also less costly 
and time-consuming than the latter. In contrast, the employed in vitro model demonstrates 
certain flaws. More specifically, the model does not allow absorption of digestive metabolites 
and/or interaction with the intestinal wall. Therefore, genotoxic metabolites formed during 
simulated digestion of meat, could not directly interact with the intestinal mucosa (and its DNA). 
In chapter II, Caco-2 DNA was added to the meat digests to measure the interaction between 
genotoxic meat digestion metabolites and human DNA. However, in contrast with initial 
expectations, O6-CMG levels did not differ with and without addition of Caco-2 DNA. 
Therefore, it was assumed that O6-CMG levels in meat digests originated from the direct 
interaction with bacterial DNA, which was overly abundant in the digestion flasks. By analogy, 
DNA adducts could also have originated from the interaction with DNA contained in the 
digested meat, although the exact origin of the DNA adduct containing DNA was not 
investigated at the time. As a result, throughout chapter II, IV and V, prokaryote DNA adduct 
formation was used as a proxy for eukaryote DNA adduct formation. Although prokaryote and 
eukaryote DNA demonstrate some distinct differences, the DNA building blocks are chemically 
identical. In addition, studies on DNA damage and DNA repair often use prokaryotic DNA as a 
tool to investigate similar processes in eukaryotic DNA [39]. Hence, it was assumed that the 
interaction between genotoxic molecules and the nucleobases in eukaryotic and prokaryotic 
DNA are similar, permitting the use of prokaryotic DNA adduct formation as a model for 
eukaryotic DNA adduct formation in the employed in vitro digestion model. Moreover, to the 
best of my knowledge, there currently is no valid in vitro model which allows the direct 
interaction with human DNA to remedy this issue.    
Previously in this chapter, 7 potential red meat digestion markers were singled out, taking into 
account the in vivo rat data as well as the in vitro GI digestion data obtained in light of this thesis. 
Unfortunately, the obtained in vitro and in vivo DNA adductomic data cannot be compared and 
  
 
Chapter VII  
 
  
260 
 
  
thus support each other directly since the matrices under investigation differ (liver and gut tissue 
vs. gut luminal content). A direct comparison between in vitro and in vivo GI DNA adduct 
formation would have been possible if the DNA adductome of the luminal content of the rat 
guts was collected and investigated. Unfortunately, this was not feasible due to 2 different 
reasons: (1) the small amount of gut luminal contents and thus also extractable DNA, and (2) the 
need for a separation of eukaryotic from prokaryotic DNA in order to properly validate the in 
vitro results; i.e. the in vitro model allows prokaryotic DNA adduct formation (as was discussed 
previously), whilst the rat model reflects prokaryotic as well as eukaryotic (due to shedding of 
epithelial cells) DNA adduct formation. Isolation of eukaryotic cells from the rest of the 
intestinal content has previously been accomplished in humans [35], but would require further 
optimisation for implementation in rats. 
 
1.5.2 DNA adduct formation vs. epigenetics 
The field of epigenetics studies the occurrence of inheritable chemical modifications in gene 
expression that cannot be explained by alterations in the underlying DNA sequence. More 
specifically, it has become clear that environmental influences can alter DNA packaging and 
expression, play a role in disease susceptibility, and can furthermore be passed on to subsequent 
generations [40]. One of the most extensively studied types of epigenetic changes is DNA 
methylation, which is involved in gene transcription. In eukaryotes, this involves methylation at 
the C5 position of cytosine, leading to the formation of 5-methylcytosine (5-MeC) [41]. In 
prokaryotes however, it is N6-methyladenine (N6-MeA) that can act as a (post-replicative) 
epigenetic signal [42]. As has already become clear throughout this thesis, the methylation of 
DNA nucleobases can not only occur naturally in light of gene expression regulation, but can 
also be induced through environmental exposure to DNA-alkylating chemicals. Taking this into 
account, there is an important overlap between chemically induced DNA adduct formation and 
epigenetics. In case of 5-MeC in eukaryotes or N6-MeA in prokaryotes, one may wonder whether 
certain environmental exposures induce this type of DNA methylation via direct attack of the 
DNA nucleobases, or whether the exposed organism actually responds to the environmental 
exposure by altering its gene regulation. There is no way to easily distinct one from the other. 
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1.5.3 DNA adduct profiling vs. fingerprinting  
When applied in full scan acquisition, the UHPLC-HRMS DNA adductomic method (as 
described in Chapter III) allows untargeted mapping or fingerprinting of all positive and negative 
ions in each extract. Preprocessing of the hence obtained data by means of SieveTM software 
enables transformation of ion intensities into a matrix of features (m/z - RT pairs) using peak 
detection, alignment and area extraction algorithms, followed by normalization, scaling and 
transformation to correct for systematic and technical variability. Subsequently, differences 
between (sub)groups of interest (i.e. red vs. white meat), and potential marker molecules can be 
discovered by means of multivariate data mining (i.e. SimcaTM software). Up until this point, 
analysis and data processing is blind, meaning that accurate mass is not linked to a possible 
identity. However, from this point on, the accurate masses of ions of interest (i.e. possible 
markers) are matched with the in-house DNA adduct database, and in this work only ‘matched’ 
ions were reported. This can provide a certain degree of bias since (1) only known types of DNA 
adducts are included in the DNA adduct database, and (2) this work mainly focused on the 
investigation of alkylation and/or oxidation induced DNA adduct types. As a result thereof, ions 
that may very well correspond to unknown adducts were not reported, although some of these 
ions did display marker potential (e.g. VIP score > 1).  
 
1.5.4 DNA adduct formation due to the digestion of chicken 
Throughout this thesis, exploration of the obtained data and discussion of the results was 
hypothesis-driven, meaning that there was a specific focus on red meat digestion related DNA 
adduct formation, but not white meat digestion related DNA adduct formation. DNA adduct 
types that decreased upon red meat digestion and/or increased upon white meat digestion were 
reported in heat maps and tables, but not discussed because of (1) the vast amount of data and 
work that was generated, and (2) the fact that the (excessive) digestion of white meat has not 
been linked to CRC risk. Therefore, increased formation of certain types of DNA adducts due to 
the digestion of chicken, as a model for white meat, was not deemed relevant. Nevertheless, 
there was no distinct quantitative difference in the total number of retrieved DNA adduct types 
upon digestion of chicken or beef, and therefore, it should be noted that the digestion of white 
meat can also affect the DNA adductome, and that beef, as a model for red meat, does not 
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induce an overall increase in DNA adduct formation compared to white meat. The same 
rationale applies for low vs. high fat content, and whether or not CaCO3 or myoglobin is added. 
 
1.5.5 Statistical interpretation of the data: suggestions for improvement 
DNA adductomics is a relatively new omics branch and therefore, a mostly uncharted field of 
research. As a result, the approach for untargeted data (pre)processing and interpretation 
requires further exploration and optimisation. In light of this PhD, several types and means of 
data processing and interpretation were explored; i.e. ToxFinderTM profiling, SieveTM pairwise 
comparison and SimcaTM modelling. As such, univariate as well as multivariate statistics were 
employed to search for relevant trends in the obtained data. However, due to the vast amount of 
data that was generated, extensive statistical validation of the obtained results was not always 
feasible, possibly leading to over-interpretation of the obtained results.  
With regard to univariate procedures, ANOVA should be preferred over ‘simple’ t-testing, 
allowing a more profound evaluation of the role of fixed and random variables, as well as 
interactions. Furthermore, when conducting multiple testing, false discovery rate controlling 
procedures (e.g. Benjamini-Hochberg) should be employed to correct for type I errors. With 
regard to multivariate testing, based on for example OPLS-DA, extensive validation of the 
obtained model (and the hence retrieved information) is required, employing a training and test 
dataset to evaluate model prediction performance and avoid over-fitting.  
Concerning the interpretation of all in vitro data, it should be kept in mind that digestions 
performed with the same fecal inoculum (e.g. comparing red vs. white meat digestion using the 
fecal inoculum of a certain individual) or different fecal inocula obtained from the same person 
are not independent. Therefore, the hence obtained results should be assessed using dependent 
statistical tests (e.g. repeated measures ANOVA or repeated measures regression analysis).  
Lastly, it should be noted that the true value and meaning of a red meat digestion marker can 
only be assessed in a sufficiently large cohort. Nevertheless, explorative as well as mechanistic 
experiments, like the work conducted over the course of this PhD, are indispensable to gain a 
more profound knowledge of underlying causes and pathways. 
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2. FOLLOW-UP RESEARCH 
2.1 Human case-control studies  
DNA adductomics is particularly well-suited for research on the exposure of the human body to 
both known and unknown endo- and exogenous hazardous chemicals and any subsequently 
formed DNA adducts [16]. Nevertheless, the search for answers does not end with DNA adduct 
mapping or biomarker establishment, as the described top-down approach does not evidently 
link genotoxin exposure to a certain environmental factor as a causal risk factor on the one hand, 
or disease outcome on the other [4]. Any information obtained from top-down omics studies 
will only prove its value if combined with bottom-up targeted analyses in both long-term studies 
and purposeful short-term intervention studies [1, 4]. Therefore, to confidently link cause and 
effect, future DNA adductomics studies aiming to investigate CRC initiation, promotion and 
progression should be based on human case-control cohorts. More specifically, we are in need of 
observational as well as interventional case-control studies to firstly, confidently link dietary (and 
other lifestyle) habits to DNA adductomic shifts, and secondly, link these DNA adductomic 
changes to actual CRC risk and development. To this purpose, the DNA adductome should be 
monitored in tumoral tissue, blood and feces of CRC patients and healthy volunteers, after 
which the obtained DNA adductomic data can be linked to dietary habits (i.e. assessed by means 
of a food frequency questionnaire), focusing on red and processed meat consumption, and 
disease status (e.g. healthy vs. adenoma vs. carcinoma). 
 
2.2 Obstacles concerning (in vivo) DNA adductomics 
Insufficient knowledge of DNA adduct fragmentation patterns and limited availability of DNA 
adduct standards currently act as a bottleneck for the full characterization and correct 
identification of untargeted and unknown DNA adducts with MS [16]. In this context, the need 
for accurate mass measurements is indisputable, whereas the establishment of a database to 
assemble all information on chemical structure and characteristics of DNA adducts, 
fragmentation patterns, stability, prevalence and origin (= initiating genotoxin + route of 
exposure) would provide a major advance by facilitating investigation of DNA adduct formation 
and its potential role in different pathophysiological pathways. In addition, technological as well 
as methodological improvements may provide the means to tackle these issues (discussed further 
on). 
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The relatively low concentration of DNA adducts in biological matrices forms an additional 
obstacle. As was mentioned previously, DNA adducts are not abundantly present in DNA. 
Furthermore, the concentration of DNA in several biological matrices is relatively low as well. In 
contrast, a considerable amount of purified DNA (> 50 µg) is required for DNA adduct analysis 
purposes. Hence, sample size requirements limit DNA adduct research possibilities. As was 
previously explained in chapter I, this issue could possibly be tackled by the collection and 
analysis of appropriate surrogate tissue(s). However, this can only be implemented if the DNA 
adductome (or a specific fraction of interest) of the surrogate tissue directly and correctly reflects 
that of the target tissue. However, at the time, and to the best of my knowledge, such 
correlations have not sufficiently been investigated. Hence, until additional research concerning 
the DNA adductome of surrogate vs. target tissue has been performed, the obstacle of required 
sample size remains. 
 
 
3. POTENTIAL TECHNOLOGICAL AND 
METHODOLOGICAL IMPROVEMENTS IN THE FIELD 
OF DNA ADDUCTOMICS  
3.1 Mass Spectrometric tools that are currently in use  
3.1.1 Triple Quadrupole Tandem Mass Spectrometry 
LC-ESI-tandem MS (LC-MS/MS) by means of triple quadrupoles is currently the most applied 
technique/instrument for the targeted quantification of DNA adducts [17]. With LC-MS/MS, 
mapping of the DNA adductome is enabled through monitoring of the constant neutral loss 
(CNL) of 2’-deoxyribose (116 Da) from positively ionized 2’-deoxynucleoside adducts. This 
approach is demonstrated for four different adducts in figure 2, where the difference between 
the precursor ion and the base peak is always 116 Da [6]. One can focus on all [M+H]+ to [M+H 
- 116]+ transitions by applying a full scan approach in Q3, the third quadrupole, or alternatively 
use selected reaction monitoring (SRM) to view [M+H]+ to [M+H - 116]+ transitions in a more 
narrow, selected range. The narrow range of SRM can be compensated by multiple injections of 
the same sample, which are then analyzed in different mass ranges, although this requires more 
time for analysis [16]. 
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The group of Kanaly et al. was one of the first to develop and apply an LC-MS/MS method for 
mapping of the DNA adductome. Analysis of human lung and esophagus DNA samples 
revealed the possible presence of more than 1000 putative DNA adducts in each tissue type. The 
use of analytical standards and isotope dilution allowed full identification of seven DNA adducts 
[10, 43]. This demonstrates the vast amount of data that can be generated and the amount of 
time involved in positively identifying the adducts within a particular sample; the analysis itself 
takes 28 to 60 min. per sample and the authors describe that the time required for data 
processing and confident identification is ‘manageable’. Examples of similar LC-MS/MS 
applications include work by several research groups, demonstrating the popularity of this type 
of instrumentation for DNA adductomics [17, 44-51]. 
 
 
Figure 2. ESI MS/MS mass spectra documenting [M+H]+ to [M+H-116]+ transitions of 
four DNA different adducts; (A) 8-oxo-dG, the main oxidative stress related DNA 
adduct; (B) M1dG, the main MDA adduct; (C) B[a]PDEdG, the main benzo[a]pyrene 
diol epoxide DNA adduct; and (D) DiB[a]PDEdG, a dibenzo[a,1]pyrene diol epoxide 
DNA adduct. Adapted from Farmer & Singh P.B.; Singh, R. Mutat. Res.-Rev. Mutat. 
2008, 659, 68-76 [6], copyright 2008 Elsevier. 
 
An alternative approach to monitoring of the mutual loss of 2-deoxyribose, is the detection of 
altered DNA nucleobases instead of altered nucleosides. Inagaki et al. reported the presence of 
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characteristic fragment ions for guanine at m/z 152 (≈ protonated guanine) and 135, which 
corresponds to fragmentation of the NH2 group, and for adenine at m/z 136 (≈ protonated 
adenine) and 119 [9], which is presumably the corresponding fragmentation although the authors 
did not show the data. Confirming part of these findings, Gregson et al. also documented 
deamination upon collision induced fragmentation of protonated guanine [52], whilst other 
independent research groups have also reported the occurrence of a product ion with m/z 152 
for guanine [53, 54] and m/z 136 for adenine [55, 56] using different systems and focusing on 
different DNA adduct types. However, at the present time, it is not clear whether those exact 
same ions are formed upon fragmentation of all purine DNA adduct types.  
The aforementioned research demonstrates that tandem MS can reveal hundreds of putative 
DNA adducts in DNA samples and thus holds great potential for biomarker discovery. However, 
one disadvantage of tandem MS/MS is the loss of sensitivity with CNL or the need for SRM 
transition optimization for each different DNA adduct in order to achieve sufficient detection 
sensitivity with pseudo-CNL [16, 17]. Secondly, since triple quadrupoles only allow low 
resolution data acquisition, and DNA adduct databases providing MS/MS spectra are not 
available, DNA adduct identity confirmation is dependent on the availability of analyte standards 
or the use of additional analytical techniques. This renders triple quadrupole mass measurements 
to be less suited for untargeted compound analysis and confident compound identification 
compared to HRMS, e.g. TOF and orbitrap, which is discussed further on [16]. 
 
3.1.2 Ion Trap Mass Spectrometry 
Ion trap MS-analyzers allow multistage scan events (MSn) that provide additional structural 
information. Just like most triple quadrupole methods, ion trap DNA adduct analysis depends 
on the detection of the neutral loss of the 2’-deoxyribose group. Bessette, Turesky and co-
workers describe the use of a linear ion trap for data-dependent LC-MS3 (DD-CNL-MS3), where 
first, the detection of a DNA adduct ion (listed in a targeted mass-list) in a limited m/z scan 
range leads to MS2 acquisition. Subsequently, the detection of the [M+H - 116]+ ion amongst the 
top ten of the most abundant MS2 ions triggers MS3 fragmentation. Bessette et al. used this 
acquisition type to study the formation of tobacco-associated DNA adducts of certain aromatic 
amines, HCAs, PAHs and aldehydes in rat livers, human hepatocytes and buccal cells [11]. MS3 
acquisition or multistage MSn scanning in general, seems a major advancement compared to MS2 
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CNL scanning techniques since MSn provides a higher specificity and further DNA adduct 
characterization [11, 16]. Unmistakable identification with the ion trap occurs through evaluation 
of the MSn product ion spectrum and co-elution with an analytical standard. If necessary (e.g. no 
analytical standard available), the use of additional analytical techniques using accurate mass 
measurements may assist in the identification of unknowns. Co-workers of Bessette and Turesky 
applied the DD-CNL-MS3 approach in research on 4-aminobiphenyl, HCA and aristolochic 
acid-related aristolactam DNA adducts with a clear focus on targeted DNA adduct detection [12, 
57]. Pietsch et al. adapted the method described by Bessette et al. to study DNA adduct 
formation by Illudin S, an antitumoral agent. They were able to study known DNA adducts in a 
colon cancer cell line, but were unable to detect or identify any untargeted DNA adducts [58]. 
This suggests that although the ion trap and DD-CNL-MS3 method have proven their worth for 
structural characterization, identification and quantitation of (a limited number of) targeted 
DNA adducts, the low resolution methodology appears less suited for holistic, untargeted omics 
applications, including DNA adductomics [59]. Figure 3 demonstrates compound identification 
by means of MS3 fragmentation patterns for three different DNA adducts of the HCA MeIQx 
(deoxyguanosine-N2-MeIQx, deoxyguanosine-C8-MeIQx, and deoxyadenosine-C8-MeIQx) [11] 
whereby the MS3 fragmentation patterns obtained allow confident compound identification.  
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Figure 3. CNL-MS3 product ion spectra of three MeIQx DNA adducts, from HCA 
exposure, clearly showing multiple fragmentations within the adducts; (A) dG-N2-
MeIQx, (B) dG-C8-MeIQx, and (C) dA-N6-MeIQx. Reproduced from Bessette, E. E.; 
Goodenough, A. K.; Langouet, S.; Yasa, I.; Kozekov, I. D.; Spivack, S. D.; Turesky, R. J. 
Anal. Chem. 2009, 81, 809-819 [11], copyright 2009 American Chemical Society. 
 
3.1.3 Time of Flight High Resolution Mass Spectrometry 
TOF instruments are most commonly used for qualitative analysis as a stand-alone instrument, 
although coupling to a second mass spectrometer offers several opportunities for DNA 
adductomics studies. Recently, Giese and co-workers developed a MALDI-TOF/TOF method 
(MALDI = matrix-assisted laser desorption/ionization) to enable untargeted DNA adduct 
detection (preceded by HPLC separation), facilitating investigation of unknown DNA adducts. 
To this purpose, they employed a tedious but highly profitable sample preparation procedure 
based on benzoylhistamine labeling of altered nucleotides. This approach enabled the specific 
detection of altered deoxynucleotides with increased sensitivity and specificity (noise was 
reduced due to the use of negative ionization) in a semi-quantitative manner [13, 60].  
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By coupling of a TOF-MS to a quadrupole, the resulting hybrid instrument can also be easily 
employed for both identification and quantitation purposes since accurate mass measurements 
are important for confident compound identification and can also eliminate spectral noise due to 
matrix interferences [18]. Esmans, Van den Driessche and colleagues published research [14, 61] 
on the use of a QTOF instrument for DNA adduct screening and characterization. 
Unfortunately, and to the best of our knowledge, both the use of the QTOF (quadrupole 
coupled to TOF) and MALDI-TOF/TOF instruments for DNA adductome mapping has not 
been explored further which may be due to the lack of available instrumentation in appropriate 
research laboratories as tandem MS instrumentation has been favoured in recent years.  
 
3.1.4 Orbitrap High Resolution Mass Spectrometry 
Orbitrap technology enables very accurate mass detection due to a high resolving power and 
mass accuracy. The technology is particularly suited and implemented for small molecule analysis 
and untargeted omics applications. The orbitrap is often coupled to an ion trap instrument (early 
on) or a quadrupole (later on), but can also be used as a standalone instrument [18].  
Recently, Balbo et al. developed a high resolution DD-CNL-MS3 method for DNA adductomics 
purposes, using a linear ion trap-orbitrap system [15]. Within the described application, the 
orbitrap ensures accurate mass measurements resulting in determination of possible elemental 
composition, selective identification of DNA adducts and avoidance of false positives. The CNL 
[M+H]+ to [M+H-116]+ transition triggers MS3 acquisition, further contributing to molecular 
structure data and assisting with identification of untargeted DNA adducts (demonstrated in 
figure 4). Therefore, this methodology appears to be suitable for wider application to 
adductomics areas of research. 
 
  
 
Chapter VII  
 
  
270 
 
  
 
Figure 4. Demonstration of the CNL-MS3 high-resolution/accurate mass adductomic 
approach with an O2-POB-dT standard (a tobacco-specific nitrosamine related DNA 
adduct). (A) MS3 scan event triggered by a mass difference of 116.0474 amu between an 
ion mass in the full scan (C) and an ion mass in the corresponding MS2 spectrum (B). 
(A.1) MS3 spectrum of O2-POB-dT, (C.1) accurate mass full scan ion chromatogram of 
O2-POB-dT (m/z = 390.1660 amu). Reproduced from Balbo, S.; Hecht, S. S.; Upadhyaya, 
P.; Villalta, P. W. Anal. Chem. 2014, 86, 1744-1752 [15], copyright 2014 American 
Chemical Society. 
 
3.2 Perspectives for Mass Spectrometry-based DNA adductome mapping 
3.2.1 Hybrid High Resolution Mass Spectrometry 
For years, triple quads have dominated the field of trace quantitation [18]. Yet, when conducting 
DNA adductome mapping, tandem MS encounters some difficulties regarding DNA adduct 
identification; since accurate mass data are not available and, at the time, sufficient knowledge on 
MS/MS spectra of DNA adducts is somewhat lacking. This necessitates that comparison with 
analytical standards and/or the use of other analytical techniques are essential for confident 
compound identification. High resolution MS provides accurate mass measurements and thus 
more information regarding compound mass, elemental composition and identity. New hybrid 
systems like QTOF and ion trap-orbitrap may not always surpass triple quadrupole instruments 
for low level quantitation of DNA adducts in terms of peak areas, but full scan HRMS 
acquisition always results in lower signal to noise ratios compared to low resolution MS due to 
elimination of noise. Therefore, comparable limits of detection and limits of quantification for 
high resolution hybrids and triple quads are definitely within reach. In any case, hybrid HRMS 
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systems offer indisputable advantages through accurate mass detection, which renders them to 
be an excellent tool for omics applications [18].  
Besides the quadrupole-orbitrap instrument I implement(ed) (i.e. the Q-ExactiveTM), the QTOF 
[61], and the linear ion trap-orbitrap [15], other hybrid HRMS systems such as the quadrupole 
ion trap-TOF and linear ion trap-fourier transform cyclotron resonance MS could be highly 
accommodating for DNA adductome mapping [62, 63]. Of course, alternative applications of 
some of the currently used hybrid HRMS technologies could also be explored. For example, a 
quadrupole-orbitrap instrument like the Q-ExactiveTM can be operated in different acquisition 
modes; full scan MS, selected ion monitoring (SIM) MS, MS2, full scan data dependent MS2 (DD-
MS2), SIM-DD-MS2 and neutral loss DD-MS2 (NL-DD-MS2), enabling different approaches for 
targeted and untargeted analysis of complex biological matrices [64]. In particular, the use of NL-
DD-MS2 for untargeted DNA adduct detection should be explored further as this approach can 
provide HRMS2 spectra of DNA adducts characterized by the loss of e.g. 2’-deoxyribose 
([M+H]+ to [M+H - 116]+ transition) upon fragmentation; a distinctive feature of nucleoside 
DNA adducts that has been commonly exploited for DNA adductomic research by means of 
both triple quads and ion traps [10, 11]. Employment of the neutral loss of 2’-deoxyribose by 
nucleosides, and the potentially characteristic loss of protonated bases (as reported by Inagaki 
and co-workers [9]) during DNA adduct fragmentation, could prove to be very rewarding as it 
allows analysts to focus their attention on the detection of potential DNA adduct biomarkers 
exclusively by ignoring all non-DNA adduct originating ions and molecules. 
 
3.2.2 Chromatographic Innovations 
As MS is usually coupled to chromatography, further advances could still be achieved by means 
of modern LC techniques. Within this framework, the use of capillary or nano capillary LC 
coupled to micro- or nano-ESI-MS could provide a rise in sensitivity [8, 17]. Due to the lower 
sample flow rates of capillary LC, the ionization and ion sampling efficiency in the electrospray 
source increase significantly, resulting in a higher amount of ions in the MS system, an improved 
sensitivity and low mass detection limits [8]. With micro- or nano-ESI, a higher electrospray 
efficiency and improved MS sensitivity are achieved in the same manner [65]. Both (nano) 
capillary LC and micro- or nano-ESI-MS have been implemented for targeted DNA adduct 
analysis [66-68] and allow sensitive DNA adduct analysis with a limited amount of sample.  
  
 
Chapter VII  
 
  
272 
 
  
To eliminate non-altered nucleosides from the sample, two-dimensional (2D-)LC can be 
implemented [68]. 2D-LC is another on-line chromatography application that could definitely 
assist with detailed DNA adduct mapping because this technique allows one sample (or its most 
interesting ‘section’) to be chromatographically separated twice (with 2 different columns), 
significantly adding to the separation power required for the analysis of complex biological 
samples like DNA. 2D-LC has already demonstrated its potential in metabolomics and 
proteomics [69], and has been used for DNA adductomics at least once by Singh et al., who used 
a trap column to isolate PAH-dihydrodiolepoxide DNA adducts in order to facilitate subsequent 
separation by means of an analytical column thereafter [17]. This approach enabled an increased 
sample throughput and a significant reduction of ionisation suppression and other matrix effects. 
Besides the elimination of unmodified DNA building blocks by means of a trap column, which 
significantly enhances the sensitivity of the analysis and also reduces the risk of artifacts [8], 2D-
LC also has the potential to assist with the combined and more adequate separation of different 
types of DNA adducts with different chemical attributes during one single chromatographic run 
when using two analytical columns. Unfortunately, according to the available literature, this has 
not been investigated yet. 
An additional technique that could be used to achieve an increase in sensitivity, consists of 
miniaturized separation techniques like LC-chip [17]. This state-of-the-art development improves 
sensitivity by a gain in ionization efficiency and also significantly reduces the required sample size 
[70, 71]. However, up to date, there are very few promising papers on DNA adduct analysis by 
means of LC-chip MS, although the technique was introduced over a decade ago. It appears that 
the specialized nature of LC-chip technology and the need for specific LC and MS equipment 
may pose important restrictions for its widespread application. Although the technique definitely 
seems very promising for DNA adduct biomarker research, its optimisation and subsequent 
application seems to be rather complex and difficult; e.g. Bani-Yaseen et al. documented 
persistent problems with the separation of similar molecular structures [72]. In contrast, Vouros 
and co-workers were able to use (commercialized) HPLC-chip MS methodology quite easily for 
the detection of dG-C8-4-ABP (a 4-aminobiphenyl DNA adduct), although they do not discuss 
its optimisation and practical use in detail [66].  
Unfortunately, none of the above-mentioned techniques have been applied for untargeted DNA 
adductome mapping, merely leaving us with the promise of a giant leap forward in this field of 
research. Thus, the potential of these chromatographic innovations has, at least in part, been 
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demonstrated for targeted DNA adduct analysis, but still needs to be established and confirmed 
for DNA adductomics purposes. 
 
 
4. JOINING FORCES TO MAXIMIZE RESEARCH 
OUTPUT: FUSED OMICS 
4.1 Interrelated fields of research 
The human metabolism is heavily influenced by e.g.  genetics, the gut microbiome, and other 
external pressures (= the exposome) besides diet [73]. Hence, in the context of diet-related CRC 
initiation and promotion, in-depth investigation of several of those interfering factors by means 
of omics applications that are complimentary to DNA adductomics, offers promising 
perspectives. In light of CRC research, metabolomics as well as metagenomics are of specific 
interest. 
 
4.1.1 Metabolomics 
A metabolic fingerprint can provide the most accurate assessment of the biological state of an 
individual because it documents all metabolites produced during metabolic processes in that 
individual’s cells, tissues and organs, and is furthermore capable to capture signals from the 
exposome. Both qualitative and quantitative changes in the metabolome reflect manifesting 
(patho)physiological changes at a very early stage, e.g. way before changes in the architecture of 
cancerous cells could be observed [74]. Therefore, assessment of the metabolome provides a 
very powerful tool for a large variety of cancer (biomarker) studies [73].  
The metabolome comprises both polar and non-polar small molecules, which can be mapped by 
respectively (polar) metabolomics and lipidomics. Both polar metabolomics and lipidomics 
studies have already demonstrated their relevance and potential by enabling more in-depth 
investigation of disease pathophysiology and disease biomarker discovery on multiple occasions 
[75, 76]. More specifically, metabolomics has already allowed investigation of shifts in the gut 
metabolome upon red meat digestion (in comparison to white meat), revealing several metabolite 
markers that may be of importance with regard to the development of CRC [77]. In addition, it 
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has been demonstrated that the polar metabolome as well as the lipidome significantly differ for 
CRC patients and healthy individuals. Apparently, CRC patients demonstrate a distinctly 
different metabolic pattern, which contains marker molecules that can be linked to e.g. the 
tricarboxylic acid cycle, amino acids and fatty acids metabolism [75]. 
 
4.1.2 Metagenomics 
Metagenomics encompasses the genomic analysis of entire communities of microorganisms, e.g. 
in the human gut [78]. As it has become clear that the human intestinal microbiota play an 
important role in several (patho)physiological processes, investigation of gut microbial 
composition is highly relevant to the field of CRC research. After all, the colonic epithelium is 
exposed directly to the metabolic products of the gut microbiome. Recently, the dominant 
interfering role of the gut microbiome in relation to CRC has become indisputable [31, 79] as 
several studies using state-of-the-art metagenomics have demonstrated that the gut microbiome 
of CRC patients significantly differs from that of healthy subjects [80] through the presence 
and/or higher abundance of certain pathogenic (e.g. E. coli) as well as commensal (e.g. Bacteroides 
spp.) species [81]. More specifically, it has become clear that the gut microbiome’s end products 
exert DNA damaging effects (e.g. DNA adduct formation) as well as induce cell proliferation, 
apoptosis and differentiation that can ultimately lead to CRC development [81]. Hence, the gut 
microbiome, and its metabolic products, strongly influence whether someone develops CRC, or 
not [31, 81], rendering metagenomics to be a field of interest in light of CRC research.  
 
4.2 The prospect of fused omics 
Combining DNA adductomics with metagenomics and metabolomics (including polar 
metabolomics as well as lipidomics) can provide highly relevant information with regard to CRC 
initiation, promotion and progression. At the time, data obtained by means of different omics 
methodologies are processed separately, requiring integration later on. A high-end bio-informatic 
platform that simultaneously integrates different types of omics data (from a different origin) 
would however constitute a significant added value and enable more in-depth CRC research. 
Concomitantly, reports from literature demonstrate that a fused strategy leads to higher accuracy 
in prediction and more exhaustive description of disease profile; e.g. fusion of proteomics and 
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metabolomics allowed better discrimination of healthy vs. diseased rats in a pre-clinical multiple 
sclerosis rat model [82, 83]. The fused omics approach also provided insight into the 
modification of metabolic pathways by the disease [83], rendering fused omics to hold great 
potential for cancer research in its many aspects as well. Hence, via the unprecedented coverage 
of biological molecules related to disease pathogenesis, the fusion of different omics applications 
into a single fused omics platform is expected to take cancer research in general, and CRC 
research specifically, to the next level [84]. As such, a multidisciplinary fused omics approach 
(presented in figure 5) represents the most efficient and comprehensive way forward. 
 
 
Figure 5. Schematic overview of the envisioned fused omics platform. 
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Epidemiological research has demonstrated that the consumption of red and processed meat 
significantly contributes to the risk of developing colorectal cancer (CRC). The exact underlying 
cause has not been fully elucidated, but several hypotheses have been put forward, aiming to 
explain this causal relationship. At the time, the main red meat-CRC hypothesis is the heme 
hypothesis, which is based on the fact that red, but not white meat consumption, has been linked 
to CRC, and that red meat like e.g. beef contains more heme iron than white meat like e.g. 
chicken. More specifically, the heme hypothesis states that the ingestion and digestion of heme 
iron stimulates the formation of N-nitroso compounds (NOCs) and lipid peroxidation products 
(LPOs). Both NOCs and LPOs can exert geno- as well as cytotoxic effects, and as such 
contribute to carcinogenesis. The research conducted within the framework of this doctoral 
thesis aimed to further unravel the carcinogenic effects of red meat consumption, primarily 
focusing on NOC and LPO induced DNA adduct formation. This was addressed in 7 different 
chapters. 
 
Chapter I – The first chapter of this dissertation contains a general introduction to diet-related 
carcinogenesis, discussing facts, figures, causes and consequences. This is followed by a 
clarification of the concept of the DNA adductome, and its position in relation to the exposome. 
Next, an overview of the current knowledge on diet-related DNA adduct formation in relation 
to carcinogenesis is given, further highlighting the use of targeted as well as untargeted DNA 
adduct research to help unravel the pathways underlying diet-related, and more specifically, 
meat-related carcinogenesis. Hence, an overview of the current hypotheses on red and processed 
meat related carcinogenesis is provided, furthermore explaining the potential role of DNA 
adduct formation. Looking ahead, important practical considerations for DNA adduct research 
are discussed briefly, after which the specific focus and aim of this PhD is revealed.  
 
Chapter II – In chapter II, the effects of red meat digestion on cell viability, gastro-intestinal 
metabolic activity, NOC formation, DNA alkylation and lipid peroxidation are investigated. To 
this purpose, the digestion of beef, pork and chicken were simulated in vitro, after which (1) the 
cytotoxic effects of different meat digests were assessed by means of a cell proliferation assay, (2) 
metabolic activity was assessed via short chain fatty acid analysis, (3) the formation of NOCs was 
measured by analysis of Apparent Total N-nitroso Compounds, (4) the malondialdehyde (MDA) 
content of meat digests was measured using the thiobarbituric acid reactive substances assay, and 
(5) DNA alkylation was determined by assessment of O6-carboxymethylguanine (O6-CMG) 
formation. The results demonstrate that the cytotoxicity and metabolic activity of beef, pork and 
chicken digests did not significantly differ. In contrast, the digestion of beef, a model for red 
meat, resulted in the increased formation of O6-CMG and MDA in comparison to the digestion 
of pork and chicken. The formation of O6-CMG furthermore appeared to be higher in pork 
digests compared to chicken digests, hinting at a heme iron induced dose-response effect. As 
such, it could be concluded that red meat digestion significantly contributes to DNA alkylation 
(reflected by O6-CMG DNA adduct formation) and lipid peroxidation although the gastro-
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intestinal formation of O6-CMG strongly differed between individuals. In fact, it could be 
confirmed that the microbiota actively contributes to O6-CMG formation, which is a clear 
reflection of the interfering role of the gut microbiome in health and disease. 
 
Chapter III – Since a top-down DNA adductomics approach can facilitate the assessment of 
environmental exposure to genotoxic chemicals, a DNA adductomics methodology was 
developed to enable in-depth investigation of diet-, and more specifically, NOC- and LPO-
related DNA adduct formation. To this purpose, an in-house diet-related DNA adduct database, 
containing known alkylation as well as oxidation induced DNA adduct types, and a high 
resolution mass spectrometry (HRMS) based methodology were established. After optimization, 
the method proved to be specific, sensitive, selective, precise and true, whilst good to excellent 
linearity could also be confirmed. The in vitro and in vivo application of the described DNA 
adductomics methodology and workflow facilitated targeted (i.e. O6-CMG, O6-methylguanine, 
pyrimido[1,2-a]purin-10(1H)-one and α-methyl-γ-hydroxy-1,N2-propanoguanine) as well as 
untargeted DNA adduct detection and profiling, offering highly promising results and future 
prospects. The DNA adduct database expedited tentative DNA adduct identification and data 
interpretation. At first, the in-house diet-related DNA adduct database contained 123 different 
DNA adduct types, but the database is in fact updated continuously, allowing up-to-date and 
top-notch research. 
 
Chapter IV – Following the development of a HRMS-based DNA adductomics methodology, 
DNA adduct formation as a result of red vs. white meat digestion could be investigated more in-
depth. In chapter IV, the results from 2 different experimental setups are described. The first 
experimental setup included DNA adductome mapping of beef digests obtained by the in vitro 
simulation of (colonic) digestion using the fecal inocula of 5 healthy volunteers. The results 
revealed a strong interindividual variability with regard to the types and levels of DNA adduct 
formation. In addition, it could be observed that some DNA adduct types originated from the 
fecal inoculum (due to in vivo occurrence/formation), but were not actively formed during in vitro 
beef digestion, whilst others significantly increased during colonic beef digestion and/or only 
appeared after completion of colonic meat digestion. The second experimental setup focused on 
differences in MDA and DNA adduct formation upon red vs. white meat digestion, using the 
repeatedly collected fecal inocula of 2 selected volunteers. By means of the supplementation of 
calcium carbonate (CaCO3) to meat preparations, the possible interfering role of calcium, which 
is hypothesized to have CRC-protective attributes, on MDA and DNA adduct formation was 
assessed as well. The obtained results confirmed the earlier reported finding that red meat 
digestion stimulates MDA and O6-CMG DNA adduct formation. CaCO3 supplementation 
resulted in both toxic and anti-toxic effects; i.e. stimulation of O6-CMG production, but 
reduction of MDA formation. The mapped DNA adduct profile differed according to digested 
meat type, uncovering different putative DNA adducts associated with digestion of beef or 
chicken with or without supplemented CaCO3. More specifically, the formamidopyrimidine-
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adenine DNA adduct was found to be discriminative for meat digests without added CaCO3, 
whilst carboxyethylcytosine was significantly higher in beef digests, and methoxymethylcytosine 
(or its hydroxyethylcytosine isomer) was found to be lower in meat digests supplemented with 
CaCO3. These findings suggest that the gastrointestinal digestion of red meat indeed stimulates 
the formation of genotoxic metabolites, which can moreover be modulated by calcium.  
 
Chapter V – The work described in chapter V is a continuation of the work outlined in chapter 
IV. More specifically, chapter V focusses on in vitro DNA adductome mapping of red vs. white 
meat digests, but on a much larger scale; i.e. using the fecal inocula of 10 healthy volunteers. 
Additional experiments encompassing the digestion of myoglobin, the heme-containing meat 
protein, allowed more in-depth assessment of the genotoxic effects of heme-rich meat digestion. 
In total, 90 DNA adduct types could be (tentatively) identified, encompassing several known 
alkylation and (lipid per)oxidation induced DNA adducts like O6- and other methylguanines, O6-
CMG, methylthymine, ethylthymine, hydroxymethylhydantion, etc. The results demonstrate a 
significant interindividual variability, but for the vast majority, the observed DNA adduct levels 
increased during colonic meat digestion, suggesting active formation by the colonic microbiota. 
More importantly, a significantly more pronounced formation of 26 DNA adduct types, 
including e.g. O6-CMG and ethylthymine, could be observed upon red meat digestion compared 
to white meat digestion. More specifically, it could be observed that (1) the levels of 
hydroxymethylhydantion and a triple malondialdehyde cytosine (M3C) adduct, which are both 
oxidatively induced nucleobase alterations, were significantly higher after small bowel beef 
digestion (in comparison to chicken), and (2) 3 DNA adduct types; i.e. hydroxyethylthymine (or 
methoxymethylthymine), carboxyethylthymine, and 3,N4-ethenocytosine, demonstrated a 
significantly increased formation upon myoglobin addition. Multivariate statistics furthermore 
revealed 4 additional beef digestion markers; methyl-, ethyl-, hydroxymethyl-, and 
tetramethylthymine. As a result, those specific alkylation and/or oxidation induced DNA adduct 
types were singled out as potential heme-rich meat digestion markers, which is in support of the 
heme, NOC and LPO hypothesis. It furthermore confirms that DNA adduct formation may 
indeed contribute to red meat related CRC risk. 
 
Chapter VI – This chapter describes the investigation of shifts in the DNA adductome of rats 
due to red vs. white meat consumption and digestion. 24 Sprague-Dawley rats were divided into 
4 randomly composed groups and either fed a low or high fat beef diet, or a low or high fat 
chicken diet during 14 consecutive days, after which the DNA adductome of liver, duodenum 
and colon were mapped. Untargeted DNA adduct analysis revealed a distinctly different DNA 
adduct profile in liver, duodenum and colon. Several DNA adduct types appeared to be 
significantly different in tissue of rats that were fed a different meat based diet. The results 
yielded a list of 22 putative DNA adducts of interest; trihydroxybutyl-U, carboxyl-A, methyl-C, 
oxohexenal-C, 1,N2-propano-G, nitro-C, 2 isomers of malondialdehyde-2x-acetaldehyde-A, 
malondialdehyde-2x-G, 2 isomers of hydroxyhydro-C, heptenal-G, hydroxyethyl-C (or 
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methoxymethyl-C) and carbamoylhydroxyethyl-G DNA adducts appeared to be higher in beef 
fed rats when compared to chicken fed rats; hydroxybutyl-A, hydroxymethyl-A (or methyl-G or 
methoxy-A) and hydroxybutyl-G increased due to the daily consumption of a meat preparation 
with added lard; and a carboxyl-A isomer, a crotonaldehyde-G isomer, carboxymethyl-G (or 
glyoxal-G), carboxyethyl-G (or carboxyhydroxyethyl-A or methylglyoxal-G) and a 
malondialdehyde-2x-acetaldehyde-A isomer appeared to be significantly higher after the daily 
consumption and digestion of beef as well as lard. Yet again, these findings suggest that the 
gastrointestinal digestion of red meat stimulates the formation of genotoxic metabolites, 
resulting in the formation of alkylation and/or oxidation induced DNA adducts. In addition, it 
was demonstrated that dietary fat can induce shifts in the DNA adductome as well.  
 
Chapter VII – The final chapter of this dissertation summarizes and discusses the most 
prominent findings of this doctoral thesis, primarily focusing on the successful development of a 
DNA adductomics methodology and the in-depth profiling of diet-induced shifts in the in vitro 
and in vivo DNA adductome. Taking into account all obtained in vivo and in vitro results, 7 DNA 
adduct types, including O6-CMG, dimethyl- or ethyl-T, methyl-G, malondialdehyde-2x-G, 
heptanal-G and malondialdehyde-3x-C (M3C) could be singled out as potential red meat 
digestion biomarkers. This is highly relevant to the red meat-CRC hypothesis because the 
formation of these DNA adduct types can be traced back to alkylation and/or oxidation of 
DNA by e.g. NOCs and/or LPOs formed during red meat digestion. Increased lipid 
peroxidation due to the red meat digestion could be confirmed on multiple occasions, but the 
hypothesized origin of DNA alkylation (i.e. NOCs) could not be identified. Therefore, follow-up 
research to further unravel the role of DNA adduct formation in the red meat-CRC pathway, 
and the mutagenic potential and human in vivo relevance of these particular DNA adduct types is 
highly recommended. In this context, the implementation of complimentary omics techniques 
would furthermore be highly beneficial, allowing more in-depth (follow-up) CRC-research. In 
particular, fusion of DNA adductomics, metagenomics and metabolomics offers favorable future 
prospects. At the time, the field of DNA addductomics encounters 2 major bottlenecks due 
restrictions with regard to DNA sample size and confident DNA adduct identification. 
Improvement of (the use of) hybrid HRMS as well as implementation of chromatographic 
innovations may however provide a remedy in the near future.  
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Epidemiologisch onderzoek heeft aangetoond dat de consumptie van rood en verwerkt vlees 
significant bijdraagt tot het risico op de ontwikkeling van dikke darmkanker (DDK). De 
onderliggende oorzaak werd nog niet volledig opgehelderd, hoewel er, over de jaren heen, reeds 
verschillende verklarende hypotheses naar voor geschoven werden. De ‘haemhypothese’ kan 
vandaag de dag op de grootste bijval rekenen. Deze hypothese steunt op het feit dat de 
consumptie van rood, maar niet wit vlees gelinkt wordt aan de ontwikkeling van DDK en dat 
rood vlees, zoals bv. rundvlees, beduidend meer haem bevat dan wit vlees, zoals bv. kip. De 
opname van haem zou ervoor zorgen dat de endogene vorming van N-nitrosoverbindingen 
(NOC’s) en vetperoxidatieproducten (VPO’s) in het gastro-intestinaal stelsel gestimuleerd wordt. 
Aangezien zowel NOC’s als VPO’s geno- en cytotoxische effecten kunnen uitoefenen, kan dit 
proces mogelijk bijdragen tot de ontwikkeling van kanker. In het kader van dit doctoraat werd 
onderzoek verricht naar de mogelijke carcinogene effecten van de consumptie van rood vlees. 
Hierbij werd voornamelijk gefocust op de opsporing van NOC en VPO gerelateerde DNA-
schade, meer bepaald DNA-adducten. Dit alles werd uitgewerkt en neergeschreven in 7 
verschillende hoofdstukken. 
 
Hoofdstuk I – Het eerste hoofdstuk van deze doctoraatsthesis bevat een algemene introductie 
over dieetgerelateerde carcinogenese. Dit wordt onder meer uitgelegd aan de hand van enkele 
belangrijke feiten en cijfers, met bijzondere aandacht voor de mogelijke oorzaken en gevolgen 
van kanker. Wat volgt, is een uitdieping van de term ‘DNA adductomics’ en de situering van het 
DNA-adductoom in en ten opzichte van het exposoom. Hierna wordt een overzicht gegeven 
van alle huidige kennis omtrent de vorming van DNA-adducten onder invloed van de 
consumptie van bepaalde voedingsmiddelen en de associatie met de ontwikkeling van kanker. 
Het belang van DNA-adducten in onderzoek naar dieetgerelateerde, en dan vooral 
vleesconsumptiegerelateerde carcinogenese wordt hierbij gedemonstreerd. Om dit 
doctoraatsonderzoek duidelijk te situeren, wordt vervolgens een overzicht gegeven van alle 
huidige hypotheses omtrent de ontwikkeling van DDK ten gevolge van de consumptie van rood 
en verwerkt vlees. In deze context wordt het belang van DNA-adductonderzoek nogmaals 
verduidelijkt en wordt er tevens aandacht geschonken aan de praktische noden van onderzoek 
naar de vorming van DNA-adducten. Finaal wordt de specifieke focus en het doel van dit 
doctoraatsonderzoek uitgelijnd. 
 
Hoofdstuk II – In hoofdstuk II wordt het effect van de consumptie van rood vlees op 
celviabiliteit, gastro-intestinale metabole activiteit, de vorming van NOC’s, alkylatie van DNA en 
vetperoxidatie onderzocht. Hiertoe werd de vertering van rundvlees, varkensvlees en kip 
gesimuleerd onder in vitro omstandigheden, zodoende de invloed van de bekomen vleesdigesten 
op (1) cytotoxiciteit, (2) gastro-intestinale metabolische activiteit onder de vorm van de productie 
van korteketenvetzuren, (3) de vorming van NOC’s, door middel van bepaling van ‘Apparent 
Total N-nitroso Compounds’, (4) de vorming van het vetperoxidatieproduct malondialdehyde 
(MDA) en (5) de alkylatie van DNA onder de vorm van de productie van O6-
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carboxymethylguanine (O6-CMG) na te gaan. De resultaten van deze analyses toonden aan dat 
de vertering van het kip, varkens- of rundvlees geen aanleiding gaf tot significante verschillen in 
cytotoxiciteit en korteketenvetzuurproductie. Daarentegen gaf de vertering van rund, als model 
voor rood vlees, wel aanleiding tot een verhoogde aanmaak van O6-CMG en MDA in 
vergelijking met varken of kip. De vorming van O6-CMG bleek bovendien hoger onder invloed 
van de vertering van varkensvlees in vergelijking met kip, wat een haemijzer gerelateerde dosis-
respons relatie suggereert. Er kon dan ook besloten worden dat de vertering van rood vlees 
significant bijdraagt tot de alkylatie van DNA (onder de vorm van O6-CMG-productie) en 
vetperoxidatie, hoewel de vorming van O6-CMG sterk persoonsgebonden is. Daarenboven kon 
vastgesteld worden dat het fecaal microbioom actief bijdraagt aan de vorming van O6-CMG, een 
reflectie van het feit dat het gastro-intestinaal microbioom een belangrijke rol speelt in zowel 
ziekte als gezondheid.  
 
Hoofdstuk III – Onderzoek naar de vorming van DNA-adducten op een niet-gerichte manier, 
nl. met behulp van DNA-adductomics, kan een grote bijdrage betekenen voor de correcte 
inschatting van de blootstelling aan genotoxische verbindingen in ons leefmilieu. In deze context 
beschrijft hoofdstuk III de ontwikkeling, validatie en toepassing van een DNA-adductomics 
methodologie die een diepgaander onderzoek naar de vorming van NOC- en VPO-gerelateerde 
DNA-adducten in relatie tot het dieet mogelijk maakt. Meer specifiek werd hiertoe een database 
met voedingsgerelateerde DNA-adducten opgesteld en een analytische methode ontwikkeld die 
gebruik maakt van hoge resolutie massaspectrometrie (HRMS). De HRMS-methode werd 
geoptimaliseerd en gevalideerd om een voldoende hoge specificiteit, gevoeligheid, selectiviteit, 
juistheid en precisie te garanderen. De beschreven methodologie creëert de mogelijkheid om 
DNA-adducten zowel op een gerichte (omvat de detectie van O6-CMG, O6-methylguanine, 
pyrimido[1,2-a]purin-10(1H)-one en α-methyl-γ-hydroxy-1,N2-propanoguanine)  als ongerichte 
manier te detecteren. Een demonstratie van de in vitro en in vivo toepassing leverde veelbelovende 
resultaten en toekomstperspectieven. Het gebruik van de eigen DNA-adductdatabase 
vergemakkelijkte daarenboven de DNA-adductidentificatie en data-interpretatie. Initieel bevatte 
de database zo’n 123 verschillende dieetgerelateerde DNA-adducten. Sindsdien wordt de 
database voortdurend bijgewerkt om te allen tijde kwaliteitsvol onderzoek af te leveren. 
 
Hoofdstuk IV – Na de ontwikkeling van een HRMS DNA-adductomics methodologie, kon een 
diepgaander onderzoek naar de vorming van DNA-adducten ten gevolge van de vertering van 
rood vs. wit vlees aangevat worden. In deze context omschrijft hoofdstuk IV de uitwerking van 2 
verschillende experimenten. In het eerste experiment werd het DNA-adductoom van 
rundvleesdigesten in kaart gebracht, gebruik makende van de fecale inocula van 5 gezonde 
vrijwilligers. Dit toonde aan dat het gastro-intestinaal DNA-adductoom een sterke 
interindividuele variatie vertoont; de detectie van welbepaalde DNA-adducten kon teruggeleid 
worden naar hun aanwezigheid in het fecaal inoculum (door de natuurlijke aanwezigheid en/of 
vorming in het lichaam), terwijl andere types DNA-adducten pas gedetecteerd konden worden 
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na simulatie van de vertering in de dikke darm. Afhankelijk van het type DNA-adduct, leidde de 
in vitro vertering van rundsvlees tot een concentratiestijging of -daling. Het tweede experiment 
maakte het mogelijk om de verschillen in vetperoxidatie en DNA-adductproductie bij de 
vertering van rood en wit vlees te vergelijken, gebruik makende van de fecale inocula van 2 
gezonde vrijwilligers. Door de supplementatie van vlees met calciumcarbonaat (CaCO3) kon 
bovendien een inschatting gemaakt worden van de interfererende invloed van calcium, wat van 
belang is omdat de consumptie van calcium reeds gelinkt werd met een verlaagd risico op DDK. 
De resultaten van dit experiment toonden wederom aan dat de vertering van rood vlees (in 
vergelijking met de vertering van wit vlees) aanleiding geeft tot een toename van MDA en O6-
CMG. De toevoeging van CaCO3 aan vleesbereidingen resulteerde daarentegen in een reductie 
van de productie van MDA, maar een verhoogde productie van O6-CMG. Zoals verwacht, 
wijzigde ook het DNA-adductoom naargelang het type vlees dat verteerd werd. Bepaalde types 
DNA-adducten konden hierbij gelinkt worden aan de vertering van rund of kip, of het feit of 
CaCO3 al dan niet toegevoegd werd aan de vleesbereiding. Meer specifiek bleek 
carboxyethylcytosine significant verhoogd na de vertering van rood vlees, terwijl de 
formamidopyrimidine-adenine en methoxymethylcytosine (of z’n hydroxyethylcytosine isomer) 
DNA-adducten beduidend frequenter aangetroffen konden worden in vleesdigesten zonder 
toegevoegd CaCO3. Deze bevindingen tonen aan dat de vertering van rood vlees aanleiding kan 
geven tot de vorming van genotoxische verbindingen en dat calcium deze effecten kan 
moduleren. 
 
Hoofdstuk V – In hoofdstuk V wordt het werk uit hoofdstuk IV verdergezet; wijzigingen in het 
in vitro gastro-intestinaal DNA adductoom ten gevolge van de vertering van rood vs. wit vlees 
wordt verder in kaart gebracht, dit keer gebruik makende van de fecale inocula van 10 gezonde 
vrijwilligers. Een bijkomend experiment met de toevoeging van myoglobine, het vleeseigen 
proteïne die de haemmolecule bevat, liet daarenboven toe om de genotoxische effecten van vlees 
rijk aan haem, diepgaander te bestuderen. In totaal konden 90 DNA-adducttypes, waaronder 
verschillende alkylatie- en oxidatie-geïnduceerde DNA-adducten zoals O6- en andere 
methylguanines, O6-CMG, methylthymine, ethylthymine, hydroxymethylhydantion, etc., 
gedetecteerd worden. Opnieuw vertonen de resultaten een uitgesproken interindividuele 
variabiliteit. De grote meerderheid van de gedetecteerde DNA-adducten vertoonde een stijging 
na (gesimuleerde) dikke darmvertering, wat een actieve vorming door de dikke darmmicrobiota 
doet vermoeden. Van groot belang is de detectie van 26 DNA-adducttypes, waaronder o.a. O6-
CMG en ethylthymine, die beduidend hogere concentraties vertoonden bij de vertering van rood 
vlees in vergelijking met de vertering van wit vlees. Zo kon onder meer vastgesteld worden dat 
(1) de concentratie van het hydroxymethylhydantion DNA-adduct en een MDA-geïnduceerd 
cytosine adduct (M3C), beiden het indirect resultaat van (vetper)oxidatie, significant hoger waren 
in digesten van rood vlees (in vergelijking met wit vlees) na de dunne darmsimulatie en (2) de 
vorming van 3 andere DNA-adducten, met name hydroxyethylthymine (of 
methoxymethylthymine), carboxyethylthymine, en 3,N4-ethenocytosine, significant steeg onder 
invloed van de aanwezigheid van toegevoegd myoglobine. Daarnaast kon multivariate statistiek 
aantonen dat digesten van rood vlees onderscheiden kunnen worden van de digesten van wit 
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vlees op basis van de productie van methyl-, ethyl-, hydroxymethyl-, en tetramethylthymine. 
Bijgevolg konden bovenstaande DNA-adducten opgelijst worden als mogelijke biomerkers voor 
de vertering van rood vlees. Gezien hun vorming resulteert uit de alkylatie en/of oxidatie van 
DNA, ondersteunen deze bevindingen de NOC-, VPO- en haemhypothese, waardoor kan 
besloten worden dat de vorming van DNA-adducten weldegelijk een rol kan spelen bij de 
ontwikkeling van DDK. 
 
Hoofdstuk VI – Dit hoofdstuk beschrijft de studie van de wijzigingen in het DNA-adductoom 
van ratten onder invloed van de opname en vertering van rood vs. wit vlees. 24 ratten (Sprague-
Dawley) werden willekeurig ingedeeld in 4 verschillende groepen die een vast dieet met kip of 
rund, al dan niet met toegevoegd vet, gevoederd werden. Het dieet werd aangehouden gedurende 
14 dagen, waarna lever-, duodenum- en colonstalen verzameld werden om het DNA-adductoom 
in kaart te brengen. DNA adductomics onthulde dat het lever-, duodenum- en colonweefsel een 
significant verschillend DNA-adductprofiel vertoonden. Bovendien bleek het DNA-adductoom 
significant verschillend bij ratten die een ander dieet kregen. Maar liefst 22 DNA-adducten 
bleken van bijzonder belang te zijn, waaronder trihydroxybutyl-U, carboxyl-A, methyl-C, 
oxohexenal-C, 1,N2-propano-G, nitro-C, 2 malondialdehyde-2x-acetaldehyde-A isomeren, 
malondialdehyde-2x-G, 2 hydroxyhydro-C isomeren, heptenal-G, hydroxyethyl-C (or 
methoxymethyl-C) en carbamoylhydroxyethyl-G die significant frequenter voorkwamen in de 
weefsels van ratten die gevoederd werden met rundsvlees in vergelijking met ratten die kip te 
eten kregen. De concentraties van 3 andere DNA-adducten, nl. hydroxybutyl-A, hydroxymethyl-
A (of methyl-G of methoxy-A) en hydroxybutyl-G, namen significant toe onder invlooed van de 
dagdagelijkse consumptie van extra dierlijk vet, terwijl een carboxyl-A isomeer, een 
crotonaldehyde-G isomeer, carboxymethyl-G (of glyoxal-G), carboxyethyl-G (of 
carboxyhydroxyethyl-A of methylglyoxal-G) en een malondialdehyde-2x-acetaldehyde-A isomeer 
beduidend hogere concentraties vertoonden na de consumptie van zowel rund als toegevoegd 
dierlijk vet (in vergelijking met een dieet met kip of een vetarm dieet). Dit alles bevestigt dat de 
vertering van rood vlees de vorming van genotoxische verbindingen in de hand kan werken, met 
de mogelijke alkylatie en/of oxidatie van DNA tot gevolg. Bovendien lijkt niet alleen het type 
vlees dit proces te beïnvloeden, maar ook de hoeveelheid geconsumeerd dierlijk vet.  
 
Hoofdstuk VII – Het laatste hoofdstuk van dit proefschrift vat alle bekomen resultaten samen 
en bespreekt de belangrijkste bevindingen. De focus ligt hierbij op de ontwikkeling van een 
DNA adductomics methodologie en de uitgebreide profilering van wijzigingen in het in vitro en in 
vivo DNA-adductoom onder invloed van de vertering van vlees. Wanneer alle in vitro en in vivo 
resultaten gebundeld worden, blijkt dat 7 verschillende DNA-adducten een sterke associatie 
vertonen met de vertering van rood vlees; het betreft O6-CMG, dimethyl- or ethyl-T, methyl-G, 
malondialdehyde-2x-G, heptanal-G en malondialdehyde-3x-C (M3C). Aangezien deze DNA-
adducten gevormd worden door de alkylatie en/of oxidatie van DNA door genotoxische 
verbindingen zoals bv. NOC’s en VPO’s, zijn deze bevindingen uiterst relevant voor de rood 
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vlees-DDK hypothese. In lijn met deze resultaten, kon een toename in vetperoxidatie kon 
meermaals aangetoond worden, hoewel dit niet het geval was voor de vorming van NOC’s. 
Bijgevolg is bijkomend onderzoek noodzakelijk om de rol van de vorming van DNA-adducten 
in relatie tot de consumptie van rood vlees en de ontwikkeling van DDK volledig op te helderen. 
Bevestiging van de humane in vivo relevantie van de teruggevonden DNA-adducten is daarbij van 
groot belang. In deze context zou het simultaan gebruik van complementaire omics technieken 
een grote meerwaarde betekenen. Zo biedt de fusie van metagenomics, metabolomcis en DNA-
adductomics erg gunstige toekomstperspectieven, met de belofte van diepgaander fundamenteel 
(vervolg)onderzoek. Wat betreft het gebruik van DNA-adductomics, moet vermeld worden dat 
dit onderzoeksveld kampt met 2 belangrijke knelpunten door beperkingen met betrekking tot de 
beschikbare staalgrootte (hoeveelheid DNA) en de onweerlegbare identificatie van gedetecteerde 
DNA-adducten. De optimalisatie van (het gebruik van) MS-hybriden en de implementatie van 
chromatografische innovaties kan hierbij echter soelaas bieden.  
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intake induce DNA adduct formation in rat liver, duodenum and colon. 18th Gut Day 
Symposium, 2016, poster presentation, Venlo, The Netherlands. 
 
Rombouts C, Hemeryck LY, Van Hecke T, De Smet S, De Vos W, Vanhaecke L. Untargeted 
metabolomics of colonic digests reveals kynurenine pathway metabolites, dityrosine and 3-
dehydroxycarnitine as red versus white meat discriminating metabolites. 18th Gut Day 
Symposium, 2016, oral presentation by Rombouts C, Venlo, The Netherlands. 
 
Rombouts C, Hemeryck LY, Van Hecke T, De Smet S, De Vos W, Vanhaecke L. Mass 
spectrometry based untargeted metabolomics of colonic digests reveals tryptophan catabolites, 
dityrosine and 3-dehydroxycarnitine as red versus white meat discriminating microbial 
metabolites. Belgian Association for Meat Science and Technology Symposium (BAMST), 2016, 
oral presentation by Rombouts C, Melle, Belgium. 
 
 
AWARDS & GRANTS 
1. Prize for the best Master Thesis in Veterinary Medicine, option Research, class of 2012. 
2. Award (First prize) for an Outstanding Scientific Communication at the ‘BELTOX 
Annual Meeting' at Louvain-La-Neuve, 6th of December 2013. 
3. FWO Grant for participation in a conference abroad (NuGO week in Copenhagen 
(Denmark), 5 – 9 September 2016). 
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Waarschijnlijk zullen menig onder jullie dit woordje van dank lezen terwijl ikzelf me op datzelfde 
moment nog doorheen mijn presentatie of vragenronde worstel. Zo ja, … betrapt!  
Hoe dan ook, ik neem het je niet kwalijk, het dankwoord is dan ook steevast het eerste dat ik bij 
dergelijke omstandigheden onder de loep neem. Dus … veel leesplezier, maar probeer ook nog 
een beetje op te letten hé! ;-)  
Mijn verhaal begint meer dan 5 jaar geleden, tijdens mijn masterjaren. De prikjes en verbandjes 
boeiden mij al een tijdje niet meer - mijn excuses voor deze verontrustende bekentenis - maar het 
radarwerk van het leven; de onderliggende fysiologie en (bio)chemie daarentegen des te meer. 
Vandaar mijn keuze om mijn kinderdroom van een dierenartsenpraktijk aan de kant te schuiven - 
tot grote spijt van mijn vader - en te kiezen voor het wetenschappelijk onderzoek. De eerste stap 
was het uitwerken van een onderzoeksmasterproef. Ik kwam nagenoeg meteen terecht bij de 
vakgroep veterinaire volksgezondheid en voedselveiligheid, meer specifiek onder de (bege)leiding 
van de 2 Julie’s (“K.” en “VDB”) en Lynn, a.k.a. Prof. Vanhaecke. Het onderwerp had iets met 
vlees te maken, maar uitgezonderd de analytiek - jeweetwel, die massaspectrometer - is er 
nagenoeg geen link met mijn doctoraatsonderwerp. Hoe dan ook, de ‘endogene vorming van 
thiouracil bij nutsdieren’ was mijn eerste kennismaking met het wetenschappelijk onderzoek en 
de toen nog bijzonder abstracte massaspectrometer. De kennismaking bleek een succes, want ik 
bleef plakken; in de zomer van 2012 werd ik aangesteld als assistent en doctoraatsstudent aan 
diezelfde vakgroep, wederom onder de fantastische begeleiding van Lynn, a.k.a. Prof. Vanhaecke. 
Het waren 4, bijna 5, bijzondere jaren met ups en downs, vallen en weer opstaan. Zoals het 
cliché wil, heeft het mij zweet, tranen, en ja, zelfs wat bloed - ik weet sinds kort de EHBO-doos 
staan! - gekost. Gelukkig heeft het mij nog veel meer opgebracht; een ruime wetenschappelijke 
achtergrond, werkervaring, mensenkennis, vrienden, en ‘last but not least’ … een nieuwe titel om 
te showen bij de bank, en op mijn visitekaartje - welja, laten we daar toch al even van uitgaan :-p. 
Er zijn verschillende mensen die, elk op hun eigen manier, een steentje hebben bijgedragen aan 
dit doctoraatsavontuur. Dit is dan ook de ideale gelegenheid om al die mensen letterlijk of 
figuurlijk in de bloemetjes te zetten. 
Eerst en vooral zou ik Lynn, a.k.a. mijn promotor Prof. Vanhaecke, willen bedanken voor haar 
uitstekende begeleiding, steun, vertrouwen, enthousiasme, werk- en strijdlust. Niet alleen ik, maar 
al je doctoraten mogen hun twee handjes kussen met een promotor als jij. Je bent altijd bereid 
om je doctoraten bij te staan met raad en daad, desondanks die overvolle agenda. Heel erg 
bedankt! 
Specifiek met het oog op vandaag, wil ik alle leden van de examencommisie bedanken. Prof. 
Decostere, Prof. Sanders, Prof. Hesta, Prof. De Smet alsook Dr. Moore en Prof. Dragsted - die 
hier hoogstwaarschijnlijk geen woord van verstaan -, bedankt om mijn werk zo aandachtig te 
lezen en zeker en vast ook bedankt voor de positieve en/of kritische commentaren. Die eerste 
zijn altijd fijn om te horen, die laatste een echte meerwaarde voor dit doctoraat en de 
verderzetting van dit onderzoek. 
Aan alle LCA-collega’s, bedankt voor de fijne tijd op het labo - die hopelijk nog een tijdje mag 
blijven duren. Ieder van jullie heeft iets bijgedragen aan dit doctoraat, al gaat het maar over al het 
  
 
Dankwoord 
 
  
310 
 
  
gelach en gezever tussendoor - en ja, ook de nodige portie drama, maar ik noem geen namen :-p. 
Jella, Julie VDB, Lieven, Julie K., Nathalie, Anneleen, Gabriel, Kaat, Caroline, Steve, Ellen en 
Simon, bedankt! Dirk, Mieke, Joke en Beata, jullie mogen zeker niet ontbreken; bedankt voor alle 
praktische tips & tricks en de vele helpende handen. Wendy, en destijds ook Soektin, bedankt 
voor het verlichten van alle administratieve rompslomp. Tevens bedankt aan alle LHT- en oud-
collega’s die in dit lijstje ontbreken. 
Bedankt ook aan alle externe collega’s, en dan denk ik voornamelijk aan het MEATNOX-
consortium; Stefaan, John, Marc, Carl, Winnok, Charlotte, Els, Sophie en zeker ook Thomas, 
bedankt voor de jarenlange ondersteuning en bijzonder fijne samenwerking! 
Misschien ook een bedankje voor de studenten die ik overheen de jaren begeleid heb tijdens de 
practica, het labo-werk en het neerschrijven van hun allereerste (semi-)wetenschappelijke 
schrijfsels. Ik heb ontelbaar keer gezucht, met mijn ogen gerold, boos gekeken - nee, dat laatste 
niet louter omwille van mijn ‘resting bitch face’, maar soms weldegelijk bewust - en zelfs een 
enkele keer mijn neus opgetrokken omdat er iets fout liep of iemand de avond ervoor te diep in 
het glas gekeken had en sindsdien wat slaap en duidelijk ook de afslag naar de douche gemist had. 
Desondanks zal ik zeker niet ontkennen dat ze mij geholpen hebben met mijn 
doctoraatsonderzoek, mij op z’n minst een beetje geduld hebben bijgebracht en ik er dus zeker 
en vast zelf ook iets uit geleerd heb.  
En dan kom ik toe aan de mensen die mij het beste kennen - en mijn ‘resting bitch face’ al 
helemaal gewoon zijn -, mijn vrienden en familie. 
De bio’s - met een ‘ir’ en een puntje -, hun opvoeders en de verloren gelopen bankdirecteur; 
Geert, Katrien, Jochen, PJ, Ken, Maaike, Kim en Jelle, bedankt voor de vele ‘komen eten’-
momenten. Binnenkort spreken we af in de speeltuin! #babyboom 
Dries en Beatrijs, de ene vriendschap gaat al wat langer mee dan de andere en ik hoop alvast dat 
we er nog vele jaren bij kunnen doen! Gust en ‘Jefke’ kunnen binnenkort de traditie verderzetten. 
#boyswillbeboys 
Aan alle dreamteamleden - inclusief de overgelopen ex-collega’s - Julie, Anneleen, Gerty, Karen 
en Iza, bedankt voor alle gekke momenten, nachtelijke filosofische gesprekken en dronken 
liefdesverklaringen. Nico, Tom, Tim, Stijn, Timen en Davy, bedankt om al dat feministisch 
geweld en de vele decibels te trotseren, maar, geef toe, jullie zouden het niet anders willen ;-). 
#dreamteamlove #chemistry #hashtagmadness 
Cindy en Didier - a.k.a. CinDidi - Ben, Sofie en de kids, bedankt voor alle knuffels, fijne 
gesprekken en dolle avonturen. #vierkantenzijnsaai 
Heleen en Bruno, bedankt voor de lach na de traan, samen met Ellebelle. 
Mémé, alle tantes en nonkels, bedankt voor de leuke familiemomenten. Bedankt om er gewoon 
te zijn. Het feit dat jullie te allen tijde klaar staan om te helpen waar nodig is van onschatbare 
waarde. 
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Willy en Marleen, bedankt om mij, ondertussen al meer dan 13 jaar geleden, in jullie armen te 
sluiten. 
Mama en papa, het is werkelijk onmogelijk om op te lijsten waarvoor ik jullie allemaal moet 
bedanken en de lijst blijft alleen maar groeien. Jullie hebben mij alle kansen gegeven, zowel op als 
naast de schoolbanken. Ontzettend bedankt voor de onvoorwaardelijke liefde en steun, ik zal het 
nooit vergeten. 
Desondanks het feit dat ik niet meteen van plan ben om alsnog als praktiserend dierenarts aan de 
slag te gaan, zijn de beestjes nog steeds alomtegenwoordig in mijn leven. Tot enkele jaren terug 
woedde nog steeds de paardengekte. Doordat er zoveel te beleven valt en er dus zoveel andere 
zaken zijn die mijn tijd opslorpen, zijn Freedom en Franco Ferre ietwat op de achtergrond 
verdwenen. Niet altijd gemakkelijk, maar ik weet dat ze ten volle genieten van het malse gras op 
de Moerse weiden, vergezeld door een kudde geiten en 2 knotsgekke border collies. Gelukkig 
lopen er bij mij thuis nog 3 schattige haarballen - Dora, Loïs en Flo - rond die altijd bereid zijn 
om gevoederd te worden, aan de deur te krabben en languit op de vensterbank te soezen. Ze 
zullen het nooit weten, maar hun knuffels - al dan niet vrijwillig - en status van levend meubel, 
slagen er altijd in om mij te ontstressen. #geiteboeremeid #paardenzot #crazycatlady. 
En tot slot, lieve Evert, die ik reeds leerde kennen in 2003 - de tijd gaat snel - en ondertussen 
nog steeds aan mijn zijde vertoeft... we hebben heel wat ups en downs gekend - zoals iedereen -, 
maar de laatste jaren zijn de ups duidelijk aan de bovenhand. Sommigen vragen zich 
waarschijnlijk nog altijd af hoe wij het bij elkaar uithouden. Jij de gekooide tijger, ik het brave 
meisje..., maar gelukkig weten wij wel beter wie in werkelijkheid de scherpste klauwen heeft ;-). 
Bedankt om er altijd voor mij te zijn, mij ‘onder dwang’ en met een grote grijns te knuffelen als 
ik - weeral - een beetje boos ben, dan toch in het cliché man/vrouw patroon te vervallen als het 
mij goed uitkomt, voor de vele spontane slows en gekke dansjes, bijzonder foute opmerkingen, 
en vooral ook het over-the-top ‘eigen kweek’-Engels.  
Thank you very muchers! #mylove #kisskiss 
Evert, onze toekomst lijkt alvast bijzonder rooskleurig. En hoewel ik er niet bepaald naar uitkijk 
om ’s morgensvroeg of middenin de nacht op te staan, begin ik meer en meer te verlangen naar 
ons volgend projectje, a.k.a. ‘Jefke’. Ik hoop alvast dat hij op zijn papa lijkt :-). #mybabyboy 
 
 
Lieselot 
Merelbeke, 15 mei 2017 
 
 
